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ABSTRACT 
 
PERCEIVED BARRIERS OF HIV STATUS DISCLOSURE OF PREGNANT 
WOMEN TO THEIR PARTNERS IN THE CAPRICORN DISTRICT, LIMPOPO 
PROVINCE 
 
STUDENT NUMBER:  33878560 
STUDENT:    MAPULA ENNIA SEROTO 
DEGREE:    MASTER IN NURSING SCIENCES 
DEPARTMENT OF HEALTH STUDIES, UNIVERSITY 
OF SOUTH AFRICA 
SUPERVISOR:   DR ES JANSE VAN RENSBURG 
 
Disclosure of a Human Immunodeficiency Virus (HIV) positive status is vital for 
prevention and promotion of the couple‟s health. The study aimed to investigate the 
perceived barriers of pregnant women diagnosed as HIV positive towards disclosure 
of their HIV status to their partners in the Capricorn District, Limpopo Province. 
Recommendations were formulated to enhance the self-efficacy. 
 
A quantitative, explorative, descriptive cross-sectional design and the Health Belief 
Model theory was used. Non-probability, convenience sampling utilised and 170 
respondents aged 18-40 years participated in the study. A questionnaire was used to 
collect data and the SSPS version 24.0 was utilised to analyse data. Overall, 87.64% 
respondents received disclosure education and 80% disclosed their status to their 
partners. Reasons for non-disclosure included fear of rejection, violent behaviour, 
blame and stigmatisation by partners. Health care workers should provide pregnant 
women with information on preventive strategies to enhance disclosure of HIV 
status. 
 
Keywords:  
Barriers, disclosure, Health Belief Model, HIV positive status and partners, 
pregnancy. 
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CHAPTER 1 
ORIENTATION TO THE STUDY 
 
1.1 INTRODUCTION 
 
Chapter 1 will provide an overview of the concept of Human Immunodeficiency 
Virus (HIV) status disclosure, the background, problem statement, purpose, 
objectives, theoretical foundation, methodology, and ethical aspects of the 
dissertation. 
 
Pregnant women‟s disclosure of their HIV status to their partners is essential for 
the prevention and spread of HIV, mother-to-child transmission (MTCT), lowering 
viral load, and adherence to treatment (Walcott, Hatcher, Kwena & Turan 2013:1). 
During pregnancy, women are at considerably higher risk of HIV acquisition (male-
to-female) and transmission (female-to-male). Disclosure may particularly be 
crucial for pregnant women to lower mortality and morbidity rates. 
 
The United Nations Programme on HIV/AIDS (UNAIDS 2015:2) reported that the 
HIV epidemic affected 36.9 million people globally in 2014. Thirty-four point three 
(34.3) million of these were adults, and 17.4 million were women. The total number 
of newly infected people with HIV in 2014 was 2 million (1.8 million adults). 
According to the Global AIDS update (UNAIDS 2016:2), there were 1.9 million new 
infections worldwide in 2015 compared to 2.2 million new infections worldwide in 
2010. The slight decline in new infections indicates that health professionals need 
to ensure on-going awareness and counselling for health care users (including 
pregnant women) and community members to increase HIV status disclosure. This 
may contribute to the decline of newly infected individuals. 
 
Pregnant women are at risk of transmitting HIV to their unborn babies through 
MTCT, to their partners, and they can also be re-infected. Pregnant women are 
offered HIV testing during antenatal clinic visits. These visits create a platform for 
health care workers to provide pre-test and post-test counselling, and disclosure 
education. Although pregnant women are given this opportunity to know their 
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status, it seems to be difficult for some to disclose their status to their partners. 
Disclosing an HIV positive status to their partners can assist the pregnant women 
to adhere to treatment protocols and provide them with support. 
 
The maternal mortality ratio in Capricorn district was reduced from 98 to 87 deaths 
per 100 000 in 2014/2015 but remained the second highest district in the South 
Africa compared with absolute number of maternal deaths (Department of Health 
2017:11). According to Alemayehu, Aregay, Kalayu and Yebyo (2014:3) in the 
study conducted in Ethiopia, 36% of HIV positive pregnant women did not disclose 
their status to their partners, causing concern for the researcher. This prompted 
the researcher to investigate if there are barriers for pregnant women to disclose 
their HIV status to their partners in the Capricorn District, Limpopo Province. 
 
1.2 BACKGROUND INFORMATION ABOUT THE RESEARCH PROBLEM 
 
According to the UNAIDS (2017:14) report, the estimated number of deaths from 
HIV-related causes in 2016 by region was as follows: Eastern and Southern Africa: 
420 000, Western and Central Africa: 310 000, Middle East and North Africa: 
11 000, Asia and the Pacific: 170 000, Latin America: 36 000, Caribbean: 9400, 
Eastern Europe and Central Asia: 40 000, Western and Central Europe and North 
America: 18 000. A total of 1 000 000 people globally. Africa had the highest 
number of people dying from HIV-related causes. According to the Saving Mothers‟ 
Report 2011-2013 (National Department of Health (NDoH) 2014), the Sixth report 
on Confidential Enquiries into Maternal Deaths in South Africa, non-pregnancy 
related infections (including HIV) remained the largest category of maternal deaths. 
The Saving Mothers‟ Report (NDoH 2014) also reveal an estimated 53.47% 
women died due to non-pregnancy related infections (NPRI). Ninety percent (90%) 
of cases in the NPRI group were infected with HIV, while 3.6% of the cases had an 
unknown HIV status, and 6.6% of the cases were HIV negative. The HIV positive 
mothers may deliver HIV positive babies, which may lead to an HIV positive 
community and complications such as ill health, which will put pressure on the 
health system. 
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UNAIDS (2016:8) reported that in 2015, new HIV infections among adults globally 
by age and sex was as follows: females 25+ years were at 27%, while 20% of 15 
to 24 years‟ old were newly infected. Males 25+ years were at 39%, while 14% 
were newly infected among the 15 to 24 year age group. According to UNAIDS 
(2016:8) new infections among adults in Sub-Saharan Africa, by age and sex in 
2015 were as follows: females 25+ years was at 31%, and 25% were from 15 to 24 
years old, while males were reported at 31% in the 25+ age group, and 12% for the 
15 to 24 year olds. Twelve percent (12%) of males were newly infected with HIV in 
the age group 15 to 24 years, which was less than the 25% of women in the same 
age group who were also newly infected with HIV. A similar rate of 31% was 
reported in the age group 25+ years for both males and females in Sub-Saharan 
Africa in 2015. 
 
According to UNAIDS (2016:8), there is a discrepancy between the percentage of 
new HIV infections among similar age females and males. Women aged 15-24 
years had a new infection rate of 25% while men in the same age group had an 
infection rate of 12%. The 15-24 year old females are of child-bearing age, 
therefore disclosure of HIV status might help to reduce the spread of infection and 
MTCT. This is an area were health care workers can provide information on HIV 
status disclosure through disclosure education of young females and their partners 
during antenatal visits to reduce the spread of the infection. Females are more 
aware of their HIV status as they are offered HIV testing at antenatal clinic visits. It 
is unclear why this discrepancy in the percentage of new infections between males 
and females exists. Several aspects can contribute, for instance the female 
anatomy (as discussed later in this chapter) (van Dyk, Tlou & van Dyk 2017:51). 
According to the study conducted in the United States by Chandler, Anstey, Ross 
and Morrison-Beedy (2016:2), college women frequently engaged in unprotected 
sex (sex without condoms), often with multiple partners. These practices expose 
them to HIV infection. 
 
UNAIDS (2016:8) reports that South Africa was severely affected by HIV, with an 
estimated 7 million people living with HIV. There were 380 000 new infections in 
2015 and in the same year 180 000 South Africans died from acquired immune 
deficiency syndrome (AIDS) related illnesses. The National Consolidated Guidelines 
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for Prevention of Mother-to-Child Transmission (PMTCT) guided the South African 
government to promulgate protocols for the treatment of HIV positive pregnant 
women to decrease the high morbidity and mortality of women and children younger 
than 5 years (UNAIDS 2014). The government initiated changes in the antiretroviral 
(ARV) therapy regimen from multiple drugs to a fixed-dose combination (FDC) ARV 
drug, whereby all HIV positive pregnant women, irrespective of their CD4 cell count, 
enrol for the ARV treatment (NDoH 2015:133). 
 
The National Consolidated Guidelines, namely the PMTCT of HIV, include the 
reduction in the transmission of HIV/AIDS infections through voluntary counselling 
and testing, and offering those pregnant women that are unaware of their HIV 
status an opportunity to know their status. The principles of HIV counselling and 
testing in many health settings for managing HIV encourage pregnant women to 
disclose their status in a confidential manner to their partner(s) or family members, 
trusted others, and health care workers (NDoH 2014:20). 
 
According to the Guidelines for Maternity Care in South Africa (NDoH 2016:109), 
the aims of PMTCT in antenatal care includes: identifying all women who are HIV 
positive, including those who seroconvert during pregnancy and breastfeeding; 
providing antiretroviral therapy (ART) the same day the HIV positive status is 
diagnosed to optimise maternal health and to prevent MTCT of HIV, and ensuring 
HIV positive pregnant and breastfeeding women are virologically suppressed on 
ART. These aims can be achieved if the HIV positive pregnant women disclose 
their HIV status to their partners soon after they are diagnosed with HIV. The 
health care workers need to assist the pregnant women to identify factors that 
might be barriers or motivate them to disclose their HIV status to their partners. 
These measures could strengthen HIV prevention efforts. 
 
According to the study conducted in Uganda in 2013 by Santelli, Edelstein, Mathur, 
Wei, Zhang, Orr, Higgins, Nalugoda, Gray, Wawer and Serwadda (2013:6), 
researchers found a considerable rate of new infections in youth living in the Rakai 
District and identified factors that placed youth at higher risk for HIV acquisition. 
Young women were at higher risk for HIV acquisition than men, particularly among 
15 to 19-year-olds. Behavioural and biological factors commonly associated with 
 5 
HIV and other sexually transmitted infections (STIs) were prominent risk factors. 
These include multiple partners, alcohol use, and evidence of other STIs. The risk 
for new infections was strongly shaped by social transitions such as leaving school 
and marital dissolution (Santelli, et al. 2013:6). 
 
In a study conducted in Sub-Saharan Africa (Ramjee & Daniels 2013), the reasons 
for the increased susceptibility of women were biological, and related exposure to 
potentially infectious fluids, with higher HIV concentrations in semen than in 
vaginal fluids, and the greater permeability of the mucous membranes of the 
vagina versus those of the penis. Women are also more likely to face increased 
tissue injury. These authors also agree that STIs increase the risk of HIV 
acquisition (Ramjee & Daniels 2013:2). 
 
Beyond biological risks factors, women in South Africa face social risk factors 
related to gender inequality, female economic dependency, the cultural 
subordination of women, gender violence, and aggressive affirmation of 
masculinity on sexual dynamics, for instance, having multiple sexual partners 
testifies to male virility (Bezuidenhout 2013:185). 
 
Mamogobo, Lekhuleni and Matlala (2013:42), in a study conducted in Limpopo 
Province, South Africa, further state that the goal of disclosure was to ensure that 
people living with HIV and AIDS negotiate and use condoms consistently with their 
sexual partners to reduce HIV transmission and decrease the viral load. In their 
study, male partners refused to use condoms despite knowledge of an HIV positive 
status. Female participants also continued to engage in unprotected sex despite 
knowing their HIV positive status, and some even fell pregnant after being 
diagnosed and counselled by health workers. 
 
Nyandat and van Rensburg‟s (2015:60) study in Kenya revealed that the benefits 
of HIV status disclosure included infant prophylaxis, absolute breastfeeding in the 
first 6 months, awareness of partner status, and male partner involvement which 
are valuable in the protection against MTCT of HIV. Overall, the non-disclosure 
rate to a partner was 16.7%, while 83.3% disclosed their HIV status to their 
partners. According to Mbokane, Ehlers and Roos (2016:16), consistent condom 
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use throughout pregnancy and breastfeeding phases is essential to prevent re-
infections which could cause the CD4 count to fall and the viral load to rise, 
increasing the risk of MTCT. Twenty-five percent (25%) of the HIV positive women 
in their study considered themselves to be protected from HIV infection because 
they only had sex with one partner. It seems vitally important that health education 
messages should emphasise that „being faithful‟ only offers protection against HIV 
infection if both partners are exclusively faithful to each other, and if both partners 
are HIV negative. 
 
According to a study conducted in Northern Ethiopia, HIV disclosure also prevents 
HIV infection of the sexual partner with a discordant HIV status. Sixteen point one 
percent (16.1%) of the respondents‟ sexual partners in that study were HIV 
negative (Alema, Misgina & Weldu 2017:57). HIV exposes the women to 
opportunistic infections which can lead to ill health and death, especially during 
pregnancy whereby the woman‟s body is compromised because of the 
physiological changes that occur. The presence of HIV further aggravates the 
pregnant woman‟s health status. 
 
Dlamini and Mkoboto-Zwane (2015:54) further state that 28.9% of the respondents 
in their study hid their HIV status and that of the child from their partners. As a 
result, 6.7% collected the HIV prophylaxis from the clinic but did not administer it to 
their children as they had not disclosed their status to their partners. The benefits 
of the pregnant woman disclosing her HIV positive status to her partner create 
opportunities such as being encouraged to seek health care services when and 
where diagnosed, and care and support in the form of support groups where 
women share their experiences. This might promote coping processes and support 
structures. With proper health management, the women may deliver HIV-negative 
infants (NDoH 2015:133). With HIV status disclosure to their partners, the 
provision of treatment, the facilitation of health care, and support to women 
infected with HIV may be attainable. The HIV positive pregnant women are 
encouraged to disclose their status to their partners as an integral practice in 
MTCT prevention programmes (Kiula, Damian & Msuya 2013:1). In the Ugandan 
study by Kiweewa, Bakaki, McConnell, Musisi, Namirembe, Nakayiwa, Kusasira, 
Nakintu, Mubiru, Musoke and Fowler (2015:5) it was indicated that only 38% of 
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women disclosed their HIV status to their partners. Women tend to avoid 
disclosure of their HIV status to their partners and prefer to disclose to significant 
others, such as family members or friends. 
 
Yako and Memeza (2013:77) report that 62% of HIV positive respondents in a study 
in the Eastern Cape Province, South Africa, disclosed their HIV status to significant 
others such as family members, but did not disclose to their sexual partners. Genet, 
Sebsibie and Gultie (2015:5) agree that it is crucial that participants disclose their 
HIV status to their sexual partners to enhance ART initiation of both partners, and to 
promote safe sex practices to lower transmission and the viral load. A low viral load 
is associated with low chances of transmitting the virus to an HIV-negative partner 
(or baby in the case of pregnant women), while a high viral load is associated with 
lower immunity and higher morality (van Dyk, et al. 2017:76). 
 
The NDoH Guidelines for Maternity care in South Africa (2015:133) further state that 
disclosure can also enhance support and adherence to treatment to lower 
transmission risks to the infant. The non-disclosure status of HIV positive pregnant 
women may have negative effects on the individual, family and sexual partners 
(Longinetti, Santacatterina & El-Khatib 2014:1). Due to non-disclosure, loved ones 
may be infected and become HIV positive, and this may affect them socially and 
economically as they will absent themselves from work due to ill health. According to 
the study conducted in Zimbabwe by Chingwaru and Vidmar (2016:29), HIV infection 
is widely known to be associated with increased neurocognitive impairment which 
impacts negatively on decision making, functionality, and adherence to treatment, 
and may point towards reduced productivity due to HIV-related mortality, and loss of 
productive hours due to HIV-related illnesses. 
 
If the problem is not addressed, the morbidity and mortality of HIV positive 
pregnant women, and the risk of infection to their partners and children, will 
increase. This will have an impact on their income, ultimately affecting the 
economy and increasing the number of child-headed families, resulting in a social 
crisis (UNAIDS 2014). 
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This study focused on investigating the perceived barriers of HIV status disclosure 
of pregnant women to their partners in the Capricorn District, Limpopo Province. 
These barriers of disclosure may be real and undermine the measures to prevent 
MTCT, re-infections, and adherence to treatment. 
 
1.3 RESEARCH PROBLEM 
 
Despite awareness campaigns about the importance of HIV status disclosure, 
prevention of the disease, the promotion of safe sex practices, and the provision of 
HIV counselling and testing in health facilities, the prevalence of HIV/AIDS remains 
high. Thirty six point seven (36.7) million people were living with HIV globally 
(UNAIDS 2017). The researcher, in her capacity of midwife working in one of the 
hospitals in Capricorn district discovered a number of pregnant women who did not 
disclose their HIV status to their partners. Non-disclosure of HIV positive status to 
the partner could expose the infant and partner to HIV infection. This prompted the 
researcher to investigate if there are challenges in disclosing the HIV status to the 
partner. There were 7.1 million people in South Africa living HIV while 270 000 
were newly infected with HIV in 2016 (NDoH 2017). Disclosure of an HIV status to 
a partner might help to reduce the infection rate, prevent MTCT, and increase 
adherence to safe sex practices. According to Kiweewa, et al. (2015:1), 62% of 
their participants did not disclose their status to their partners. In a study conducted 
in China by Xiao, Li, Qiao, Zhou, Shen and Tang (2015:76) it was revealed that 
88.6% of participants did not disclose their status to their partners. According to 
Mamogobo, et al. (2014:39), 40% of the women participating in their study did not 
disclose their status to their partners. It appears that there are barriers that prevent 
pregnant women from disclosing their HIV status to their partners in Limpopo 
Province. 
 
According to epidemiology in HIV and AIDS in South Africa (NDoH 2015:1), South 
Africa had the biggest HIV epidemic profile with 19.2% of the adult HIV prevalence 
in the world in 2015. Considering the high HIV infection rate of the adult population, 
pregnant women are at risk. Non-disclosure of an HIV positive status to their 
partners may enhance morbidity and mortality, resulting in economic and social 
losses. According to Moyer, Igonya, Both, Cherutich and Hardon (2013:65), in their 
 9 
Kenyan study participants pointed out that non-disclosure had negative 
consequences as living with a secret was psychologically stressful, leading to 
isolation, and unwarranted fear as people tend to imagine the worst scenario. In 
that study, poverty, including insufficient food (because they would be rejected by 
their partners and asked to fend for themselves) and other urgent material needs 
were also mentioned as a reason for avoiding status disclosure (Walcott, et al. 
2013:5). Mbokane, et al. (2016:16) reported that 88.5% of their respondents 
experienced emotional turmoil after being diagnosed HIV-positive. Habedi, Nolte 
and Temane (2015:116) state that HIV-positive pregnant women were afraid to 
disclose their status and some were rejected by their families due to stigmatisation. 
The Saving Mothers report 2011-2013 (NDoH 2014) on confidential enquiries into 
maternal deaths in South Africa indicated that 34.7% of maternal deaths were due 
to NPRIs which could result in child-headed households. Thus, the researcher was 
prompted to investigate the perceived barriers of pregnant women‟s HIV status 
disclosure to their partners in the Capricorn District, Limpopo Province. 
 
1.4 AIM OF THE STUDY 
 
The aim of this study was to investigate the perceived barriers of HIV status 
disclosure of pregnant women to their partners in the Capricorn District, Limpopo 
Province, to enhance status disclosure to partners through disclosure education by 
health care workers. 
 
1.5 RESEARCH OBJECTIVES 
 
The research objectives were to: 
 
 Explore and describe the perceived barriers of HIV status disclosure of pregnant 
women to their partners in the Capricorn District, Limpopo Province. 
 Make recommendations on disclosure education to health care workers 
performing Voluntary HIV Counselling and Testing (VHCT) to enhance the self-
efficacy of these women to disclose their HIV status to their partners based on the 
study findings. 
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1.6 RESEARCH QUESTIONS 
 
The following research questions were asked: 
 
 What are the perceived barriers of pregnant women‟s HIV status disclosure to 
their partners? 
 What recommendations on disclosure education can be made to health care 
workers performing VHCT to enhance the self-efficacy of these women to disclose 
their HIV status to their partners? 
 
1.7 THEORETICAL FOUNDATIONS OF THE STUDY 
 
Polit and Beck (2017:124) state that theoretical and conceptual frameworks play 
several interrelated roles in the progress of science. Theories allow researchers to 
integrate observations and facts into an orderly scheme. They are efficient 
mechanisms for drawing together accumulated facts, often from separate and 
isolated investigations. The linkage of findings into a coherent structure can make a 
body of evidence more accessible and thus, more useful. Theories and models can 
guide a researcher‟s understanding of not only the “what” of the natural phenomena 
but also the “why” of their occurrence. 
 
The researcher used the Health Belief Model (HBM) (Polit & Beck 2017:124) as 
theoretical framework in this study. This model postulates that health-seeking 
behaviour, which is the need to disclose their HIV status to their partners, is 
influenced by the presence of a perceived barrier(s) posed by a health problem and 
the value associated with disclosure of HIV status to their partners. The HBM was 
developed to change harmful, health-related behaviours (van Dyk, et al. 2017:187). 
 
1.7.1  Research assumptions 
 
The research assumptions were based on the following components of the HBM 
(Polit & Beck 2017:124): 
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Perceived susceptibility – is a person‟s perception that a health problem is personally 
relevant or that the diagnosis is accurate (Polit & Beck 2017:124). Susceptibility: 
means that people will not change their behaviour unless they believe that they are 
at risk, therefore HIV positive pregnant women will not disclose their HIV status to 
their partners unless they perceive the risk of not disclosing. The HIV positive 
pregnant women were diagnosed as HIV positive and accepted their diagnosis after 
an accurate diagnosis was made by the health care workers at the primary health 
care facilities in the Capricorn District, Limpopo Province. 
 
Perceived severity – Even when one recognises personal susceptibility, action will 
not occur unless the individual perceives the severity to be high enough to have 
serious implications (Polit & Beck 2017:124). The respondents will follow the planned 
programme (which entails disclosure of HIV status, taking ARVs, and adhering to 
preventive strategies such as consistent condom usage during sexual relations to 
prevent MTCT of HIV and infections to the partners) if they perceive the seriousness 
of the condition. The respondents needed to be aware of the impact of non-
disclosure of their HIV status to their partners, which can result in MTCT, an 
increased viral load, and infection of partners (socio-economical influence). 
 
Perceived benefits – are the patient‟s beliefs that a given treatment will cure the 
illness or help prevent it (Polit & Beck 2017:124). The respondents may comply with 
the given treatment (ARVs) if they believe it will prevent MTCT or the treatment will 
enhance their quality of life. The HIV positive pregnant women needed to know the 
benefits of disclosing their HIV status to their partners so that their partners will be 
given treatment which will lower the re-infection rate and result in a lower viral load, 
adherence to treatment, and getting support from partners. 
 
Perceived costs – are financial implications (Polit & Beck 2017:124). These will 
determine if respondents have the financial means which will provide confidence to 
comply with the HIV status disclosure to their partners. 
 
Perceived barriers/challenges – include the complexity, duration and accessibility of 
the treatment (Polit & Beck 2017:124). Respondents need to be assured of where 
they will get the treatment and for how long they will be required to take the 
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treatment. Treatment is lifelong, and they need the intention to disclose their status 
to adhere and comply with treatment. According to literature in the background of 
this chapter, it seems that some HIV positive pregnant women have 
barriers/challenges to disclosure of their HIV status to their partners, such as fear of 
rejection and stigmatisation. 
 
The motivation – is the desire of the patient to comply with the treatment. 
Respondents need to be motivated enough to be able to comply with the treatment 
regimen without interruptions (Polit & Beck 2017:124). Support from their partners 
when the respondents are faced with ill health might assist them to disclose their 
status to their partners, thus improving compliance to treatment. 
 
The researcher was interested in exploring and describing the perceived barriers of 
HIV positive pregnant women to disclose their status to their partners. The HBM was 
applicable in this study as it could be applied to respondents‟ compliance with HIV 
status disclosure to their partners and the preventive health care practices of HIV 
transmission from respondents to their partners and MTCT. Perceived susceptibility 
might indicate that a health problem exists and that the diagnosis is accurate. The 
perceived severity of not disclosing an HIV status to partners can result in 
deterioration of health as physical consequences, stigma, and rejection from their 
community as social consequences. The benefits of HIV status disclosure might 
enhance preventive measures such as consistent condom usage, preventing 
unwanted/unplanned pregnancies, and MTCT. The respondents are to take lifelong 
treatment (ARVs); therefore, these might enhance status disclosure since the 
partners will become aware, as the ARVs are taken even after the pregnancy. The 
respondents may be motivated by ill health to disclose their status as there will be no 
need to hide their illness and they will need physical, emotional, and financial 
support from their partners. 
 
1.8 DEFINITIONS OF TERMS 
 
Antigen: is any foreign (or invading) substance which, when introduced into the 
body, elicits an immune response such as the production of antibodies that react 
specifically with these antigens (van Dyk, et al. 2017:697). In this study, antigen 
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refers to when HIV enters the pregnant women‟s bodies to disrupt the normal 
immune system response to be incapable to fight opportunistic infections. 
 
Barriers: are obstacles, problems, rules or situations that prevent movement or 
access to certain aspects, that prevent or hinder communication or progress (Hornby 
2015:108). In this study, barriers refer to aspects which can be either physical, 
social, and emotional that prevent HIV positive pregnant women to disclose their 
positive status to their partners. 
 
Disclosure: is the act of making a secret or new information known or public 
(Hornby 2015:424). In this study, disclosure will refer to when an HIV positive 
pregnant woman shares her HIV status with her partner. 
 
Health Belief Model (HBM): the model postulates that health-seeking behaviour is 
influenced by a person‟s perception of a threat posed by a health problem and the 
value associated with actions aimed at reducing it (Polit & Beck 2017:124). In this 
study, respondents will engage in disclosing their HIV status to their partners when 
they perceive the following: susceptibility: means that people will not change their 
behaviour unless they believe that they are at risk therefore HIV positive pregnant 
women will not disclose their HIV status to their partners unless they perceive the 
risk of not disclosing. Respondents perceive the HIV diagnosis as correct. Severity: 
when the respondents recognise personal susceptibility, action will not occur unless 
they perceive the severity to be high enough to have serious implications. 
Respondents will be able to disclose their HIV status when they believe that the 
diagnosis is real and serious enough to cause health-related problems. 
 
Benefits and costs: are the patient‟s beliefs that a given treatment will cure the 
illness or help prevent it, and the financial implications thereof. Respondents will be 
motivated to disclose their status to their partners when there are benefits and they 
are able to meet the financial needs. The barriers/challenges include the complexity, 
duration and accessibility of the treatment. The motivation, enabling or modifying 
factor is the desire to comply with the treatment. When the respondents believe that 
there are benefits, they have stronger intentions (motivation). Even though obstacles 
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exist, there is greater possibility that they will disclose the HIV status to their 
partners. 
 
HIV positive status: the HIV positive status refers to the presence of antibodies for 
the HIV antigen. It indicates that evidence of HIV has been found via a blood test 
(either HIV antibodies or viral particles, depending on the test used). An HIV-infected 
person can transmit the HI virus during sexual intercourse, through his or her blood, 
or during pregnancy, child birth, and breastfeeding (van Dyk, et al. 2017:703). When 
a person is HIV positive, it means that the individual was exposed to the HI virus. In 
this study, it refers to pregnant women who tested positive for HIV in the Capricorn 
District, Limpopo Province. 
 
Mother-to-child transmissions (MTCT): or vertical transmission of HIV from the 
mother living with HIV to her infant during pregnancy, labour and delivery, or during 
breastfeeding (van Dyk, et al. 2017:61). In this study, MTCT is the transmission of 
HIV from the mother to the unborn baby during pregnancy and birth. 
 
Partner: the person that you are married to or having a sexual relationship with 
(Hornby 2015:1087). In this study, a partner refers to a person who has a sexual 
relationship with the HIV positive pregnant woman. This could be a spouse or any 
male partner of the woman, who have a sexual relationship with her. 
 
Perception: is the way you notice things, especially with the senses or the ability to 
understand, interpret and to be aware of the true nature of the situation, an idea, or a 
belief (Hornby 2015:1105). In this study, perception refers to how the pregnant 
women think, understand, interpret and are aware of their HIV positive status and the 
impact it might have on disclosing their HIV status to their partners. 
 
Pregnancy: is the gestational process; the period of intrauterine development from 
conception through birth (Davidson, London & Ladewig 2014:8). In this study, 
pregnancy is the period whereby an HIV positive woman is carrying a foetus from 
one month until the baby is born. 
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1.9 RESEARCH METHODOLOGY 
 
The following sub-headings will be discussed under research methodology: research 
design, setting, population, sample and sampling, sample size, data collection, and 
data analysis. A more detailed discussion will follow in Chapter 3. 
 
1.9.1  Research design 
 
Research designs are types of inquiry within qualitative, quantitative, and mixed 
methods approaches that provide specific direction for procedures in a research 
design (Creswell 2014:12). The research design is the plan for obtaining answers to 
the research questions. In designing studies, researchers select a specific design 
and identify strategies to minimise bias. The research design indicates how often 
data will be collected, what types of comparisons will be made, and where the study 
will take place (Polit & Beck 2017:56). A quantitative research design that is 
explorative, descriptive, and cross-sectional was used in this study. 
 
1.9.1.1 Quantitative research design 
 
Polit and Beck (2017:741) define „quantitative research‟ as the investigation of 
phenomena that lend themselves to precise measurement and quantification, often 
involving a rigorous and controlled design. This paradigm was chosen due to the 
sensitivity of the topic; respondents may find it difficult to disclose their status to their 
partners and therefore might find it difficult to disclose or discuss their HIV status 
with the researcher. 
 
1.9.1.2 Exploratory research 
 
Exploratory research begins with a phenomenon of interest, but rather than simply 
observing and describing it, exploratory research investigates the full nature of the 
phenomenon, the way it is manifested, and other factors to which it is related (Polit & 
Beck 2017:15). The full nature of the perceived barriers of HIV status disclosure of 
pregnant women to their partners in the Capricorn District, Limpopo Province was 
investigated. 
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1.9.1.3 Descriptive research 
 
Descriptive research entails precise measurement and reporting of the 
characteristics of the population or phenomenon (Botma, Greeff, Mulaudzi & Wright 
2016:50-51). Descriptive research methods are used to report the distributions (or 
spread) of a sample or population across a wide range of variables (using all four 
levels of measurement which are: descriptive, association, causation and 
inferences). The aim of this method was to produce a scope of characteristics of 
such distributions through frequencies, measures of central tendency, and dispersion 
(De Vos, Strydom, Fouchė & Delport 2017:251). In this study, the researcher aimed 
to describe and report with descriptive statistics on pregnant women‟s perceived 
barriers of HIV status disclosure to their partners in the Capricorn District, Limpopo 
Province. 
 
1.9.1.4 Cross-sectional research 
 
Polit and Beck (2017:725) state that a cross-sectional design is a study in which data 
are collected at one point in time. The information on a specific topic is collected at 
the same time from the same participants and no identical study will be undertaken 
after a specific period. The study is limited to a given time period. A cross-sectional 
design involves obtaining data from a cross-section of the population at a point in 
time and indicating that the data are from a specific sample (Botma, et al. 2016:113; 
Polit & Beck 2017:168). HIV positive pregnant women from hospital ARV clinics were 
involved in the study. A questionnaire was given to the respondents during a specific 
timeframe, from 1st February to 3rd May 2017, and the information was 
representative of that point in time. 
 
1.9.2  Study setting 
 
The setting is the physical location and condition in which data collection takes place 
in a study (Polit & Beck 2017:744). Research can be undertaken in a variety of 
settings at the specific places where information is gathered and at one or more 
sites. Some studies take place in naturalistic settings in the field, such as in people‟s 
homes, while other studies are conducted in controlled laboratory or clinical settings. 
 17 
The study was conducted in three hospital ARV clinics based at three hospitals in 
the Capricorn District, Limpopo Province. Two of these hospitals were in the rural 
area, while one hospital was in an urban area. Refer to Chapter 3 for more detailed 
information. 
 
1.9.3  Study population 
 
Quantitative researchers need to clarify the group to whom study results can be 
generalised, that is, they must identify the population to be studied (Creswell 
2014:158). Polit and Beck (2017:739) define „population‟ as the entire set of 
individuals or objects having some common characteristics. For this study, the 
accessible population comprised of the HIV positive pregnant women who were 
attending ARV clinics at three hospitals in the Capricorn District, Limpopo Province. 
More detailed information follows in Chapter 3. 
 
1.9.4  Sample and sampling 
 
A sample is a subset or portion of the accessible population identified for the study, 
while sampling is the process of selecting the subset or portion of the population to 
represent the accessible population (Botma, et al. 2016:124). The HIV positive 
pregnant women who were at the ARV clinic, on ART, and who met the inclusion 
criteria, were invited to participate in the study. The inclusion criteria were: HIV 
positive pregnant women in the age range of 18-40 years who were attending the 
ARV clinics at specified hospitals in the Capricorn District during the data collection 
period, and who were willing to participate in this study. Health records (register and 
an antenatal card) were utilised to the identify HIV positive pregnant women who had 
undergone counselling and testing at least one month prior to the study formed part 
of the respondents. HIV positive pregnant women who had signed an informed 
consent form took part in the study. 
 
The exclusion criteria were HIV positive pregnant women younger than 18 and older 
than 40 years of age, and respondents who received their HIV test results less than 
a month before recruitment to participate in the study. HIV positive pregnant women 
who did not sign an informed consent form were also excluded from the study. 
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Non-probability sampling is the selection of sampling units (e.g. respondents) from a 
population using non-random procedures (such as convenience sampling) (Polit & 
Beck 2017:736). Purposive sampling is a non-probability sampling method in which 
the researcher selects participants based on personal judgement about which ones 
will be most informative (Polit & Beck 2017:741). Non-probability sampling was used 
and purposive and convenience sampling was applied. In this study, women who 
were HIV positive and pregnant had a choice to disclose or not disclose their status 
to their partners. The respondents were selected purposively as they were viewed as 
experts at being pregnant and HIV positive, and had a choice to disclose or not 
disclose their HIV status to their partners. 
 
De Vos, et al. (2017:232) define „convenient sampling‟ as accidental, availability or 
haphazard sampling which is utilising respondents that are usually nearest and most 
easily available for the study. Convenience sampling entails using patients that are 
available and willing to participate (Polit & Beck 2017:252). In this study, 
convenience sampling was used. HIV positive pregnant women aged between 18-40 
years were invited to participate in the study and were present during the data 
collection period from 1st February to 3rd May 2017 at the ARV clinic in the three 
specified hospitals. 
 
The hospitals were purposively and conveniently sampled as they had ARV clinics 
and the women are referred for high risk antenatal care in hospitals from local 
clinics/hospitals as they need to book for delivery at district/tertiary hospitals which 
provide specified services. These hospitals and ARV clinics have large patient 
numbers with HIV. The researcher selected the three ARV clinics as they were 
convenient in terms of accessibility, financial viability, and time. All three hospitals 
were accessible to the researcher and they were financially viable for the researcher 
to access (geographically close to the researcher). 
 
1.9.4.1 Sample size 
 
According to Botma, et al. (2016:129), the sample size should be calculated at the 
design stage of the study, as the sample size will influence the feasibility of the 
study. All HIV positive pregnant women who were willing and available to participate 
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in the study were invited. According to ARV clinic registers, 356 HIV positive 
pregnant women were seen at the facilities from January to June 2015 (ARV Clinic 
hospital records 2015). A Raosoft calculator was utilised to calculate the sample size 
(www.raosoft.com > sample size) of 186. Refer to Chapter 3 for more details. 
 
1.9.5  Data collection methods and procedures 
 
Botma, et al. (2016:131) describe data gathering as the precise and systematic 
gathering of information to be able to address the research purpose. The goal of 
data collection in quantitative studies is to achieve consistency in what is asked and 
how answers are reported, to reduce biases, and facilitate analysis (Polit & Beck 
2017:266). In this study, the researcher used a questionnaire as data collection tool. 
The rationale for using a questionnaire was to achieve consistency in what was 
asked and to reduce bias. The topic under study was sensitive, therefore, some 
respondents found it easier to write than to communicate verbally about intimate and 
personal information with somebody they do not know. Data were collected over 3 
months, from 1st February to 3rd May 2017. 
 
The researcher obtained ethical approval from the Higher Degrees Committee, 
Department of Health Studies University of South Africa (UNISA) (Reference 
number: HSHDC/484/2015) (Annexure A), and approval was also obtained from 
Limpopo Department of Health (Annexure C), the three hospital ARV clinic units‟ 
managers/facility supervisors (Annexure D), developers of the questionnaire before it 
was adapted for the study context (Annexure E), and respondents were requested to 
sign informed consent to ensure voluntary participation (Annexure H). 
 
A pre-test is conducted to refine the instrument by identifying flaws or assessing time 
requirements (Botma, et al. 2016:284). A pilot test was conducted to identify if the 
respondents would be able to understand the questions and to assess the time 
required to complete the questionnaire, which would guide the actual data collection 
process. In this study, a pre-test was conducted with five HIV positive pregnant 
women who did not participate in the primary study. These HIV positive pregnant 
women were randomly selected to participate in the pre-test. Some of the questions 
were not clear to the respondents. The researcher re-structured the questionnaire 
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with the help of the supervisor and the statistician, and changes were made 
according to their recommendations. More details are provided in Chapter 3. 
 
During data collection, the researcher visited the ARV clinics from the three selected 
hospitals from 1st February to 3rd May 2017, and information was provided to 
potential respondents through information leaflets with the aim and objectives of the 
study. The HIV positive pregnant women who complied with the inclusion criteria 
were invited to participate in the study. The researcher adapted a pre-existing 
instrument, after obtaining permission (Addendum E) from the developers (Deribe, 
Woldemichael, Wondafrash, Haile & Amberbir 2008:4-7) for the context of this study. 
The HBM was utilised as theoretical framework for the development of the 
instrument. A literature review was conducted to ensure that all the relevant aspects 
were covered in the questionnaire. Structured and open-ended questions were 
added to the questionnaire to enhance the depth of the data collected. The 
respondents who were available and willing to voluntarily take part in the study were 
given self-administered questionnaires by the researcher as no research assistant 
was involved in the study. The researcher was available to answer questions from 
the respondents. One hundred and eighty-six (186) respondents received self-
administered questionnaires. Out of 186 respondents, 171 completed and returned 
the questionnaires. One questionnaire was incomplete and discarded. Data from 170 
questionnaires (N = 170) was analysed. The response rate was 91.39%, which is 
high enough to guarantee accurate results. 
 
The respondents who were literate completed the questionnaires on their own in a 
quiet private room at the ARV clinics. The respondents who were illiterate were 
assisted by the researcher to complete the questionnaire. The answers that the 
respondents provided were re-read to them by the researcher to ensure that there 
was data accuracy. A box was provided for the respondents to post the completed 
questionnaires and the researcher collected the box on the same day. Additional 
details will be discussed in Chapter 3. 
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1.10 VALIDITY AND RELIABILITY 
 
Validity refers to the degree to which an instrument measures what it was intended 
to measure and reliability refers to the ability of the instrument to provide reliable 
results. More details will be presented in Chapter 3. 
 
1.10.1 Validity 
 
Validity indicates whether the conclusions of the study are justified based on the 
design and interpretation (Botma, et al. 2016:174). Polit and Beck (2017:747) define 
„validity‟ as a degree to which inferences made in a study are accurate and well-
founded; in measurement, the degree to which an instrument measures what it is 
intended to measure. Validity was ensured by the utilisation of an existing 
questionnaire which was adapted to include the HBM after a review of relevant 
literature. The questionnaire was pre-tested with five HIV positive pregnant women 
aged 18-40 years who were not included in the main study sample. The pre-test 
enhanced validity as it ensured the clarity of questions. The questionnaire was 
reviewed by the researcher‟s supervisor and the statistician before it was 
administered. Corrections and adjustments were made in the final questionnaire. 
 
1.10.1.1 Content validity 
 
Content validity refers to the representativeness or sampling adequacy of the content 
of an instrument (De Vos, et al. 2017:173). Some of the questions were adapted 
from a previous questionnaire with the permission of the developers as mentioned 
earlier (Annexure E). The content of the instrument was discussed with field experts 
to ensure the relevance of the questions to the context of the study. Questions were 
verified with field experts, through a pre-test, and with the supervisor and statistician 
before actual data collection. Data were analysed by computer software (SPSS 
version 24) with the assistance of a statistician. More detail is provided in Chapter 3. 
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1.10.2 Reliability 
 
Reliability refers to the accuracy and consistency of information obtained in the study 
(Polit & Beck 2017:160-161). Reliability represents the consistency of the measure 
achieved. This means that if a valid measuring instrument is applied to different 
groups under similar circumstances, it should produce similar results (Botma, et al. 
2016:177). 
 
Respondents completed the same questionnaire during data collection which 
facilitated the analysis, comparison, and discussion of the study findings. The 
researcher collected data at the ARV clinics. The respondents who were illiterate 
were assisted by the researcher to complete the questionnaire. The answers that the 
respondent provided were re-read to ensure data accuracy. Stability and 
equivalence were enhanced as components of the instrument were adapted from 
previous studies where it was implemented and tested to fit the study context. Refer 
to Chapter 3 for additional information. 
 
1.11 DATA ANALYSIS 
 
Data analysis is the systematic organisation and synthesis of research data, and in 
quantitative studies, the testing of hypotheses using those data (Polit & Beck 
2017:725). In this research, data were captured and analysed using the SPSS 
version 24 computer software program, with the assistance of a statistician. 
Descriptive statistics were used to analyse and describe the data obtained. Open-
ended questions were asked at the end of the questionnaire and focused on 
motivators and barriers/challenges of disclosure, as well as benefits and 
disadvantages of disclosure. The open ended questions were analysed using 
thematic coding and provided depth to the quantitative data. Refer to Chapter 3 for 
more information. 
 
1.12 ETHICAL CONSIDERATIONS 
 
Ethics is a set of moral principles suggested by an individual or group, which is 
subsequently widely accepted, and offers rules and behavioural expectations about 
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the correct conduct towards experimental subjects and respondents, employers, 
sponsors, other researchers, assistants, and students (De Vos, et al. 2017:114). 
Botma, et al. (2016:129) state that important issues that should be explored with 
experimental subjects are that no harm should come to them; that prospective 
respondents should give their informed consent; that respondents should not be 
deceived in any way; and that researchers should be competent and responsible. 
Throughout this study, the researcher observed and applied the ethics pertaining to 
research. 
 
In this study, the researcher utilised the ethical moral code which includes respect for 
persons, right to privacy (anonymity and confidentiality), justice, beneficence, respect 
for human dignity, and informed consent which are applicable during the data 
gathering phase (Botma, et al. 2016:17). More details follow in Chapter 3. 
 
1.12.1  Permission to conduct the study 
 
According to Polit and Beck (2017:137), researchers are obliged to respect ethical 
issues when dealing with human beings during their studies. The government 
establishes rules for researchers to adhere to which are related to the protection of 
human beings and the prevention of exploitation. The researcher obtained ethical 
approval from the Higher Degrees Committee of the Department of Health Studies at 
UNISA (HSHDC/484/2015) (Annexure A). Approval was obtained from Limpopo 
Department of Health (Annexure C), three hospital managers, and the ARV clinic 
unit managers (Annexure D). Respondents were requested to voluntarily participate 
in this study and no incentives or remuneration was provided. The respondents were 
also given an information leaflet and were requested to sign an informed consent 
form (Annexure H) to ensure voluntary participation and to indicate that they 
received the relevant information for the study. Ethical principles that should be 
applied during research are discussed next. 
 
1.12.2  Ethical principles protecting the respondents 
 
The National Health Research Ethics Council (NHREC) has developed ethical 
guidelines that need to be adhered to when conducting research using human 
 24 
beings as respondents (Botma, et al. 2016:11-12). The following principles will be 
covered: privacy, beneficence, justice, confidentiality and anonymity, and respect for 
human dignity. 
 
1.12.2.1 Principle of privacy 
 
Privacy, in its most basic meaning, is to keep to oneself that which is normally not 
intended for others to observe or analyse (De Vos, et al. 2017:119). A private room 
at the ARV clinic away from the public was utilised by the researcher to avoid 
stigmatisation as this is a sensitive topic. The researcher explained the nature and 
purpose of the study, and ensured respondents that participation might contribute to 
better support and education by health care workers relating to HIV status disclosure 
to partners. To ensure privacy the respondents‟ names were not mentioned in the 
final report. 
 
1.12.2.2 Principle of beneficence 
 
The right to beneficence was observed by the researcher. The principle of 
beneficence is grounded in the premises that a person has the right to be protected 
from harm and discomfort; one should do good, and above all, no harm (Botma, et 
al. 2016:20). As the topic under discussion is sensitive, the researcher debriefed 
each respondent after completion of the questionnaire, to express their feelings and 
ask questions. There was no respondent who needed to be referred to a 
psychologist for further support and counselling at the ART clinics. The respondents 
were provided with a referral option which was free of charge, but they all declined. 
The researcher‟s contact details were given to the respondents in the event of further 
questions, comments, or complaints at a later stage. Respondents were assured that 
their involvement in this study would not subject them to any form of harm. The 
respondents were informed of their right to withdraw from the study at any time they 
wish, without fear of being victimised. 
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1.12.2.3 Principle of justice 
 
The right to fair treatment includes equitable distribution of benefits and burdens of 
research (Polit & Beck 2017:141). The respondents who met the inclusion criteria 
were selected according to fair treatment, irrespective of their race, educational 
status, creed, or any other socio-economic status. Refer to Chapter 3 for more 
detailed information. 
 
1.12.2.4 Confidentiality and anonymity 
 
Confidentiality can be viewed as a continuation of privacy, which refers to 
agreements between persons that limit others‟ access to private information (De 
Vos, et al. 2017:119). Botma, et al. (2016:277) state that it is the responsibility of the 
researcher to prevent data gathered during the study from being linked to individual 
respondents, divulged or made available to any other person. According to Polit and 
Beck (2017:719), anonymity is the protection of participants‟ confidentiality such that 
even the researcher cannot link individuals with the data provided. Confidentiality 
was maintained by the researcher by ensuring that the respondents‟ names were not 
written on the questionnaires. Raw data was entered into the computer using codes. 
No names or that of the hospitals appeared in the research report as an HIV positive 
status is highly confidential. The questionnaires were not made available to anyone 
who was not directly involved in the study. Those involved signed a confidentiality 
agreement. Refer to Chapter 3 for more information. 
 
1.12.2.5 Respect for human dignity 
 
Respect for people‟s dignity is demonstrated by maintaining anonymity and 
confidentiality (Botma, et al. 2016:17). The following topics will be discussed under 
respect for human dignity: the right to self-determination, the right to full disclosure, 
and informed consent. 
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a) The right to self-determination 
 
De Vos, et al. (2017:116) state that humans should be treated as autonomous 
agents, capable of controlling their actions. The right to self-determination means 
that prospective participants can voluntarily decide whether to take part in the study, 
without risk of prejudicial treatment. It also means that people have the right to ask 
questions, to refuse to give information, and to withdraw from study if they so wish. 
The researcher provided the respondents with an information leaflet to read and an 
informed consent form was signed upon agreement to participate in the study. 
Respondents were told that participation in the study was not compulsory, and they 
may terminate at any time if they so wish without losing benefits. The respondents 
voluntarily completed the questionnaire at the ARV clinics. 
 
b) Right to full disclosure 
 
Polit and Beck (2017:140) state that full disclosure means the researcher has fully 
described the study, the person‟s right to refuse participation, the researcher‟s 
responsibilities, and the likely risks and benefits. A written information leaflet which 
was comprehensive regarding the purpose, objectives, and process of the research, 
was given to the respondents. Refer to Chapter 3 for more details. 
 
c) Informed consent 
 
Respondents were briefed on the purpose of the study and its implications, to be 
able to make an informed decision on whether to participate or not. Each respondent 
signed informed consent before completing the questionnaire without being coerced. 
The respondents‟ decision to participate or terminate was respected in this study. 
 
1.13 SIGNIFICANCE OF THE STUDY 
 
Evidence from the study should have the potential to meaningfully contribute to 
nursing practice. The study should be original, but it could also be a replication to 
answer previously asked questions with greater rigor or with a different population 
(Polit & Beck 2017:73). Creswell (2014:119) states that researchers often include a 
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specific section of the study for selected audiences that may profit from reading and 
using the study. A clear rationale for the importance of the study is created. This 
study investigated the perceived barriers of HIV status disclosure of pregnant women 
to their partners in the Capricorn District, Limpopo Province. The study contributed 
towards the knowledge on barriers that prevent HIV status disclosure of pregnant 
women to their partners to enhance health care provision through disclosure 
education, to limit MTCT, and lower viral load resulting in lower morbidity and 
mortality. 
 
1.14 SCOPE AND LIMITATIONS OF THE STUDY 
 
The study focused on perceived barriers of HIV status disclosure of pregnant women 
to their partners in the Capricorn District, Limpopo Province. 
 
1.14.1  Scope of the study 
 
Only HIV positive pregnant women aged 18-40 years who were attending ARV 
clinics were included in the study. The rationale for including women in the specific 
age group was that they were of child-bearing age. The HIV positive pregnant 
women who were attending hospital ARV clinics in the Capricorn District, Limpopo 
Province, took part in this study. The three hospitals were included based on the 
scope of the study and the limited resources of the researcher. The findings could be 
generalised for all HIV positive pregnant women in the Capricorn District, Limpopo 
Province. The researcher intended that the guidelines could be used by health care 
workers to address perceived barriers of HIV positive pregnant women to enhance 
disclosure of their HIV status to their partners during disclosure education. The 
limitations will be discussed in terms of research, methodological, and theoretical 
limitations. 
 
1.14.2  Research limitations 
 
Polit and Beck (2017:12) state that a study that uses human beings as instruments 
through which information is gathered has several limitations: humans are extremely 
intelligent and sensitive, but fallible tools. The subjectivity that enriches the analytic 
 28 
insights of skilful researchers can yield trivial and obvious findings among less 
competent ones. The generalisability of findings from constructivist inquiries is an 
issue of potential concern. 
 
Methodological limitations can limit the credibility of the findings and restrict the 
population to which the findings can be generalised. Methodological limitations result 
from such factors as an unrepresentative sample, weak design, single setting, limited 
control over treatment implementation, measurement instruments with limited 
reliability and validity, limited control over data collection, and improper use of 
statistical analyses. The data collection was done from a single setting; therefore, 
study respondents‟ representation may be limited. The study respondents included 
only HIV positive pregnant women on ARVs; their partners were not included and 
their views were therefore not heard. 
 
Theoretical limitations restrict the abstract generalisability of findings and are 
reflected in the study framework and the conceptual and operational definitions of 
the variables. Theoretical limitations might include (1) a concept that lacks clarity of 
definition in the theory used to develop the study framework, (2) the unclear 
relationships among some concepts in the theorist‟s work, (3) a study variable that 
lacks a clear link to a concept in the framework, and (4) an object, question, or 
hypothesis that lacks a clear link to a relationship expressed in the HBM (Polit & 
Beck 2017:124). The study respondents may be unwilling to share details about their 
private life with anyone, thus a small number of people may participate in the study. 
Therefore, the researcher used a questionnaire as data collection tool rather than 
interviews during data collection. The researcher encouraged respondents to 
participate voluntarily; no one was coerced. One hundred and eighty-six (186) 
respondents were given questionnaires, 171 completed and returned the 
questionnaires, and one was incomplete and discarded. The response rate was 
91.39%. 
 
1.15 STRUCTURE OF THE DISSERTATION 
 
This study is organised into five chapters as outlined next: 
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Chapter 1: Orientation to the study 
This first chapter provides a general overview of the study. It contains background to 
the research problem, problem statement, purpose of the study, research objectives, 
research questions, theoretical framework, definition of key concepts, research 
design and methodology, validity and reliability, data collection, data analysis 
methods, ethical considerations, significance of the study, scope and limitations. It 
also offers an outline of the chapters. 
 
Chapter 2: Literature review 
The second chapter offers insight into similar studies conducted by other 
researchers. The chapter outlines the historical background of HIV, previous 
research conducted on epidemiology of HIV, signs and symptoms of HIV, diagnosis 
of HIV, treatment of HIV during pregnancy, patient counselling and adherence, and 
HIV disclosure. The benefits, the motivating/enabling factors, factors influencing 
disclosure, impact/consequences of disclosure, and the predictors of HIV status 
disclosure are also reviewed. 
 
Chapter 3: Research design and methodology 
This chapter presents the research design and methods used in the study, validity 
and reliability, and ethical considerations. 
 
Chapter 4: Analysis, presentation and description of the research findings 
In Chapter 4, data management and analysis, and the presentation and description 
of the research findings are presented. 
 
Chapter 5: Findings, conclusions, limitations and recommendations 
This chapter presents interpretations of the research findings, literature synthesis, 
conclusions, recommendations, contributions of the study, and research limitations. 
 
1.16 SUMMARY 
 
This chapter provided a general overview of the study, followed by a brief 
explanation of what prompted the researcher to undertake the study. The research 
problems, the aim of the study, and the significance of the study were discussed. 
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The definition of key concepts, the foundation of the study, research design, 
research methods, validity and reliability, ethical considerations, the scope and 
limitations of the study were clarified. Chapter 2 presents a detailed review of 
literature. 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1  INTRODUCTION 
 
A literature review is defined as a critical summary of research on a topic of interest, 
often prepared to put a research problem in context (Polit & Beck 2017:733). 
Creswell (2014:31) also defines a literature review as a means of locating and 
summarising studies on a topic which may include conceptual articles or opinion 
pieces that provide frameworks for thinking about the topics. The following topics will 
be discussed in this chapter: the historical background of HIV, the epidemiology of 
HIV, signs and symptoms, diagnosis of HIV, the management of HIV, patient 
counselling and adherence, HIV disclosure, the benefits, motivating factors, as well 
as the barriers, the impact and predictors of HIV status disclosure. 
 
According to Polit and Beck (2017:54), quantitative research is typically conducted in 
the context of previous knowledge. To contribute new evidence, quantitative 
researchers strive to understand existing evidence. A thorough literature review 
provides a foundation on which to base new evidence and is typically conducted 
before data are collected. The literature review will also assist the researcher to 
identify a theoretical or conceptual framework for the study, as well as appropriate 
study methods and instruments or tools to measure the study variables. 
 
The following keywords were used by the researcher during the literature review: 
barriers, pregnancy, disclosure, HIV status, partners, and the HBM. Relevant 
research articles from Science Direct, Sabinet and EBSCO Host which are related to 
the topic under study were downloaded by the researcher with the assistance of a 
subject librarian from UNISA. The researcher used available literature to support the 
study. Information was obtained from journals, articles and books, government 
circulars/reports, grey sources, health service documents, and websites. The 
literature search focused on the years 2013 – 2018. One hundred and ninety-seven 
(197) documents related to the topic under study were retrieved both in quantitative 
and qualitative studies, and ninety-nine (99) relevant documents were utilised. Other 
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research documents were not used because they were not applicable to the topic. 
The study targeted pregnant women diagnosed as HIV positive and attending ARV 
clinics. The literature review process focused on both South Africa and the global 
context of HIV status, pregnant women‟s disclosure to their partners, and the 
benefits and factors preventing disclosure/barriers of disclosure. 
 
The questionnaire used to collect data was developed from the literature reviewed as 
well as the HBM, which included the following aspects: The socio-demographic 
characteristics, sexual and reproductive health information, motivating and enabling 
factors, challenges/barriers of disclosure, and the predictors of HIV status disclosure. 
The open-ended questions focused on the motivators and challenges/barriers, 
benefits, and disadvantages of HIV status disclosure. The mode of HIV transmission 
in this study is mostly through exposure to infected blood, MTCT, and unprotected 
sexual intercourse. The theoretical framework identified for this study is the HBM 
(Polit & Beck 2017:124), which focuses on patient compliance and preventive health 
care practices. The model postulates that health-seeking behaviour is influenced by 
a person‟s perception of a threat posed by a health problem and the value 
associated with actions aimed at reducing the threat (Polit & Beck 2017:124). The 
researcher used the concepts of the HBM in conjunction with the insights about 
factors that influence disclosure from literature to plan the study and develop the 
questionnaire. This study was conducted to explore and describe the perceived 
barriers of HIV status disclosure of pregnant women to their partners in the 
Capricorn District, Limpopo Province to enhance status disclosure to partners 
through disclosure education by health care workers. Perceived susceptibility relates 
to a person‟s perception that a health problem is personally relevant or the diagnosis 
is accurate. 
 
2.2  HISTORICAL BACKGROUND OF AIDS 
 
In 1981, the first AIDS cases were documented in United States of America (USA) in 
the form of pneumonia caused by a parasite called pneumocystis carinii, 
cytomegalovirus infections, thrush, and Kaposi sarcoma in homosexual men. Soon 
after, a new disease was identified in Central Africa which undermined the immune 
system and caused diarrhoea and weight loss in heterosexual people (van Dyk 
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2013:4). In 1983, it was discovered that the disease was caused by a virus known as 
Lymphadenopathy associated virus (LAV) and human T. Lymphotropic virus type III. 
In 1983 in France HIV was found to be underlying the course of illness. In 1984, 
Robert Gallo of the USA also discovered that HIV causes AIDS. After this discovery, 
the WHO started collecting statistics on HIV/AIDS prevalence, incidence, and spread 
worldwide (van Dyk 2013:4-6). 
 
In 1990, there were some theories that AIDS had been present in Central Africa for 
centuries but not identified due to a lack of sophisticated medical facilities to 
diagnose the disease. It was discovered that HIV (the human virus) was related to 
SIV (simian immunodeficiency virus) found in primates. There was a possibility that 
different strains of SIV (associated with different species of monkeys and apes) had 
crossed the species barrier to humans at different times, causing strains of HIV (van 
Dyk, et al. 2017:7). The researchers discovered that an ancestor of HIV-1 group M 
had been transmitted from a chimpanzee (pan troglodytes) which occurred sometime 
around the 1930s in equatorial West Africa where primates were often hunted for 
bush meat as indicated by van Dyk, et al. (2017:8). The virus was probably 
transmitted from the chimpanzee to the hunter when he was bitten or cut while 
hunting or butchering the animal (van Dyk, et al. 2017:7; avert.org; Simelela & 
Venter 2014:249). 
 
In 1996 the spread of HIV peaked with an estimated 3.5 million new infections 
worldwide. According to UNAIDS (2016:2), the global AIDS epidemic was 2.1 million 
new HIV infections in 2015; a reduction of 1.4 million new HIV infections globally. 
 
According to the WHO (2005), HIV infection in Swaziland was identified for the first 
time in 1986 and the first AIDS case was recognised in 1987 (WHO 2005). The 
number of persons living with HIV and AIDS increased rapidly throughout the 
population. In 2017, Swaziland had the highest HIV prevalence in the world despite 
its small population size, with 27.2% of the adult population living with HIV (NDoH 
2017). Eight-thousand, eight hundred (8 800) people in Swaziland were newly 
infected with HIV and 3 900 people died of an AIDS-related illness in 2017 (NDoH 
2017:1). In 2016, 220 000 adults and children were living with HIV in Swaziland. 
Women aged 15 and over living with HIV totalled 120 000, while 76 000 men aged 
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15 years and over were living with HIV. In the context of the entire population, 31% 
of all women were living with HIV, compared to 20% of men. Children aged 0-14 
years living with HIV amounted to 15 000 (NDoH 2017:2). 
 
In South Africa, the first person with AIDS was diagnosed in 1983 and by 1985 all 
blood products were screened for HIV. The number of pregnant women who were 
HIV positive in South Africa increased from 4.3% in 1994 to an estimated 17% in 
1998 (van Dyk, et al. 2017:12). In 2010 the provision of ARV treatment to special 
groups (such as pregnant women and patients with HIV/TB co-infections) was 
implemented by the South African Department of Health. Consequently, new clinical 
guidelines described how HIV and AIDS in adults, adolescents and children should 
be managed, and guidelines for the prevention of MTCT of HIV were implemented in 
2002 (NDoH 2015). As from 2015, South Africa started treating people who were 
HIV-infected according to WHO guidelines adopted in 2013 by starting ARV 
treatment at CD4 cell counts of less than 500 cells/mmᵌ (instead of CD4 cell counts 
of less than 350 cells/mmᵌ used previously). On 10 May 2016, the South African 
Department of Health removed the CD4 cell count as an eligibility criterion for an HIV 
positive person to enrol for ARV treatment. South Africa‟s ARV programme is 
currently the largest in the world (van Dyk, et al. 2017:14), with the South African 
Department of Health providing treatment for HIV positive people. These people 
should take responsibility in the fight for preventing new infections and MTCT by 
disclosing their HIV status to their partners. 
 
The historical background provided brief information related to the origin of HIV 
infection to mankind. The next section will offer an overview of the global 
epidemiology of HIV. 
 
2.3  EPIDEMIOLOGY OF HIV 
 
According to the WHO (2018), epidemiology is the study of the distribution and 
determinant of health-related states or events (including disease), and the 
application of this study to the control of diseases and other health problems. The 
incidences, distribution (who, when and where), and determinants of illness will be 
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discussed. The global, African, Southern African, South African, and Limpopo areas 
will be covered. 
 
2.3.1 Globally 
 
Figure 2.1 indicates that in 2016, 360 000 people in the Eastern Mediterranean were 
living with HIV, 1 500 000 in the Western Pacific, 2 400 000 in Europe, 3 300 000 
Americans, South-East Asia 3 500 000 and 25 600 000 Africans were infected with 
HIV (UNAIDS 2016). The African continent is the most affected by the HIV epidemic. 
 
Figure 2.1 Epidemiology of HIV    (Source: UNAIDS 2016) 
 
UNAIDS (2016:3) reported that globally, in 2015, 36.7 million people of all ages were 
living with HIV, 34.9 million were adults, 17.8 million were women, and 1.8 million 
were children under 15 years. There were 2.1 million people who were newly 
infected with HIV, 1.9 million were adults, and 150 000 were children under 15 years 
in 2015 (UNAIDS 2016:3). One point one (1.1) million AIDS-related deaths occurred 
in 2015; 1 million were adults, while 110 000 were children under 15 years (UNAIDS 
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2016:3). It is evident that a greater percentage of women than men (17.1 million) are 
living with HIV in the world, thus women are encouraged to disclose their status to 
their partners. 
 
The UNAIDS report (2015) further reported AIDS-related deaths of children below 15 
years in 2014 as follows: North America, Western and Central Europe were <200, 
Eastern and Central Europe were <1000, Middle East and North Africa 1200, Asia 
and the Pacific were 13 000, Caribbean were <1000, Latin America was 1800, Sub-
Saharan Africa were 130 000. An estimated 150 000 children below 15 years died 
from AIDS in 2014. It is evident that 86.6% of children from the Sub-Saharan Africa, 
who were younger than 15 years old, died from AIDS in 2014 (UNAIDS 2015). 
 
According to UNAIDS (2017:12), the global summary of the AIDS epidemic in 2016 
was: of 36.7 million people living with HIV, 34.5 million were adults, 17.8 were 
women, 16.7 million were men, and 2.1 million were children under 15 years. There 
were 1.8 million people newly infected with HIV; 1.7 million were adults, and 160 000 
were children under 15 years in 2016 (UNAIDS 2017:12). One (1) million AIDS-
related deaths were reported in 2016; 890 000 were adults, and 120 000 were 
children under 15 years (UNAIDS 2017:12). The global epidemiology of HIV 
indicates that AIDS-related deaths of children (<15 years) is rising. 
 
2.3.2 Africa 
 
In 2015 the Western and Central African region reported that 6.5 million adults and 
children were living with HIV, 410 000 adults and children were newly infected with 
HIV, and there were 330 AIDS-related deaths of adults and children (UNAIDS 
2016:4). According to UNAIDS (2017:14), in 2016 the Western and Central African 
region reported 6.1 million adults and children living with HIV, 370 000 adults and 
children were newly infected with HIV, and there were 310 AIDS-related deaths of 
adults and children (UNAIDS 2016:4). Although there is a reduction in the number of 
newly infected people with HIV, this is still a concern because of the effects it has on 
the population at large. 
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2.3.3 Southern Africa 
 
The burden of the HIV epidemic varies considerably from country to country and 
among regions, with Sub-Saharan Africa being the worst affected region in the world; 
nearly 70% of the world HIV infections occur in this region, with women and children 
bearing the brunt of the disease (van Dyk, et al. 2017:9). The Eastern and Southern 
Africa regions had 19 million adults and children living with HIV in 2015 out of 36.7 
million people globally living with HIV (UNAIDS 2016). In 2016, Sub-Saharan Africa 
was severely affected; nearly one in every 25 adults (4.2%) was living with HIV, 
accounting for nearly two-thirds of people living with HIV worldwide. South Africa had 
the highest profile of HIV in the world, with an estimated 7 million people living with 
HIV in 2015 (UNAIDS 2016). In the same year, there were 380 000 new infections, 
while 180 000 South Africans died from AIDS-related illnesses. 
 
In Swaziland between 1992 and 2010, HIV prevalence among pregnant women 
increased from 4% to 41% (NDoH 2016:4). As a result, PMTCT was scaled up and 
viewed as a vital entry point for accessing HIV services for the entire family. Some 
improvement has been seen, with HIV prevalence among this group standing at 37% 
in 2013 (Department of Health Swaziland (NDoH 2016:4). In 2015, less than 500 
children (aged 0-14 years) were newly infected with HIV, compared to 1 600 in 2010. 
According to Swaziland‟s Ministry of Health (2016) 95% of pregnant women living 
with HIV received ARV treatment. Around 64% of children (aged 0-14) living with HIV 
were receiving ARV treatment (Department of Health Swaziland (NDoH 2016:4). 
 
According to the Zimbabwe Demographic Health Survey (NDoH 2015:276), the 
percentage of children with at least one deceased parent who was HIV positive 
increases steadily from 1.5% among children age 0-4 years, to 4.5% among children 
age 5-9 years, and 7.0% among children age 10-14 years. Children whose mothers 
have HIV are more likely to be HIV positive themselves than children whose mother 
is HIV negative. Among children of HIV positive mothers, 6.4% of children aged 0-4 
years, 10.7% of children aged 5-9 years, and 8.8% of children aged 10-14 years are 
HIV positive themselves. In contrast to South Africa, Zimbabwe had steady 
increases of HIV positive children. Unless women disclose their HIV status to their 
partners, MTCT will not decrease. 
 38 
According to the Zimbabwe Demographic Health Survey (NDoH 2015:247), young 
women have sexual relationships with men who are considerably older. This practice 
contributes to the spread of HIV and other STIs because a younger, uninfected 
partner having sex with an older, infected partner can be infected with the virus. 
Seventeen percent (17%) of young women aged 15-19 years had sexual intercourse 
in the past 12 months with a man 10 or more years older than them (Zimbabwe 
Demographic Health Survey (NDoH 2015:247). 
 
The Demographic Health Survey in Zimbabwe (2015:277) concurs with the UNAIDS 
(2016) report which indicates that among young women, HIV prevalence increases 
steadily with age, from 2.7% of women aged 15-17 years to 13.9% of women aged 
23-24 years. Among young men, HIV prevalence holds steady at around 2.5% until 
the age of 23-24 years, when it increases to 6.0%. The sooner health professionals 
engage in health awareness for young adults, the sooner effective results on the 
disclosure of HIV status and prevention of unwanted pregnancies, re-infections, 
utilisation of condoms, safe infant feeding, and adherence to ARV therapy can be 
achieved. 
 
UNAIDS (2016) global, the Sub-Saharan region, and Zimbabwe health reports are 
consistent with the South African report which also found that in 2012, HIV 
prevalence among South African women was nearly twice as high as for men. Rates 
of new infections among women aged 15-24 years were more than four times 
greater than that of men the same age, and this age group accounted for 25% of 
new infections in South Africa (UNAIDS 2016). 
 
2.3.4 South Africa 
 
UNAIDS (2016) reported that 7 million South Africans were living with HIV in 2015, 
390 000 had new infections, and 180 000 AIDS-related deaths were reported. Five 
thousand (5 000) children aged 0-14 years had new HIV infections while 4.1 million 
South African girls and women were living with HIV in 2015 (UNAIDS 2016). In 2016, 
7.1 million South Africans were living with HIV, 270 000 had new infections and 126 
755 AIDS-related deaths were reported (UNAIDS 2017; STATS SA 2017:7). 
Disclosure of HIV may reduce the number of people living with HIV in South Africa. 
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MTCT or vertical transmission of HIV from the mother to the child is one of the major 
causes of HIV infection in children (van Dyk, et al. 2017:61). The majority (90% to 
95%) of young children with HIV infection contracted the infection through MTCT. 
Unless preventive measures are taken (such as ARV therapy, safe delivery 
techniques, safe infant feeding, and disclosure of HIV status to partners), children 
born from HIV-infected women in Africa are likely to be infected (van Dyk, et al. 
2017:61). According to van Dyk, et al. (2017:61) MTCT of HIV has reduced from 
70 000 babies born to HIV-positive women in 2004, to less than 7 000 in 2015. Great 
strides have been made in the PMTCT of HIV, with coverage of HIV testing of 
pregnant women now being close to 100% (NDoH 2015). PMTCT is offered in 
almost all health facilities in South Africa (98%), thus, the percentage of HIV-positive 
pregnant women receiving ARV treatment to reduce MTCT which has steadily 
increased from 83% in 2009 to 87.1% in 2012, should decline. MTCT decreased to 
2.7% in 2011 (NDoH 2015; Barron, Pillay, Doherty, Sherman, Jackson, Bhardwaj, 
Robinson & Goga 2013:71). HIV status disclosure enables women to make proper 
arrangements for safe delivery, safe feeding options, and administration of 
prophylactic treatment to their babies to prevent MTCT. 
 
In 2013, an estimated 360 000 South African children aged 0-14 years were living 
with HIV (NDoH 2016). From 2002 to 2012, unlike the report on Zimbabwe‟s HIV 
status, the prevalence declined among children, mainly due to PMTCT programmes. 
The scaling up of ART has reduced child mortality by 20% (UNAIDS 2016). More 
than 2.3 million children in South Africa were orphaned by HIV and AIDS in 2015 
(UNAIDS 2016). Orphans are particularly vulnerable to HIV transmission; they are 
often at risk of being forced into sex or have sex in exchange for support, and they 
also become sexually active earlier than other children (UNAIDS 2016). The impact 
of non-disclosure of HIV status to partners resulted in an increase in viral load and 
had an effect on the children, as some parents died due to AIDS-related conditions. 
It is beneficial to disclose an HIV status to adhere to preventive measures of MTCT, 
and improve one‟s health and that of the partner. 
 
The Saving Mothers‟ Report 2011-2013 (NDoH 2014:v) clearly identified that there 
are three conditions that contribute to the majority of preventable maternal deaths in 
South Africa namely: NPRI, obstetric haemorrhage, and hypertension. NPRIs and 
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HIV are the main cause of maternal deaths related to infections which account for 
53.47% of deaths (NDoH 2014:v). A lack of antenatal care prevents the mother from 
getting information on safe infant feeding, prevention of sexual infections, and 
PMTCT therapy. The preventive measures can be achieved if the HIV positive 
pregnant woman discloses her status to her partner. 
 
2.3.5 Limpopo Province 
 
The Limpopo Provincial AIDS Council‟s (2016) annual progress report of 2014/015, 
report the prevalence of HIV for people 2 years and older as follows: from 9.8% in 
2002 to 9.4% in 2012. The Capricorn District recorded HIV prevalence rates of 
21.1%. This is higher than the provincial average of 20.3% in 2013 (Department of 
Health (NDoH) 2016:7-8). 
 
In the epidemiology of HIV, the impact of HIV on the entire population has been 
outlined from Eastern Mediterranean, Western Pacific, Europe, America, South-East 
Asia, to Sub-Saharan Africa and South Africa. The next section will discuss the signs 
and symptoms of HIV. 
 
2.4  SIGNS AND SYMPTOMS OF HIV 
 
The signs and symptoms of HIV according to the WHO (2007:11) include four clinical 
stages: Clinical stage 1 involves no HIV symptoms and is called an asymptomatic 
latent stage. A person may infect the partner unknowingly. There may be persistent 
generalised lymphadenopathy on the neck, below the jaw, and armpits. At this stage, 
there are two types namely the rapid and the slow progressors. The rapid 
progressors denote people who progress fast and develop AIDS sooner, while the 
slow progressors remain without any manifestations of clinical disease (van Dyk 
2013:71-72; van Dyk, et al. 2017:86-98; NDoH 2015:123). 
 
Clinical stage 2 is characterised by minor symptoms of HIV disease with the 
following manifestations: moderate, unexplained weight loss up to ten percent (10%) 
of measured body weight, recurrent respiratory tract infections, herpes zoster, 
recurrent oral ulcers, angular chellitis which are cracks or splits of the lips and 
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corners of the mouth, seborrhoeic dermatitis which is an itchy scaly skin condition 
which affects the scalp, face, upper trunk and perineum, popular pruritic eruptions 
that occurs in the legs, and fungal nail infections of the fingers which are painful, red 
and swollen nail beds (van Dyk 2013:71-72; van Dyk, et al. 2017:91; NDoH 
2015:123). 
 
Clinical stage 3 is the major symptomatic stage where the immune system continues 
to deteriorate. It gives rise to opportunistic infections caused by micro-organisms that 
are not pathogenic in a healthy immune system. This stage is characterised by 
severe unexplained weight loss, unexplained chronic diarrhoea for longer than one 
month, unexplained fever or night sweats for longer than one month, oral 
candidiasis, pulmonary tuberculosis (TB), severe bacterial infections such as 
pneumonia, meningitis, pleural effusion, pyomyositis, and bacteremia (van Dyk 
2013:71-72; van Dyk, et al. 2017:91; NDoH 2015:123). 
 
Clinical stage 4 is the last stage with the most severe symptoms. This is the AIDS 
defining stage which is characterised by more persistent and unbearable 
opportunistic conditions and cancers, as the immune system fails. The signs and 
symptoms include HIV wasting syndrome of more than 10% of body weight, plus 
diarrhoea lasting for more than one month, or unexplained prolonged or intermittent 
fever for one month or more. Bacterial pneumonia, chronic herpes simplex viral 
infection, pneumocystis jiroveci pneumonia (PCP), oesophageal candidiasis, extra-
pulmonary tuberculosis, Kaposi sarcoma, cytomegalovirus (CMV), toxoplasmosis 
protozoal infection of the brain which is characterised by fevers, headaches, focal 
neurological signs, and confusion. Cryptococcal meningitis presents, which affects 
the central nervous system with the following: fever, severe headache, nausea, 
vomiting, neck stiffness, mental status changes and seizures. HIV encephalopathy is 
characterised by memory loss, poor concentration, tremors, headaches, confusion, 
loss of vision and seizures (WHO 2007; van Dyk 2013:71-72; van Dyk, et al. 
2017:91; NDoH 2015:123-125). 
 
The signs and symptoms guide health care workers with information for proper 
diagnosis and staging of the HIV infection. The next section will explain how HIV can 
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be diagnosed and how the CD4 cell count assists in the staging of disease 
progression. 
 
2.5  DIAGNOSIS OF HIV 
 
According to HBM (Polit & Beck 2017:124), perceived susceptibility is a person‟s 
perception that a health problem is personally relevant or that a diagnosis is 
accurate. Therefore, the diagnosis process and accuracy is vital to enhance 
perceived susceptibility. In this study, HIV positive pregnant women who were 
diagnosed more than one month before data collection took place were included in 
the sample, while those who were diagnosed less than a month before data 
collection were excluded from the sample, to allow them to accept their status and 
disclose to their partners. 
 
In South Africa, pregnant women are encouraged to visit the health care workers as 
soon as they suspect pregnancy for complete assessment of gestational age and 
risks. One of the assessments during pregnancy is to screen for HIV, to initiate 
measures to prevent MTCT, and to provide appropriate treatment, care and support 
to their children and family. Pregnant women are encouraged to use condoms to 
prevent status conversion. Condom use can be achieved more successfully if a 
woman has disclosed her HIV status to her sexual partner, as the reasons for 
condom use are linked to a decrease in the viral load and prevent transmission 
(NDoH 2016:109). 
 
According to a study conducted in Kenya by Nyandat and van Rensburg (2015:55), a 
determinant of disclosure is the duration of status awareness. Women who are 
aware of their status for a longer period are more likely to disclose their HIV status. 
The longer the duration since the diagnosis, the higher the ability to disclose the HIV 
status to the sexual partner (Genet, et al. 2015:5). A shorter period of HIV diagnosis 
leads to a greater likelihood of non-disclosure of the positive status to the partner. 
 
Unless the HIV positive pregnant women perceive that a health problem is relevant, 
and the diagnosis is accurate, disclosure of HIV status to the partner may be 
unlikely. It is the responsibility of the health care workers to counsel HIV positive 
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pregnant women to acknowledge that a health problem exists (HIV positive status). 
Information on HIV status disclosure to their partners needs to be shared with 
respondents to facilitate the prevention of MTCT, to enhance adherence to treatment 
regiments, and to prevent re-infections. 
 
The Guidelines for Maternity Care in South Africa (NDoH 2015:132) presents the 
HIV diagnosis process as follows: pre-counselling is done by health care workers in 
a private room at the primary health care facilities after verbal consent was provided 
by the pregnant woman, who proceeds to consent in writing. A rapid test is 
performed on a finger prick sample of blood. If the test is positive, a second rapid 
HIV test – using a test kit from a different supplier – will be performed on a second 
finger prick sample. If both tests are positive, the health care workers will confirm 
that the woman is HIV positive. If the first rapid test is positive and the second rapid 
test is negative, then a laboratory Enzyme-Linked Immunosorbent Assay (ELISA) 
test is performed on a venipuncture blood sample. Positive results will confirm the 
diagnosis. Post-test counselling is offered to the women irrespective of the outcomes 
of the result; that is, reactive (having HIV antibodies/positive) or non-reactive (not 
having HIV antibodies/negative). A woman with confirmed positive results is then 
clinically staged according to the signs and symptoms, and blood is taken for CD4 
cell count and serum creatinine (NDoH 2015:79, 132). The CD4 cell count is the 
laboratory test used to estimate the level of immune deficiency in HIV-infected 
individuals by counting the CD4 cells. These cells play an important role in keeping 
the immune system healthy. When an HIV-infected person has > 500 cells/mm3 
CD4 cell count, it is regarded as (asymptomatic) Stage 1. Stage 2 is characterised 
by mild symptoms of HIV with a CD4 cell count of between 350-499 cells/mm3. 
Stage 3 is characterised by advanced symptoms of HIV with a CD4 cell count of 
between 200-349 cells/mm3. Stage 4, which is the last stage according to the WHO 
clinical staging, manifests with severe symptoms of HIV diseases, with a CD4 cell 
count fewer than 200 cells/mm3 (van Dyk, et al. 2017:88). 
 
There is a relationship between a person‟s viral load and CD4 cell counts whereby 
the higher the viral load, the lower the CD4 counts, because the virus destroys the 
CD4 cells. A lower viral load is reciprocated by a higher CD4 cell counts as there are 
fewer viruses in the blood and the immune system gets a chance to increase CD4 
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cells (van Dyk, et al. 2017:84). The health care workers should offer disclosure 
education to HIV positive pregnant women to disclose their HIV status to their 
partners soon after diagnosis to promote adherence to treatment and to lower the 
viral load (Refer to Section 2.7). Early diagnosis may enhance effective management 
and treatment of HIV infections.   
  
2.6  TREATMENT OF HIV 
 
ART is lifelong according to the national ART programme (UNAIDS 2016:5). In 2015, 
the WHO released guidelines recommending that people living with HIV be offered 
ART immediately following diagnosis regardless of CD4 counts. South Africa began 
implementing this recommendation in 2015 (UNAIDS 2016:5). The HIV positive 
pregnant woman needs to take treatment every day without failure for proper 
functioning of the treatment (to supress the viral load below undetectable levels of 
available assays < 50 copies/ml) (van Dyk, et al. 2017:8). The woman also needs to 
adhere to safe sex practices by using condoms to prevent re-infections, she must 
prepare for safe delivery and safe feeding options, and prophylactic treatment for the 
baby. This can be achieved if the pregnant woman can disclose her HIV status to her 
partner to ensure support and to enhance adherence to treatment. 
 
The ART regimen for HIV positive pregnant women includes: Tenofovir/ 
Emitricitabine/Efavirenz as a FDC (NDoH 2016:110). If tuberculosis (TB) is 
diagnosed, the HIV positive pregnant woman will be commenced with ART after it is 
clear that TB symptoms are improving and that TB therapy is tolerated (van Dyk 
2013:116). TB treatment can only be successful if the patient adheres to the 
treatment by taking a complete and uninterrupted course of the drug therapy (NDoH 
2015:116; van Dyk, et al. 2017:113). Adherence to treatment is enhanced when the 
HIV positive pregnant woman discloses her status to her partner as she will receive 
emotional and financial support and will not have to hide her treatment. The ART 
regimen will suppress the viral load to an undetectable level, while the immunity of 
the HIV positive pregnant women will improve. This will reduce MTCT of HIV if the 
woman has disclosed her status to her partner, as adherence will improve and 
transmission to her partner will be prevented. 
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Table 2.1 provides a summary of ART regimens that are available in South Africa 
which include: drug, dosage, side effects, and contra-indications (van Dyk, et al. 
2017:148-149). There are four classes of ARV drugs that interfere with the viral 
enzymes and one class that inhibit entry into the host cell. These are nucleoside and 
nucleotide reverse transcriptase inhibitors and non-nucleoside reverse transcriptase 
inhibitors, which interrupt the lifecycle of HIV by interfering with the reverse 
transcriptase enzyme during the early replication of the virus. Protease inhibitors 
inhibit the creation of new viruses by “paralysing” the protease enzyme. Integrase 
inhibitors interfere with the integrase enzyme and prevent HIV DNA to integrate into 
the nucleus of the CD4 cell. The virus will be unable to replicate. Entry inhibitors stop 
HIV from entering the host cell by affecting the interaction between the virus and the 
cell (van Dyk, et al. 2017:148-149). 
 
Table 2.1: Guidelines for HIV treatment 
DRUG DOSE SIDE EFFECTS 
CONTRA-
INDICATIONS 
Tenofovir (TDF)  300mg daily 
Bone density 
reduction, 
flatulence, nausea, 
diarrhoea, abdominal 
discomfort, asthenia, 
acute/chronic renal 
insufficiency, 
Fancony syndrome 
 Serum creatinine of 
>85µmol/L 
Emitricitabine 
(FTC) 
200mg daily 
Severe skin and 
hypersensitivity 
reaction 
 
Lamivudine (3TC)  300mg daily 
Headache and dry 
mouth 
 
 
Nevirapine (NVP) 
200mg daily 
X14 days then 
200mg twice 
daily 
Hepatitis, 
hepatotoxicity, rash, 
hypersensitivity 
reaction, Stevens-
Avoid NVP if CD4 
count is >250 
cells/µL for women 
and >400 cells/µL for 
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DRUG DOSE SIDE EFFECTS 
CONTRA-
INDICATIONS 
Johnsons syndrome men  
Efavirenz (EFV)  
600mg at 
night (400mg 
<40kg) 
Hepatitis, persistent 
central nervous 
system toxicity (such 
as abnormal dreams, 
depression or mental 
confusion) 
Active psychiatric 
illness present 
Lopinavir/Ritonavir 
50mg (2 tabs 
twice daily), 
preferably 
taken with 
food 
Diarrhoea, nausea & 
vomiting, 
dyslipidaemia, 
elevation in liver 
function tests, test 
perversion 
 
Zidovudine (AZT) 
300mg daily Nausea, anaemia, 
neutropenia, 
myopathy, 
lipoatrophy, or 
lipodystrophy, lactic 
acidosis or severe 
hepatomegaly with 
steatosis 
Avoid is severe 
anaemia (Hb<8 or 
<7 g/dl in pregnant 
women) 
Stavudine (D4T) 
Discontinue 
use 
Replace with TDF 
 
Source: NDoH 2014:75-78; van Dyk, et al. 2017:148-155 
 
For women of child-bearing age who are not on reliable contraception (not using dual 
contraception) and those who are pregnant, Nevirapine is preferred rather than 
Efavirenz as Efavirenz is teratogenic to the foetus, especially in the first trimester 
(van Dyk 2013:113-116). The first line of treatment for pregnant and breastfeeding 
women, as well as all other adults as recommended by the WHO (NDoH 2015:89-
91), and implemented by the South African Department of Health consists of two 
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nucleoside and nucleotide reverse transcriptase inhibitors and non-nucleoside 
reverse transcriptase inhibitors. Regimens that include FDCs that are taken only 
once daily are preferred. The favoured regimen used in the public sector for first line 
treatment is: TDF (tenofovir) + 3TC (lamivudine) or FTC (emtricitabine) + EFV 
(Efavirenz) (van Dyk, et al. 2017:155). 
 
First line regimen includes: Tenofovir (TDF) plus Lamivudine plus Efavirenz. If a 
patient is contraindicated to Tenofovir due to renal disease, AZT plus 3TC and EFV 
or NVP can be given (van Dyk 2013:113-116). 
 
Second line regimen includes: Failing in AZT based first line regimen may be given 
Tenofovir plus 3TC plus Lopinavir. Failing TDF based first line regimen may be given 
AZT plus 3TC and Lopinavir (van Dyk 2013:113-116). 
 
Salvage therapy: Failing any second line regimen will require specialised care. 
Therefore, the patient will be referred to a specialist. Unless there are some side 
effects on the drugs in the first line regimen, drugs prescribed during pregnancy may 
be continued for life (van Dyk 2013:113-116; NDoH 2015:49-50; NDoH 2016:110-
115). 
 
Counselling on treatment adherence needs to be given to pregnant women so that 
the desired outcomes can be achieved. The next section that follows will be 
counselling and pregnant women‟s adherence. 
 
2.7  PATIENT COUNSELLING AND ADHERENCE 
 
According to van Dyk (2013:121), an adherence level of at least 90% is necessary to 
sufficiently suppress the virus to avoid risks of maturation and to prevent the 
development of drug resistance. The adherence level can be achieved when HIV 
positive pregnant women disclose their HIV status to their partners and the viral load 
is suppressed to an undetectable level. “Undetectable” means that the viral load in 
the blood is lower than the bottom limit of detection for a particular test that is being 
used (van Dyk 2013:121). An undetectable viral load does not mean that the person 
is no longer infected with HIV. The virus is still in the body, but at a very low level 
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(van Dyk 2013:121). Eliminating HIV transmission requires a multidisciplinary 
approach whereby the health care workers need to assist the patient to cope with the 
disease physically, psychologically, and spiritually (van Dyk, et al. 2017:432). 
Pregnant women should be counselled by the health care worker about the benefits 
of HIV status disclosure in collaboration with other stakeholders like psychologists, 
social workers, pharmacists, dieticians, medical practitioners, support groups, and 
supportive partners to facilitate effective care. 
 
During pre- and post-test counselling, disclosure education is provided to all 
pregnant women on their first encounter with the health care worker at the health 
facility. Information on the benefits of testing for HIV is outlined so that the women 
can make informed choices. The process of HIV testing is explained to the women, 
they are told that they are not forced to be tested and it should be explained why 
they need to be tested (van Dyk 2013:269-270). 
 
Post-test counselling provides an opportunity to discuss the importance of linking 
other HIV-related services. The health care worker should allow and encourage 
pregnant women to invite a supportive adult or a partner to support them. At the time 
of HIV diagnosis, the health care worker should involve the patient in the decision 
making process of ART initiation and the treatment plan/follow-up visit schedules 
during HIV counselling and testing (HCT). The health care worker should identify and 
address any possible barriers of linkage to care. Assessment for ART eligibility 
should be done by the health care worker. Where possible the mother will be 
introduced to post-diagnosis peer support groups. The peer support groups are led 
by pregnant and postpartum women, who were diagnosed with HIV, who had 
accepted their diagnosis and disclosed their status to their partners to help their 
peers in overcoming the challenges of disclosing their status to their partners so as 
to share their personal testimonies (NDoH 2015:33). 
 
The health care workers should spend time with the woman and explain the disease, 
the goals of therapy, and the need for adherence. Discussions should be held on the 
role of viral load and suppression. A treatment plan should be negotiated that the 
woman can understand and commit to. How to avoid adverse drug-drug interactions 
should be explained to the woman. The woman should understand the possible 
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consequences of mixing other prescribed or recreational drugs and substances 
(NDoH 2014:36). Counselling before ART initiation includes discussions on safer sex 
practices and reproductive health which entails: consistent condom use; family 
planning; contraception; pregnancy; and how to prevent MTCT. Disclosure to 
partners and/or other members of the household is also encouraged (van Dyk, et al. 
2017:154). 
 
The effectiveness of adherence to the treatment regimen are increased when the 
pregnant woman has disclosed her HIV status to her partner. The next section 
outlines disclosure of HIV status. 
 
2.8  HIV DISCLOSURE 
 
Disclosure education and HIV status disclosure is discussed next. 
 
2.8.1 Disclosure education 
 
Disclosure is when a person shares personal information with another person (van 
Dyk, et al. 2017:146). In this study, disclosure is when pregnant women disclose 
their HIV status to their partners. The health care workers should offer HIV-related 
information as disclosure education to the HIV positive pregnant women with pre-test 
and post-test counselling after their status is confirmed to promote/encourage HIV 
status disclosure to the partners. The health care workers should support all HIV 
positive pregnant women in disclosing their status and partner notification (NDoH 
2015:45). It is vital that pre- and post-test disclosure education follows a planned 
process. The process of disclosure education is cyclical (like a circle); the health 
care workers need to re-educate community members through all forms of media 
and at every contact with the patients as new information or deeper levels of 
information are shared (NDoH 2015:45). 
 
Firstly, the health care worker needs to do preparation and planning which include a 
conducive environment, documenting every process, and providing appropriate 
information for disclosure. After preparation and planning, assessment follows. 
Emotions are assessed and the type of disclosure is decided on. Assessment is then 
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followed by disclosure and health promotion tasks: linkages of information and 
follow-up dates need to be given to the patient. Lastly, the disclosure and health 
promotion tasks are followed by support and follow-up dates. Multidisciplinary team 
involvement is encouraged and on-going assessment of patients‟ well-being is 
ensured (NDoH 2015:45). 
 
According to Selebogo, van der Merwe and Smith (2014:96) in their South African 
study most of their respondents (73.6%) indicated that members of the community 
have knowledge about HIV status disclosure (although not enough) – of making their 
HIV status public. This statement implies that many people know that they should 
disclose their HIV status. The health care workers should continue to disseminate 
the information until HIV positive pregnant women in the community are able to 
disclose their status to partners. 
 
Adherence to lifelong treatment requires a continuous process whereby more 
information is provided to pregnant women. Therefore, the health care workers need 
to assess and provide information so that the patient can make an informed decision 
on disclosure. Disclosing an HIV status is discussed next. 
 
2.8.2 HIV status disclosure 
 
The health care workers need to remember that patients should be comfortable with 
their diagnosis before disclosing it to others, and they should protect the patients 
against undue pressure to disclose their HIV status (van Dyk, et al. 2017:411). In a 
Tanzanian study by Yonah, Fredrick and Leyna (2014:3), most of the respondents 
preferred not to disclose their HIV status to their partners; 19% disclosed to parents, 
50.8% to close relatives, 4% to a friend, 0.8% to others. Only 25.4% disclosed their 
status to their partners. Reasons given by 16.66% of respondents who did not 
disclose their status included fear of divorce when they disclosed their status to their 
partners. According to another study conducted in Tanzania, disclosure of HIV status 
by a pregnant woman to her family/significant other is important as they may offer 
her support to reduce stress. However, disclosing her status to her partner is 
paramount as it will protect the uninfected partner from HIV infection since 
adherence to safe sex practices is enhanced. This prevents re-infections, and 
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facilitates discussions on contraceptives to prevent unintended pregnancies. It also 
ensures that the partner is tested and provided with treatment, enhancing adherence 
to treatment and preventing MTCT of HIV (Moshi, Helleve & Grandmann 2016:19). 
The next section centres on the benefits of disclosure. 
 
2.8.2.1 The benefits of HIV status disclosure 
 
According to the HBM, health-seeking behaviour is influenced by a persons‟ 
perception of a threat posed by a health problem and the value associated with 
actions aimed at reducing the threat (Polit & Beck 2017:124). Pregnant women 
should perceive the severity of the problem so that action can be taken to enhance 
disclosure and to ensure treatment adherence. Even though the South African 
government provides ARVs in public health facilities, women need to be ready to 
disclose their HIV status to their partners to reduce HIV transmission to their partners 
and to prevent MTCT. 
 
According to Yonah, et al. (2014:4), the benefits of HIV status disclosure include: 
improving quality of life for people living with HIV and AIDS, freedom to use ARVs 
without hiding, financial and moral support, and the use of protection to prevent re-
infection. According to the HBM, perceived benefits are the patients‟ beliefs that a 
given treatment will cure the illness or help prevent it. Pregnant women who perceive 
that ARVs may help in the prevention of MTCT and promote a healthy life will 
consider it beneficial to disclose their HIV positive status to their partners. Alema, et 
al. (2017:58) further indicate that the benefits of disclosure included on-going support 
whereby frequent discussions related to HIV topics are addressed, resulting in 
behavioural changes. As a result, individuals were able to overcome feelings of 
shame which related to the disclosure of their HIV positive status. 
 
According to Selebogo, et al. (2014:105) their respondents believed that there are 
some benefits in disclosing one‟s HIV status; 92.5% indicated it prevents the spread 
of HIV; 91.5% indicated it decreases the HIV/AIDS mortality rate. These benefits are 
achieved when the pregnant woman can disclose her HIV status to her partner. 
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The benefits of HIV status disclosure of pregnant women also include: access to 
medical services, care and support, access to ART, protecting oneself and others, 
and openness about their HIV status which may help in negotiating safe sex 
practices (condom use). It may also help to reduce stigma, discrimination, and denial 
that surround HIV/AIDS (van Dyk 2013:298). 
 
2.8.2.2 Availability of ARVs in the health facilities 
 
According to the study conducted in United Kingdom (UK) by Greenhalgh, Evangeli, 
Frize, Foster and Fidler (2016:283), the availability of ART for children has improved 
survival for individuals with perinatally acquired HIV (PAH) (this is an infection that 
occurred at or around the time of birth) (Greenhalgh, et al. 2014:283). Within the UK, 
around 50% of those with PAH are now aged ≥15 years. This study confirms that the 
availability of ARVs in health facilities can prolong life as long as HIV positive women 
disclose their status to their partners. This will enable them to give treatment to their 
babies without fear of being seen or judged. 
 
According to UNAIDS (2016:3), the scale-up of ART is on a fast-track trajectory (the 
curved path) that has surpassed expectations. Global coverage of ART reached 46% 
at the end of 2015. Gains were greatest in the world‟s most affected region, Eastern 
and Southern Africa. Coverage increased from 24% in 2010 to 54% in 2015, 
reaching a regional total of 10.3 million people. 
 
2.8.2.3 Accessibility ARVs 
 
According to the study by Earnshaw, Smith, Shuper, Fisher, Cornman and Fisher 
(2014:1510) in South Africa, increased access to ART can potentially reduce self-
stigma by normalising HIV infection. This study eludes that the availability of 
treatment may motivate pregnant women to disclose their HIV positive status to their 
partners so that the partner might also have access to ARVs. 
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2.8.2.4 Treatment (ARVs) coverage and initiation 
 
UNAIDS (2016:4) states that treatment coverage in Latin American and the 
Caribbean reached 55% in 2015. In the Asia and Pacific region, coverage more than 
doubled, from 19% in 2010 to 41% in 2015. Western and Central Africa and the 
Middle East and North Africa also made important gains but achieved lower levels of 
coverage in 2015, 28% and 17% respectively. In Eastern Europe and Central Asia, 
coverage increased by just a few percentage points in recent years to 21%; about 
one in five people living with HIV in the region. 
 
The reduction in AIDS-related deaths since 2010 has been greater among adult 
women (33% decrease) compared with adult men (15% decrease), reflecting higher 
treatment coverage among women than men, 52% and 41% respectively (UNAIDS 
2016:4). According to UNAIDS (2016:4), the gender gap for treatment among adults 
highlights the impact of gender norms that delay initiation of treatment among men, 
which reduce treatment adherence, blunt the preventive effects of treatment, and 
lead to men accounting for 58% of adult AIDS-related death. Higher treatment 
coverage may be linked to antenatal care and offering HIV tests during pregnancy as 
the women who test HIV positive is started on treatment. 
 
According to UNAIDS (2016:3), South Africa alone had nearly 3.4 million people on 
treatment, more than any other country in the world. After South Africa, Kenya has 
the largest treatment programme in Africa, with nearly 900 000 people on treatment 
at the end of 2015. Botswana, Eritrea, Kenya, Malawi, Mozambique, Rwanda, South 
Africa, Swaziland, Uganda, the United Republic of Tanzania, Zambia and Zimbabwe 
all increased treatment coverage by more than 25 percentage points between 2010 
and 2015. Even though HIV treatment is available in public health facilities, it is the 
responsibility of the HIV positive pregnant women to commit to lifelong treatment and 
to disclose their HIV status to their partners as part of the vital role to promote the 
health status of couples and to prevent MTCT. 
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2.8.2.5 Condom use 
 
Based on the study conducted by Clum, Czaplicki, Andrinopoulos, Muessig, Hamvas 
and Ellen (2013:197) in Miami, New York City, and Philadelphia in the USA, women 
who were clear that they would not have sex without a condom were the most likely 
to practice safe sex. This was done to avoid disclosing their HIV positive status. Less 
assertive women and those who did not believe they could control condom use in 
partners were less likely to use condoms. For those women who consistently used 
condoms in the study by Clum, et al. (2013:197), condoms were utilised to avoid 
disclosure of HIV status. 
 
When condoms are used consistently and correctly, latex condoms are very effective 
in preventing the transmission of HIV and other STIs (van Dyk, et al. 2017:116). 
According to a study by Grov, Agyemang, Ventuneac and Breslow (2013:77) in the 
USA, the majority of men (78.6%) responded that they would use condoms with their 
partners regardless of whether they met online or not. The predominant sentiment 
from these respondents was that they had made a priority decision to use condoms 
all the time; thus, it was not an issue for them. It seems persistent condom use may 
prevent the transmission of HIV among partners. 
 
According to the Zimbabwe Demographic and Health Survey (2015:241), 14% of 
women and 37% of men had sexual intercourse with a non-marital, non-cohabitating 
partner (higher risk sexual partners) in the past 12 months. Two-thirds of women 
(67%) and more than 8 in 10 men (85%) used condoms at last intercourse with such 
a partner. The report indicates that Zimbabwean men are able to negotiate condom 
use during sexual relations than women. If women are not able to negotiate condom 
use, they should disclose their status to their partners which will create an 
opportunity to discuss safe sex practices to prevent re-infections and MTCT. 
 
Jones, Peltzer, Villar-Loubet, Shikwane, Cook, Vamos and Weiss (2013:706), in 
contrast with Grov, et al. (2013:77), claim that HIV transmission during pregnancy is 
higher than among non-pregnant couples. This study identified high rates of 
unprotected sex during pregnancy as well as sero-conversion (the point at which a 
person‟s HIV status converts or changes from being HIV negative to HIV positive) 
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among the control group of women by 32 weeks pregnancy. This study by Jones, et 
al. (2013:706) indicates that pregnant women did not utilise protective measures 
such as latex condoms, which exposed them to HIV infections and increased their 
viral load. 
 
According to Mbokane, et al. (2016:16), 92.0% of their respondents were shocked to 
be diagnosed as HIV-positive. The respondents became pregnant because they did 
not use condoms effectively. The health care workers need to provide information to 
the pregnant women on the importance of effectively and consistently using 
condoms. Condoms are not only used for contraception, but also for protection 
against STIs and re-infections, which is achievable after disclosure of HIV status to 
partners has taken place. 
 
Condom use seems to be closely linked with HIV prevention and status disclosure. 
Some respondents in Clum, et al‟s. (2013:197) study negotiated condom use to 
avoid disclosing their HIV status to their partners. On the other hand, only 67% of 
respondents, according to the Zimbabwe Demographic and Health Survey 
(2015:241), used condoms with high risk partners. The role of condom use in safe 
sex practices relating to disclosure of HIV status needs to be further explored in 
future research. 
 
The studies discussed indicate that pregnant women may benefit from disclosing 
their HIV status to their partners. They may then have improved quality of life, 
condoms will be used consistently to prevent re-infections, they will have freedom to 
use ART, receive financial and moral support from their partners, and behavioural 
change will take place. The benefits can be achieved if the respondents are 
motivated to disclose their status to their partners. The next topic is the motivating 
and enabling factors of disclosure. 
 
2.8.3  The motivating and enabling factors for HIV status disclosure 
 
Motivation is defined as to make somebody want to do something; especially 
something that involves hard work or an effort (Hornby 2015:979). Motivation to 
comply with treatment is one of the components of the HBM (Polit & Beck 2017:124). 
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In this study, HIV positive pregnant women need to have the motivation/desire to 
disclose their status to their partners and to comply with the treatment. Unless the 
respondents are motivated to follow the planned MTCT programme and promote 
their own health and that of their partners, HIV status disclosure may not be attained. 
 
According to a study conducted by Xiao, et al. (2015:79) in China, the duty to 
inform/educate one‟s partner was the only motivating factor that was related to HIV 
disclosure. The duty to inform/educate one‟s partner was consistent with “a sense of 
obligation” as an important motivator for HIV disclosure in intimate relationships. In 
HIV status disclosure, a pregnant woman is obliged to inform her partner about her 
HIV status so that he can also receive treatment, to prevent re-infections and MTCT. 
In Mbokane, et al‟s. (2016:14) study, 70.5% of respondents disclosed their status to 
their sexual partners. One primary motivation appeared to be feelings of guilt over 
not disclosing sooner and a sense of moral obligation to disclose their HIV status 
(Clum, et al. 2013:195). 
 
2.8.4  Factors influencing HIV status disclosure 
 
The UNAIDS (2016:3) reports that there was a decline in new HIV infections among 
adults, with an estimated annual static number of nearly 1.9 million in 2015. One of 
the reasons why there were still a number of new infections might be challenges 
relating to HIV status disclosure that is detrimental to HIV prevention. 
 
In a study conducted in Kenya by Moyer, et al. (2013:65), participants pointed out 
that fear of disclosure has negative consequences as living with a secret was 
psychologically stressful. It led to isolation and often unwarranted fear as people 
tend to imagine the worst reactions from family, friends and partners such as 
abandonment, rejection and lack of family support. Moyer, et al. (2013:65) state that 
some participants pointed out that fear of disclosure could interfere with treatment 
adherence since people who were hiding their HIV positive status were also likely to 
hide their medicines or stop taking them. 
 
A study conducted in South Africa by Yako and Memeza (2013:82) indicated that 
59% of respondents did not disclose as they were afraid of losing friends and 
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popularity. Some wanted to deliberately infect others (22%), since their sexual 
partners had not disclosed their own positive status. They expressed their anger at 
not being given the opportunity by their partners to make informed decisions about 
practising safe sex or the continuation of the relationships. The respondents in this 
study were still in the grieving process as evidenced by the anger they displayed in 
relation to HIV status disclosure to their partners. According to Yako and Memeza 
(2013:82), respondents need continuous support from health care workers and 
support groups to help them come to terms with the new condition. 
 
The following factors that influence disclosure will be discussed next: fear of 
abandonment and physical abuse, loss of economic/financial status, stigma, HIV 
status duration and disclosure, traditional and modern belief, breach of 
confidentiality, lack of on-going support, and biographic barriers. 
 
2.8.4.1 Fear of abandonment and physical abuse 
 
Atuyambe, Ssegujja, Ssali, Tumwine, Nekesa, Nannungi, Ryan and Wagner 
(2014:290), in the study conducted at Kampala, Uganda, claim that people do not 
want to disclose their HIV status as they fear disclosure repercussions such as 
violence, separations, withdrawal of support, and negative emotional reactions. 
Yaya, Saka, Landoh, Patchali, Patassi, Aboubakari, Makawa, N‟Dri, Senanou, 
Lamboni, Idrissou, Salaka and Pitche (2015:6) conducted a research in Togo, and 
also state that 39% of respondents living with HIV/AIDS did not disclose their HIV 
status. The situation reflects the extent to which HIV remains a myth among 
populations and the factors that influence disclosure include stigma from neighbours, 
rejection, and physical abuse from partners. The researcher was curious if the 
pregnant women from the Capricorn District in Limpopo Province experience similar 
barriers in status disclosure to their partners. 
 
In Tshisuyi and Davis‟ (2014:59) Botswana study, 65% HIV positive pregnant women 
reported that they were afraid that they would be blamed, 42% feared rejection, and 
50% feared abuse as the reasons thought to have contributed to non-disclosure. 
Letsoalo and Madiba (2014:9) conducted a study on HIV positive postnatal women 
receiving PMTCT interventions in South Africa, and also identified similar barriers of 
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disclosure; most women felt that their male partners might react violently and blame 
the women for the HIV infection. Letsoalo and Madiba (2014:9) further showed that 
33.33% of HIV positive postnatal women who disclosed their HIV results were 
abandoned by their male partners after disclosure. According to Nyandat and van 
Rensburg (2015:61), 17% of HIV positive women did not disclose their status due to 
fear of abandonment, withdrawal of social support from partners, discrimination, and 
violence. These studies indicate that intimate violence, blame and abandonment/ 
rejection were factors that influenced HIV status disclosure. 
 
Kiweewa, et al. (2015:4), in a study conducted at Kampala University in Uganda, 
showed that 38% of respondents who had not yet disclosed their HIV status to their 
partners also feared separation, 34% feared loss of financial support, 26% were 
separated or not living with the partner (not having opportunities to disclose), and 2% 
feared stigmatisation. Other reasons included fear of causing worry to the partners 
and fear of a harmful reaction from the partners. Respondents were afraid that their 
partners may harm themselves or become abusive, and 38% were not yet ready to 
disclose their HIV status. 
 
In the study conducted by Tshweneagae, Oss and Mgutshini (2015:4) in a hospital in 
the Northern Cape Province, South Africa, it was found that 9 out of 13 of their 
participants disclosed their HIV status to their sexual partners. Three participants 
had not disclosed because they were not involved in relationships at the time of the 
study. However, these participants maintained that if they were in relationships, they 
would tell their partners. One did not disclose his status because he feared rejection. 
The majority of the study participants were females and the minority were males. 
This study differs from the context of the current study as it involved non-pregnant 
HIV positive women and HIV positive male participants. Similar to the study by 
Kiweewa, et al. (2015:4), fear of being rejected by the partner was considered a 
factor that influenced HIV status disclosure to partners. 
 
These studies indicated the most common factors influencing HIV status disclosure 
included fear by the respondents relating to violence, blame and 
abandonment/rejection. Another factor that can influence status disclosure is loss of 
economical/financial status. 
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2.8.4.2 Loss of Economical/financial status 
 
Tam, Amzel and Phelps (2015:447) report that respondents with low wage 
employment and who were financially dependent on their partners, believed that 
disclosure would cause divorce and loss of monetary support, and were less likely to 
disclose their HIV status to their partners. According to Kiweewa, et al. (2015:4), 
99% of respondents had disclosed their HIV status to at least one person, while 1% 
had never told anyone about her status. Among the respondents who had not yet 
disclosed their HIV status to their partners, 34% feared separation which can result 
in loss of monetary or financial support. Pregnant women need their partners‟ 
financial support even if they are working, as they will have a baby to provide for in 
future. Therefore, it is vital to let the pregnant women compare the benefits of 
disclosure which will benefit the woman, partner and the baby, versus non-disclosure 
of the HIV status. 
 
Kiula, et al. (2013:6-7) state that 41% of respondents – mostly married/cohabiting 
HIV positive pregnant women attending antenatal care in Morogoro, Tanzania – had 
disclosed their HIV status to their partners. Among 148 pregnant women who had 
not disclosed, 43% planned to disclose to their partners in the future, while 56.75% 
did not plan to disclose at all as they were afraid to lose financial support. 
Respondents who depended on their partners for food, rent, and school fees, were 
less likely to disclose their HIV status to their partner/spouse, than others. Other 
markers of low economic status such as low income and lower educational level of 
the woman or partner also negatively affected disclosure. 
 
Nyandat and van Rensburg‟s (2015:61) study revealed that pregnant women must 
overcome a number of difficulties when disclosing their HIV status to their partners, 
including fear of a loss of economic support. Therefore, women who choose not to 
disclose their HIV status due to fear of financial loss, should note that secrecy has 
been identified as a risk for MTCT, and delays in starting ART, poor compliance, lack 
of postnatal infant prophylaxis, or breastfeeding. 
 
Most of the Sub-Saharan countries, including African countries, belong to the 
developing world and are financially deprived. Women are mostly affected by lack of 
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finances whereby dependency on the partner is not a choice, but a reality to abide 
by. This may negatively affect the motivation to disclose their HIV status due to fear 
of financial loss. The next section on barriers of HIV status disclosure is stigma. 
 
2.8.4.3 Stigma 
 
According to the study conducted in Russia by Shilovskaya (2015:11), it was 
indicated that the government does not provide social security for HIV positive 
people and they refused to accept them in open hospitals. Two-thirds (71%) of 
respondents were aware of what stigma is, and none of them admitted revealing 
their HIV positive status openly to the community, even if they were asked directly. 
Some of the reasons for reluctance in disclosure were: 27% feared public neglect, 
27% feared negative attitudes towards their children, and 12% feared dismissal from 
work. Disclosure had potential risks such as discrimination, stigma, and violence 
from partners. Disclosure may also negatively affect the quality of family 
relationships. 
 
In the Ugandan by Batte, Katahoire, Chimoyi, Ajambo, Tibingana and Banura 
(2015:6), in contrast to Shilovskaya‟s findings, the level of stigma was low among 
people who disclosed their HIV positive status. It was suggested that the low level of 
stigma in their study was attributed to the increased awareness of HIV care which 
has been created by the government of Uganda and non-governmental 
organisations. 
 
The primary reasons for not disclosing one‟s status offered in Yako and Memeza‟s 
(2013:84) study were also to avoid stigma and discrimination by significant others. 
Although HIV/AIDS was discovered in 1982 (van Dyk 2013:4-6), stigmatisation still 
exists. It is evident that stigma from the community, family and partners may hamper 
the good intension of pregnant women to protect themselves and their partners 
against HIV re-infection through disclosure. 
 
Van Rooyen and Mhlongo (2015:56) also state that participants witnessed fellow 
community members being stigmatised when a person was identified as HIV-
positive, especially females. Stigma was directly linked to public knowledge of one‟s 
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status. Consequently, disclosure of their HIV status was avoided due to witnessing 
the experience of stigmatisation. 
 
2.8.4.4 The HIV status duration and disclosure 
 
The prenatal period is also defined as the gestational process which is a period of 
intrauterine development from conception until the birth of an infant (Davidson, et al. 
2014:8). More specifically, physicians worldwide calculate the duration of pregnancy 
from the first day of the last menstruation (Louw & Louw 2014:67). HCT are offered 
at any time the woman presents herself for antenatal clinic assessment. If the 
woman delivers without being tested for HIV, this can be offered in the postpartum 
period. Postpartum is the period from the completion of the delivery (end of third 
stage of labour) to the end of the first 6 weeks, during which time the woman‟s body 
returns to the normal non-pregnancy state (Dippenaar & da Serra 2014:760). Even if 
the first HIV test was negative, this does not mean that the woman is immune to 
infection and this is the motivation behind encouraging a re-test at 3 months and 
continuation of condom use (NDoH 2016:111). 
 
According to the study undertaken in China by Qiao, Li, Zhou, Shen and Tang 
(2016:39), the average duration since HIV diagnosis and disclosure was almost 4 
years. Even 4 years after receiving their diagnosis, 50% of respondents were unable 
to disclose their HIV status to their partners. According to van Dyk, et al. (2017:463), 
disclosure is a process, not an event. Disclosure is an on-going process that may 
last for several years. The HIV positive pregnant women should first accept that they 
have the HIV infection. They should also have enough information and courage, 
which will enable them to deal with any negative reactions that can arise during the 
disclosure process before the actual disclosure. 
 
The duration for disclosure of HIV may be limited for pregnant women as some are 
diagnosed late in pregnancy and may not have enough time to be able to disclose 
their HIV status so as to utilise MTCT preventive strategies. Pre-pregnancy HIV 
counselling may be enhanced for women who are planning to become pregnant so 
as to have ample time to come to terms with the new diagnosis, which will facilitate 
disclosure. 
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2.8.4.5 Traditional and modern belief 
 
There are certain traditions that can be a factor in non-disclosure of HIV status. 
Some traditions prescribe male-dominant and female-submissive roles, therefore, 
traditional African beliefs and customs must be considered when developing HIV 
prevention programmes in Africa (van Dyk, et al. 2017:202-203). Many traditional 
people are especially concerned about secrecy and confidentiality where HIV and 
AIDS are concerned, because they fear rejection by the community if their HIV status 
becomes general knowledge. Even in the (modern) present time, the socio-cultural 
environment might not be conducive to HIV status disclosure as women are afraid 
they will be killed (van Dyk, et al. 2017:327). Health care workers need to 
acknowledge the traditional and modern beliefs of HIV positive pregnant women to 
be able to assist them in disclosing their status to their partners. 
 
According to Seeling, Mavhungu, Thomas, Adelberger and Ulrichs (2014:273), in 
their study conducted in Namibia interference with Pentecostal churches also turned 
out to create a challenge for HIV status disclosure. Faith healing, including healing of 
diseases that are classified as incurable in scientific medicine – like HIV infection – 
was a challenge. An increasing number of patients defaulted treatment because 
some Pentecostal churches in Namibia encouraged their congregations to stop 
taking medications for HIV. 
 
Tshibangu-Kalala and Mavhandu-Mudzusi (2014:41) agree that cultural beliefs are 
among the factors contributing to young refugee girls being vulnerable to 
intergenerational sexual relationships. Cultural beliefs tend to decrease young girls‟ 
ability to discuss safe sex when dealing with older men. This increases the likelihood 
of young refugee girls being infected with HIV. This is because dominant African 
cultural norms prescribe that women must be obedient to their male partners and 
that young people must have respect for and show obedience to older people. It is 
the responsibilities of the health care workers to offer holistic health care that 
includes cultural sensitivity and awareness without compromising confidentiality of 
the HIV positive pregnant women in their care. The next section will cover breach of 
confidentiality. 
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2.8.4.6 Breach of confidentiality 
 
According to Nie, Walker, Qiao, Li and Tucker (2015:86), in their study conducted in 
China there was a practice of informing family members before patients are given 
the nature of their conditions. This practice caused potential tension between what 
has been called “Chinese familism” and patients‟ rights to information, privacy, and 
independence. Many physicians experienced this tension directly in their practice. 
Moreover, it does not negate the importance of those other rights, and when 
involving families in a patient‟s care, the health care workers should be alert to the 
possibility that the patient may need to keep some information private, or to maintain 
some degree of independence. 
 
In Nie, et al‟s. (2015:86) study, close to 90% of people living with HIV chose to exert 
their control over their private information in the form of non-disclosure of their HIV 
status to their partners. The common concern of the respondents was that if they 
disclose their HIV status to their partners, they have to reveal other secrets as well 
(such as sexual orientation and practices), or their partners would tell a third party 
about their HIV status. This finding indicates that concerns about privacy inhibit HIV 
disclosure to the partner (Xiao, et al. 2015:78). 
 
Van Dyk‟s (2013:52) study showed that 60% of respondents did not plan to be tested 
for HIV in the future as they were afraid that confidentiality would be compromised 
during their testing. The respondents‟ concerns were fear of stigma and 
discrimination, the need for privacy, and confidentiality from health care workers. 
Respondents viewed a lack of trust in the health care workers as a factor for not 
being tested. The lack of trust was caused by the fear that their confidential 
information would be divulged. Mbokane, et al. (2016:15) also found that 33.3% of 
respondents indicated that other people gossiped about HIV-positive individuals. In 
contrast to van Dyk‟s (2013:52) results, it appears that with time the respondents‟ 
fears gradually reduced to 33.3% as indicated in the study by Mbokane, et al. 
(2016:15). Continued engagement with community members may win the trust of 
HIV positive pregnant women and enable disclosure to partners to occur. The next 
section focusses on a lack of on-going support as a factor for non-disclosure. 
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2.8.4.7 Lack of on-going support 
 
Being HIV positive affects people psychologically, emotionally, socially, and 
spiritually (van Dyk, et al. 2017:432). While the health care workers‟ focus is on 
providing support to the patient, the patient should still receive specialised treatment 
from suitably trained professionals. Counselling and casework management should, 
when indicated, include identifying and making referrals to third parties who can best 
assist the patient (van Dyk, et al. 2017:432). Lack of on-going support may prolong 
the disclosure process of respondents to their partners. 
 
Selebogo, et al. (2014:91) investigated the non-disclosure of HIV status of pregnant 
women at primary health care clinics in the West Rand Health Region, South Africa. 
The results indicated that 46.2% of the respondents claimed that HIV positive 
women could not rely on the support of their partners. This study revealed that the 
respondents were likely not to disclose their HIV status to their partners as they 
could not count on their partners‟ support. 
 
Social support gives pregnant women hope that at least somebody cares and it 
reduces depression. Support can also facilitate disclosure to the partner. Biographic 
barriers will be discussed in the next section. 
 
2.8.4.8 Biographic barriers 
 
Tam, et al. (2015:447) claim that factors that influenced disclosure were: nulliparous 
(never having given birth to a baby before), disclosure to a female relative was 
associated with lower disclosure to partners, a need for approval from partners 
before testing, being married or co-habiting <2 years or >2 years (as compared to 
married >2 years). Tam, et al. (2015:447) further state that respondents believed 
disclosure would cause divorce, low wage employment, financial dependence on a 
partner, living with extended family or own family without a partner, a lack of coping 
behaviour, and having a co-spouse (a person in a group marriage who shares a 
spouse in common with another person in that group marriage). HIV positive 
pregnant women who belong to this type of marriage are associated with a lower 
likelihood to disclose their HIV status to their partners. 
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According to the Zimbabwe Demographic and Health Survey (2015:277), the 
following HIV prevalence was identified: 58% of women were married and living with 
HIV, 28% were divorced or separated, and 15% of women were never married but 
have had sex with someone who was HIV positive in 2015. These are some of the 
biographical factors that may hinder the disclosure of HIV status to the partners. HIV 
prevalence was slightly lower (14.7%) among women who reported that they were 
currently pregnant compared with 16.8% of those who said that they were not 
pregnant or not sure. 
 
Polit and Beck‟s (2017:124) HBM model states that modifying factors that have been 
identified are personality variables and socio-demographic characteristics. The 
personality variables and the socio-demographic characteristics may affect the 
disclosure rate of HIV positive pregnant women to their partners, either positively or 
negatively. For example, the personality variables and the socio-demographic 
characteristics in Tam, et al. (2015:447) and the Zimbabwe Demographic and Health 
Survey (2015:277) associated with a low rate of disclosure of HIV status to the 
partners were: young age, unemployed, low parity, being submissive to the partner, 
group marriage, and having low family support. The next section will address the 
impact/consequences of disclosure. 
 
2.8.5  The impact/consequences of disclosure 
 
Literature indicated positive and negative consequences of disclosure. 
 
2.8.5.1 Positive consequences of disclosure 
 
According to a study by Law, Gogolishvili, Globerman and Rueda (2013:1), the 
following positive consequences of disclosure were identified: higher quality social 
support, stronger family cohesion and relationships, reductions in anxiety and 
depression, and improvements in physical health. These possible outcomes are 
conducive for HIV positive pregnant women to disclose their status to their partners. 
 
Longinetti, et al. (2014:6) found another positive consequence was that individuals 
on ARTs who disclosed their status to family members, demonstrated good 
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adherence to treatment. Letsoalo and Madiba (2014:19) further reported that 
condom use and couple counselling was viewed as positive consequences after 
status disclosure. Couple counselling and testing increased the acceptance of 
condom use by couples, which will prevent re-infections and unwanted pregnancies. 
According to Atuyambe, et al. (2014:276), in Kampala, Uganda, HIV disclosure was 
necessary for critical public health benefits such as HIV prevention advocacy, HIV 
testing, protection from infection, and early enrolment on ARTs and adherence to 
medications. These studies indicate the positive outcomes of disclosure that can be 
achieved by HIV positive pregnant women if they disclose their status to their 
partners. 
 
Support from their partners was identified as another positive consequence of HIV 
status disclosure (Kiweewa, et al. 2015:4). In Uganda, 38% of respondents disclosed 
their HIV status to their partners, 67% received support from partners, and 9% of 
their partners subsequently underwent HIV testing as a result of disclosure. Forty-six 
point one five percent (46.15%) of Tshweneagae, et al.‟s (2015:5) participants also 
stated that they received support from their partners after disclosure. Although the 
partners had an initial negative reaction to the news, they later accepted the 
information and offered their support. 
 
These studies reveal that disclosure enhanced positive consequences such as 
stronger family cohesion and relationships, social support, and adherence to 
treatment regimens. This may reduce stressors/depression and encourage partners 
to receive HIV testing, which may contribute to the reduction of HIV transmission. 
The HBM indicate that the positive consequences/the modifying factors that have 
been identified were socio-demographic factors. A conducive environment enables 
the respondents to be able to recover from the burden of HIV infection, thus 
facilitating disclosure to partners. Despite the positive consequences, negative 
consequences of disclosure were also identified in literature. 
 
2.8.5.2 Negative consequences of disclosure 
 
The negative outcomes which were found in a review by Law, et al. (2013:1) 
included: rejection, abuse, violence, stigma, and discrimination. The negative 
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attitudes may hamper individuals‟ lives by delaying the HIV positive pregnant woman 
from seeking treatment and using preventive measures which may prolong her life 
and prevent MTCT. 
 
According to a study conducted in the Netherlands by Stutterheim, Brands, Baas, 
Lechner, Kok and Bos (2017:6-8), health care workers living with HIV reported 
experiences whereby they felt that their colleagues and management had reacted 
poorly upon discovering that they had HIV. Two of the ten participants reported 
management wanting to inform other employees about their HIV status due to 
perceived risks to employees and patients. Other negative reactions included 
restrictions placed on work duties, gossiping, hurtful and judgemental comments 
made, and difficulties in acquiring work. Stutterheim, et al‟s. (2017:6-8) study 
highlights the negative reactions that were encountered by participants, which led to 
non-disclosure of the HIV status. 
 
Letsoalo and Madiba (2014:19) confirm negative consequences of disclosure were 
that women living with HIV and AIDS were abandoned and rejected by their 
significant others after disclosing their status. Women are social beings; 
abandonment and rejection may add additional stress to an individual who is trying 
to cope with the symptoms of HIV infection and pregnancy. 
 
There were also negative consequences of prolonged non-disclosure to children who 
were born HIV positive from mothers in the study conducted in Botswana. These 
children were rebellious, they refused to take medications, and angry confrontations 
with parents emerged (Lowenthal, Jibril, Sechele, Mathuba, Tshume & Anabwani 
2014:48). According to Madiba and Mokgatle (2017:179), some of the caregivers 
were afraid to disclose the HIV status to the child as they feared that the child could 
harm him/herself by committing suicide. 
 
Kiweewa, et al. (2015:4) found that 8% of the women who disclosed their HIV status 
to their partners in Uganda were neglected and separated from their partners, 5% 
lost monetary support, and 9% received negative reactions such as violence, 
stigmatisation, and confidants telling others. This is supported by Letsoalo and 
Madiba (2014:19), who also reported that women living with HIV and AIDS were 
 68 
abandoned and rejected by their significant others after disclosing their status. 
Seventy-two percent (72%) of their respondents disclosed their status to their male 
partners. 
 
The HBM indicates that even though one recognises susceptibility, action will not 
occur unless the individual perceives the severity to be high enough to have serious 
implications. Rewards from the HIV status disclosure to the partner outweigh 
obstacles, and they need to possess the skills required to perform and maintain the 
behaviour. Health care workers need to enhance self-efficacy by instilling confidence 
in the HIV positive pregnant women with the belief that they can disclose their status 
to their partners and overcome the anxieties related to non-disclosure. The 
predictors of HIV disclosure are discussed next. 
 
2.8.6  The predictors of HIV disclosure  
 
Deterioration of health was identified as a predictor of HIV status disclosure in South 
Africa (Mamogobo, et al. 2013:43). Similar to the study by Mamogobo, et al. 
(2013:43), Longinetti, et al. (2014:4-6) state that an advanced HIV stage was a 
predictor of disclosure to sexual partners. Since it is evident that the women were 
showing signs of HIV infection, there was a need to seek social support. The time of 
HIV diagnosis significantly influenced HIV disclosure to partners. Length of time 
since diagnosis had an impact as an individual had enough time to come to terms 
with the diagnosis. Like other previous studies, Longinetti, et al. (2014:6) further 
report that advanced HIV status, stage, and length of time since diagnosis had an 
impact in the number of confidants informed. Ill health/advanced HIV status was a 
predictor of HIV status disclosure as the participants felt that they had nothing to 
hide. 
 
According to Kiula, et al. (2013:9-7), women who had discussed HIV testing with 
their partners before undertaking the HIV test, were seven times more likely to 
disclose their status to their partners than those who did not. The involvement of a 
partner before HIV testing provides an opportunity for the pregnant woman to 
disclose her status to the partner. 
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Kiweewa, et al. (2015:4) found that women with HIV-infected babies, who was a 
house wife, with low educational level, and who were married, were likely to disclose 
their status. Thus, women who were depending on partners were likely to disclose 
their HIV status to their partners. 
 
Obtaining demographic information and assessing pregnant women‟s health 
problems may assist health care workers with the HIV disclosure process. Self-
efficacy is discussed next. 
 
2.8.6.1 Self-efficacy 
 
Self-efficacy is the belief in ones‟ ability to perform a desired behaviour, for instance, 
to insist on condom use or to adhere to ART (van Dyk, et al. 2017:189). The 
respondents are required to have a strong belief in their ability to negotiate condom 
use and to disclose their HIV status to their partners without fear to enhance safe 
sex practices. 
 
Pregnant women are provided with information that ART is lifelong and 100% 
adherence is important to prevent drug resistance as resistance to one drug, 
specifically the non-nucleoside reverse transcriptase inhibitors (NNRTIs), could lead 
to resistance to other drugs in the same class. These resistant viruses could be 
transmitted to other people (van Dyk, et al. 2017:154-164). 
 
According to Alemayehu, et al. (2014:5), in their study conducted in Northern 
Ethiopia, 66.7% respondents used condoms while 33.3% did not use condoms 
during sexual relations. Sixty-four point six percent (64.6%) indicated that they 
always use condoms, while 35.4% stated that they sometimes used condoms. This 
information suggests that the respondents did not believe in their own capacity or 
have the motivational readiness or self-efficacy to adhere to consistent condom use. 
 
2.9  SUMMARY 
 
The development of the questionnaire was aided by the literature reviewed and the 
HBM to identify the relevant information and establish content validity. In this 
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chapter, the literature presented the historical background of AIDS, the epidemiology 
of HIV in South Africa, signs and symptoms of HIV, a diagnosis of HIV, the benefits 
of disclosure of HIV, the motivating factors, barriers, the positive and negative 
consequences, and predictors of disclosure. Chapter 3 will present the research 
methods and design. 
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CHAPTER 3 
RESEARCH DESIGN AND METHODOLOGY 
 
3.1  INTRODUCTION 
 
In Chapter 2, a detailed literature review of HIV status disclosure to sexual partners 
was conducted. This chapter elaborates on aspects of the research methodology 
such as the research design, population, settings, sample and sampling techniques, 
data collection and analysis, as well as ethical considerations. A quantitative, 
descriptive, exploratory, and cross-sectional research design was used to investigate 
the perceived barriers of HIV status disclosure of pregnant women to their partners 
in the Capricorn District, Limpopo Province. 
 
3.2  RESEARCH DESIGN 
 
A research design is the architectural backbone of the study (Polit & Beck 2017:56). 
It provides the structure for the research methods and design decisions that must be 
taken to plan the study (Botma, et al. 2016:108). 
 
A quantitative, explorative, descriptive, and cross-sectional research design was 
used to address the objectives of this study. The objectives were to explore and 
describe the perceived barriers of HIV status disclosure of pregnant women to their 
partners in the Capricorn District, Limpopo Province and to make recommendations 
on disclosure education for health care workers performing VHCT to enhance the 
self-efficacy of these women to disclose their HIV status to their partners based on 
the study findings. 
 
3.2.1  Quantitative research 
 
Quantitative research is defined as the inquiry into a social or human problem, based 
on testing a theory composed of variables, measured with numbers, and analysed 
with statistical procedures to determine whether the predictive generalisations of the 
theory hold true (De Vos, et al. 2017:64). Creswell (2014:4) defines „quantitative 
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research‟ as an approach for testing objective theories by examining the relationship 
among variables. These variables, in turn, can be measured, typically on 
instruments, so that numbered data can be analysed using statistical procedures 
(Creswell 2014:4). The researcher used the numerical information on the survey 
instrument (questionnaire) to answer the study‟s research questions. Quantitative 
research is an essential tool for generating knowledge in nursing science and for 
providing evidence for nursing practice, education, and management (Botma, et al. 
2016:82). 
 
The HIV positive pregnant women might find it challenging to disclose their status to 
their partners and may not be willing to discuss their status with a researcher face-to-
face; therefore, they may feel more comfortable to report on a questionnaire. Thus, 
this method was chosen to obtain information from the respondents without the 
barriers of face-to-face reporting, to aid in making recommendations on disclosure 
education to health care workers to enhance these women‟s self-efficacy to disclose 
their HIV status to their partners. 
 
3.2.2  Exploratory research 
 
An exploratory research is defined as a study that explores the dimensions of a 
phenomenon or that develops or refines hypotheses about relationships between 
phenomena (Polit & Beck 2017:728). The researcher was interested in investigating 
and exploring the perceived barriers of HIV status disclosure of pregnant women to 
their partners in the Capricorn District, Limpopo Province. 
 
3.2.3  Descriptive research 
 
Polit and Beck (2017:726) define „descriptive research‟ as research that typically has 
the accurate portrayal of people‟s characteristics or circumstances and/or the 
frequency with which certain phenomena occur as its main objective. Descriptive 
research presents a picture of the specific details of a situation, social setting, or 
relationship (De Vos, et al. 2017:96). 
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This descriptive research study gathered information from representative 
respondents through utilisation of a questionnaire to present a picture on the 
perceived barriers of HIV status disclosure of pregnant women to their partners in 
Capricorn District, Limpopo Province. 
 
3.2.4  Cross-sectional research 
 
A cross-sectional design involves obtaining data from a cross section of the 
population at a point in time and indicating that the data are gathered once from a 
specific sample (Botma, et al. 2016:113). It is cost and time effective as a large 
amount of data are collected at one point and makes results more readily available. 
A comprehensive in-depth study of the specific phenomenon takes place. The status 
of the phenomenon or relationships among phenomena at a given time is 
investigated (Polit & Beck 2017:168-170). 
 
In this study, HIV positive pregnant women from three hospital ARV clinics were 
involved during data collection at a specific time. The researcher visited the ARV 
clinics to identify HIV positive pregnant women who fit the inclusion criteria, and 
invited them to participate in the study. Data were collected from 1st February to 3rd 
May 2017 at three hospital ARV clinics in the Capricorn District, Limpopo Province. 
Questionnaires were given to the respondents at one point in time and no follow-up 
information was obtained. 
  
3.3  RESEARCH METHODOLOGY 
 
The research methodology is the techniques used to structure, gather and analyse 
information in a systematic fashion in a study (Polit & Beck 2017:743). It covers the 
study setting, study population, sample and sampling, data collection, validity and 
reliability, and data analysis. 
 
3.3.1  Study setting 
 
A study setting is the overall location for the research; it could be an entire 
community or an institution like a hospital (Polit & Beck 2017:47). The study was 
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conducted in three public hospitals‟ ARV clinics in Capricorn District, Limpopo 
Province. One tertiary, one regional, and one district hospital was chosen so that the 
sample of the population was represented, and were accessible and convenient to 
the researcher. The hospitals were chosen as large numbers of HIV positive 
pregnant women are referred from five districts of Limpopo province for specialised 
care. The tertiary hospital is situated in an urban setting while the other two hospitals 
are situated in rural settings. The ARV clinics in these hospitals operate during the 
week from 07h30 – 16h30, Mondays to Fridays. The health care workers working in 
the ARV clinics have specialised training on ARV/ART and nurse-initiated 
management of antiretroviral therapy (NIMART), and they do not rotate. There are 
123 ARV/ART clinics in Capricorn District; 9 clinics are in hospitals, while 114 are in 
local areas.  
 
The rationale for choosing ARV clinics in hospitals was that more women are 
referred for high risk antenatal care to hospitals from local clinics/hospitals to make a 
booking for delivery. District hospitals render services such as trauma and 
emergency care, in-patient and out-patient visits, paediatric and obstetric care 
(NDoH 2016:18). District hospitals employ specialists including 
obstetricians/gynaecologists and paediatricians (NDoH 2016:18). Regional hospitals 
render services at a general specialist level, receive referrals from district hospitals, 
and they serve as a platform for training and research. They may also provide some 
district services within the local sub-district. Experienced specialists lead the teams 
and the medical disciplines include general surgery, general medicine, paediatrics, 
obstetrics and gynaecology, and anaesthetics (NDoH 2015:21). Tertiary hospitals 
render specialist and sub-specialist care to a number of regional hospitals and serve 
as a platform for training health care workers and research. They may also render 
some regional services (NDoH 2015:22). Therefore, a higher number of pregnant 
women are referred from different levels of care to the ARV clinics in these hospitals. 
 
3.3.2  Study population 
 
A population is all the individuals or objects with common, defining characteristics 
(Polit & Beck 2017:56). According to De Vos, et al. (2017:223), a population is the 
totality of persons, events, organisation units, case records or other sampling units 
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with which the research problem is concerned. The study population comprises of 
accessible and target population. 
 
3.3.2.1 Accessible and target population 
 
The accessible population is the aggregate of cases that conform to designated 
criteria and are accessible for the study. The target population is the aggregate of 
cases about which the researcher would like to generalise (Polit & Beck 2017:249). 
A target population might consist of all diabetic people in New York, but the 
accessible population may comprise of all patients with diabetes who attend a 
particular clinic (Polit & Beck 2017:249). The target population is the entire set or 
aggregation of objects, persons, behaviour or events, or any other single units of a 
study, sometimes called elements, that meet the sampling criteria (Botma, et al. 
2016:124). In this study, the target population was all HIV positive pregnant women 
who were attending ARV clinics in the Capricorn District, Limpopo Province. The 
accessible population comprised of all the HIV positive pregnant women who were 
attending ARV clinics in three identified hospitals in the Capricorn District, Limpopo 
Province (more details follow under Section 3.3.3). The rationale for choosing three 
out of nine hospital was that they were accessible to the researcher and two of the 
three hospitals are referrals therefore large patient numbers of HIV positive pregnant 
women are seen. 
 
3.3.3  Sample and sampling 
 
A sample consists of elements or subsets of the population considered for actual 
inclusion in the study, or it can be viewed as a subset of measurement drawn from a 
population in which the researcher is interested. Sampling is studied to understand 
the population from which it was drawn (De Vos, et al. 2017:223-224). There are two 
types of sampling: probability and non-probability sampling methods (Botma, et al. 
2016:124-125). Probability sampling is defined as the selection of sampling elements 
from a population using random procedures while non-probability sampling is the 
selection of sampling units from the population using non-random procedures (Polit 
& Beck 2017:736;740). In this study, non-probability, purposive and convenience 
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sampling methods were used to sample both the three hospitals with ARV clinics 
and the respondents. 
 
Purposive sampling is a non-probability sampling method in which the researcher 
selects participants based on personal judgement about which ones will be 
informative to the research topic (Polit & Beck 2017:741). In this study, respondents 
who were HIV positive and faced with the choice to share/not share their status with 
their partners were purposefully selected as they were viewed as experts at being 
pregnant women who are HIV positive. Polit and Beck (2017:724) define 
„convenience sampling‟ as the selection of the most readily available persons as 
participants in a study. De Vos, et al. (2017:232) define „convenient sampling‟ as 
accidental, availability or haphazard sampling which utilises respondents that are 
usually nearest and most easily available for the study. The hospitals were chosen 
as they had ARV clinics and the women were referred for high risk antenatal care in 
hospitals from local clinics/hospitals to make a booking for delivery as district 
hospitals provide specified services. These hospital ARV clinics have large patient 
numbers with HIV. 
 
The chosen sample was convenient for the researcher as all three hospitals were 
geographically close to the researcher and financially viable. In this study, HIV 
positive pregnant women aged 18-40 years were conveniently sampled as they were 
available at the time of data collection at the ARV clinics in the identified hospitals. 
 
All the respondents in this study were selected since the convenience sampling 
method was used. The topic under discussion is sensitive, and many people do not 
want to share their private life with anyone. Therefore, anyone who met the study 
criteria at the specified ARV clinics, who was willing to participate, was invited. 
 
The USA‟s child-bearing age was 13-46 years (Davidson, et al. 2014:87). According 
to Statistics South Africa (NDoH 2017: 7), the reproductive age is 15-49 years. The 
inclusion criteria for this study were HIV positive pregnant women in the age range of 
18-40 years who were attending ARV clinics at the specified hospitals, during the 
period of data collection and willing to participate in this study. HIV positive pregnant 
women who had undergone counselling and testing at least one month prior to the 
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study formed part of the respondents and signed an informed consent form to 
participate in the study. Exclusion criteria were pregnant women who tested HIV 
positive but who were younger than 18 or older than 40 years of age, and those who 
received their HIV test results less than a month before recruitment for the study. 
The HIV positive pregnant women who were younger than 18 and older than 40 
years were excluded from this research, since few women deliver in this age group, 
even though they received their HIV test results more than a month before 
recruitment for the study. 
 
3.3.4  Sample size 
 
Polit and Beck (2017:258) state that the larger the sample is, the more 
representative of the population it will likely be. According to ARV clinic registers of 
the three hospital ARV clinics in the Capricorn District, Limpopo Province, 356 HIV 
positive pregnant women were seen at the facilities from January to June 2015 (ARV 
Clinic hospital records 2015). A total of 186 respondents were invited to participate in 
the study as sampled using the sample size calculator (Raosoft 2004). This sample 
size was calculated by the Raosoft calculator with the assistance of a statistician 
from the University of Limpopo. According to the Raosoft calculator, if the total 
population is 356, the sample size should be 52% of the total population. Therefore, 
52% of 356 is equal to 185.12 which is approximately 186. Out of 186 respondents, 
171 completed the questionnaire and one was discarded as it was incomplete. The 
response rate was 170/186 x 100 = 91.39%. This number represented the 
population to allow for reliable statistical inferences to be made about the study 
population. 
 
3.3.5  Data collection methods and procedures 
 
Data gathering is the precise and systematic gathering of information to be able to 
resolve the research purpose. The data are usually numerical (Polit & Beck 
2017:725; Botma, et al. 2016:131). A pre-existing questionnaire with the permission 
from the original researchers/developers (Deribe, et al. 2008:4-7) (Annexure E) was 
adapted to fit the context of this study, and was used as a data collection instrument. 
 78 
Refer to Section 1.9.6 for the rationale for using a questionnaire for this study. A pre- 
test was also conducted, which is further explained under Section 3.3.6. 
 
The researcher visited the ARV clinics at the three selected hospitals from the 1st of 
February to the 3rd of March 2017 and provided information on the aim and 
objectives of the study through information leaflets to potential respondents. The HIV 
positive pregnant women who met the inclusion criteria were invited to participate in 
the study. The researcher was available to answer questions from the respondents 
during the data collection period. 
 
A private room was used to collect data and a “Do not disturb” sign was put up to 
avoid disturbance. An informed consent form was signed by respondents who were 
willing to take part in the study, to indicate that they voluntarily agreed to participate 
and there was no coercion. Questionnaires were given to the respondents who were 
available and willing to take part in the study. The respondents who were able to 
read and write completed the questionnaires on their own. There were 8 out of 170 
(4.70%; f=8) respondents who could not read or write; they were assisted by the 
researcher to complete the questionnaire. The information was read back to them to 
ensure it captured the meaning they intended. The researcher provided the 
respondents with a sealed box for completed questionnaires to be returned. The box 
was kept under lock and key in the ARV clinics and was collected by the researcher 
on the same day. 
 
As mentioned, one hundred and eighty-six (186) questionnaires were handed out; 
171 were returned and one was incomplete and discarded, resulting in 170 
respondents (N=170). The questionnaire took 20-25 minutes to complete (Annexure 
G). The questions on the questionnaire were written in English, and consisted of 
structured and open-ended questions to enhance the depth of the data. The 
questions were divided into four sections: Section A: socio-demographic 
characteristics of the respondents, Section B: sexual and reproductive health 
information, Section C: the motivating and enabling or modifying factors, and Section 
D: the challenges/barriers of HIV status disclosure (Refer to Table 3.1). 
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Table 3.1: Sections of the questionnaire 
SECTION MAIN-HEADING SUB-HEADING 
Section A 
Socio-demographic 
characteristics 
The age, religion, marital status, current 
partner, number of children, period of 
pregnancy, place of origin, employment 
status, level of education, head of household, 
and knowledge of anyone who is HIV positive. 
Section B 
Sexual and 
reproductive health 
information 
The diagnosis, disclosure of HIV status, the 
use of condoms, and CD4 cell count. 
Section C 
The motivating and 
enabling or 
modifying factors 
The knowledge of HIV transmission, ARVs, 
and disclosure. 
Section D 
The 
challenges/barriers 
of HIV status 
disclosure 
The barriers of HIV status disclosure of 
pregnant women to their partners. 
 
3.3.5.1 Refinement of the questionnaire 
 
The researcher adapted the questionnaire from the developers (Deribe, et al. 
2008:4-7) for the context of this study. Permission to use the questionnaire was 
granted by the researchers who developed the questionnaire (Annexure E). A 
literature review was conducted to ensure that all the relevant aspects were covered 
in the questionnaire and the HBM was used as a theoretical framework to develop 
the instrument. The literature reviewed and the HBM aided in ensuring that the 
questionnaire covered all the components of the model desired to investigate the 
perceived barriers of HIV status disclosure of pregnant women to their partners in 
the Capricorn District, Limpopo Province. The questionnaire was re-structured with 
the assistance of the supervisor and the statistician, and changes were made 
according to their recommendations (Annexure G). Two health professionals/field 
experts who had undergone training on HIV management and who work at the ARV 
clinics also reviewed the instrument to enhance the validity and to ensure clarity of 
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the questions. A pre-test was used to ensure the questions were clear and easy to 
understand. The questionnaire was adjusted according to the feedback received 
from the pre-test. 
 
3.3.6  Pre-test 
 
Botma, et al. (2016:275) define a „pre-test‟ as a small-scale version of the study 
which is carried out with a few participants that meet the inclusion criteria, but who 
will not form part of the sample. Data collected during this process are not included 
in the main study. The purpose of the pre-test is to determine whether the potential 
participant will understand what needs to be done, and to check if the instructions 
are clear. 
 
In this study, the researcher pre-tested the questionnaire with five HIV positive 
pregnant women at one of the ARV clinics (not part of those chosen for the study) 
before actual data collection took place (Annexure F). The five HIV positive pregnant 
women were randomly selected to participate in the pre-test and were not included in 
the main study. The respondents met the inclusion criteria of HIV positive pregnant 
women attending specified ARV clinics in the age range of 18-40 years. The 
respondents were diagnosed with HIV one month prior to taking part in the pre-test. 
The facility that participated in the pre-testing was chosen based on the convenience 
for the researcher in terms of accessibility, money, and time. The ARV clinic that 
participated in the pre-test was not included in the main study. The feedback from 
the respondents in the pre-test led to some adjustments to the questionnaire. Minor 
technical aspects were addressed and changes were made in consultation with the 
supervisor and statistician. The pre-test also assisted the researcher in determining 
the estimated time required to complete the questionnaire. 
 
3.4  VALIDITY AND RELIABILITY 
 
Quantitative researchers use several criteria to assess the quality of a study. Two 
especially important criteria that will be discussed are validity and reliability (Polit & 
Beck 2017:175). 
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3.4.1  Validity 
 
Validity is a quality criterion referring to the degree to which inferences made in a 
study are accurate and well-founded, in measurement and the degree to which an 
instrument measures what it is intended to measure (Polit & Beck 2017:747). Validity 
indicates whether the conclusions of the study are justified based on design and 
interpretation (Botma, et al. 2016:174). In this study, the pre-test was used to 
evaluate the validity and reliability of the instrument. The types of validity included in 
this study were content, face, and construct validity. 
 
3.4.1.1 Content validity 
 
Polit and Beck (2017:310) define „content validity‟ as the extent to which an 
instrument‟s content adequately captures the construct, that is, whether an 
instrument has an appropriate sample of items for the construct being measured. 
The main aim is to evaluate individual items of the instrument, and to assess 
whether individual items are relevant and appropriate in terms of the construct (Polit 
& Beck 2017:310). The researcher adapted a pre-existing questionnaire that was 
used in a previous study by Deribe, et al. (2008:4-7). 
 
The HBM was used to structure the questionnaire because it focuses on patient 
compliance and preventive health care practices. The supervisor and statistician 
were requested to evaluate the items on the instrument. The UNISA and Mankweng 
librarians assisted the researcher in the literature search on information related to 
HIV status disclosure. The researcher extensively reviewed the literature which deals 
with HIV disclosure to refine the instrument. 
 
The data collection instrument was tested with a pre-test on a small number of 
respondents from the population, to investigate the feasibility of the proposed study 
and to test the data collection instrument prior to the main research. The pre-existing 
questionnaire enhanced validity as it was previously implemented and tested. The 
supervisor and two field experts assisted the researcher in the refinement of the 
instrument. 
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3.4.1.2 Face validity 
 
Face validity refers to whether the instrument looks like it is measuring the target 
construct (Polit & Beck 2017:310). The researcher constructed the questionnaire in 
such a way that it identified and described the perceived barriers of HIV status 
disclosure of pregnant women to their partners in the Capricorn District, Limpopo 
Province. Two field experts who worked in the ARV clinics were asked to review the 
instrument used in the study, to determine whether the questionnaire measured what 
it was supposed to measure. Based on their feedback, the questionnaire was 
refined. They recommended that two questions: “have you ever experience sexual 
assault” and “do you drink alcohol?” should be removed as they were not associated 
with HIV status disclosure. 
 
3.4.1.3 Construct validity 
 
Construct validity is defined as the degree to which evidence about a measure 
scores in relation to other scores support the inference that the construct has been 
appropriately represented. Construct validity occurs when investigators use 
adequate definitions and measures of variables. Construct validity is especially 
relevant for abstract constructs that are measured either by self-report or through 
observational methods, but may also be relevant for performance tests (Polit & Beck 
2017:315). 
 
The research instrument measured feelings such as anxiety related to fear of 
rejection or discrimination, grief related to abandonment by a partner and in relation 
to the topic under study. The questionnaire covered these emotions in detail. The 
researcher also obtained information from the HBM regarding perceived 
susceptibility, perceived severity, perceived benefits and costs, motivation, and 
enabling or modifying factors. Self-efficacy was ensured as components of the HBM 
were covered in the questionnaire. Literature, the two field experts who were offering 
their services to the HIV positive pregnant women who are on ART, and the 
researcher‟s supervisor, also assisted in ensuring construct validity. 
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3.4.2  Reliability 
 
Reliability is the extent to which a measurement is free from error, more broadly, the 
degree to which scores for people who have not changed are the same for repeated 
measurements; statistically, the proportion of total variance in a set of scores that is 
attributable to true differences among those being measured (Polit & Beck 
2017:742). It indicates whether scores to items on an instrument are internally 
consistent, stable over time, and whether there was consistency in test 
administration and scoring (Creswell 2014:247). It means that a reliable 
measurement procedure will produce identical or nearly identical measures if the 
same variable is measured under the same conditions. The questionnaire was tested 
for reliability, and specifically for internal consistency during the pre-test. Reliability 
was enhanced as components of the instrument were adapted from previous studies 
where it was implemented and tested. The instrument was structured in such a way 
that only data necessary to achieve research objectives was collected. Chronbach‟s 
alpha co-efficient was used by the original developers of the questionnaire (De Vos, 
et al. 2017:177-178). Data were entered into an Excel spreadsheet and SPSS 24 
was utilised to analyse data. 
 
In this study, short and close-ended questions, as well as structured and open-ended 
questions were prepared by the researcher in English for accuracy and consistency 
of information gathered. Respondents who were unable to read and write were 
assisted by the researcher. The researcher re-read the information provided by the 
respondents to make sure that the information written was the respondents‟ words. 
The researcher was always available to provide clarity to respondents if required to 
increase response rate. During the instrument‟s development phase, the following 
steps were taken to ensure that only relevant information was considered: stability of 
the research instrument, internal consistency, and equivalence reliability. Internal 
consistency addresses the extent to which all reliability was appropriate when the 
instrument is examining one concept at a time, for example, “disclosure” (Botma, et 
al. 2016:177). 
 
The instrument was consistent as it enabled the researcher to analyse the collected 
data, and it illustrated similarities and differences. 
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3.5  DATA ANALYSIS 
 
In data analysis, the researcher observes patterns in data, asks questions about 
those patterns, forms conjectures, confirms or refutes conjectures, collects data from 
specific individuals on targeted topics, continuously analyses data, asks additional 
questions, seeks more data, and does further analysis by sorting, questioning, 
thinking about, and constructing and testing conjectures (Botma, et al. 2016:221). 
According to De Vos, et al. (2017:249), quantitative data analysis can be regarded 
as the techniques by which researchers convert data to numerical form and subject it 
to statistical analysis. The purpose of analysis is thus to reduce data to an intelligible 
and interpretable form so that the relations of research problems can be studied and 
tested, and conclusions drawn. 
 
The collected data were transformed or coded into numbers before data analysis 
was done. A data set was obtained followed by statistical analysis. Coded data were 
entered into an Excel spreadsheet to create a data set and wild codes were verified 
by the researcher. Data were captured and analysed using the SPSS version 24 
computer software program, with the assistance of a statistician. Descriptive 
statistics were used to describe and summarise data by converting and condensing 
the collected data into an organised, visual representation or picture in the form of 
percentage and frequency. Thematic coding was done to analyse open-ended 
questions. It was used to provide depth to the quantitative data as it focused on 
motivators and challenges of disclosure, as well as its benefits and disadvantages. 
 
Studies that involve human beings need to observe certain ethical standards, to 
protect and promote the well-being of the individual. The next topic will explain 
ethical principles in detail. 
 
3.6  ETHICAL CONSIDERATIONS 
 
The previous section elaborated on criteria for evaluating an instrument. This section 
will explain ethical aspects relating to this study. Prior to the beginning of the study, 
the researcher needed to consider codes of ethics. Therefore, the researcher applied 
to the institutional review board of the college and university campuses, got 
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respondents to sign an informed consent form agreeing to the study before they 
provided data, obtained necessary permissions, and selected a site without vested 
interests (Creswell 2014:95-96). According to the guidelines set by the NHREC 
(2015: 10 Section1.4), all research involving human participants in South Africa must 
be reviewed by an accredited research ethics committee (Botma, et al. 2016:12). 
 
Research that involves humans as subjects should comply with the basic ethical 
principles when generating or refining knowledge, including protecting human rights, 
understanding informed consent, understanding institutional review of research, and 
examining the balance between the benefits and risks of the study. According to Polit 
and Beck (2017:137), the following codes of ethics were observed in this study: 
permission to conduct the study, ethical principles for protecting respondents, right to 
privacy, beneficence, justice, and confidentiality and anonymity. 
 
3.6.1  Permission to conduct the study 
 
The researcher obtained ethical approval from the Higher Degrees Committee of the 
Department of Health Studies at UNISA (Reference number HSHDC/484/2015) 
(Annexure A). Approval was obtained from the Limpopo Department of Health 
(Annexure C), three hospital ARV clinic units‟ managers/facility supervisors 
(Annexure D), the developers of the questionnaire (Annexure E), and respondents 
gave informed consent (Annexure H). Respondents signed an informed consent 
form as an indication that they received the relevant information and voluntarily 
participated in the study before completing the questionnaire. 
 
3.6.2  Ethical principles for protecting respondents 
 
Polit and Beck (2017:727) define „ethics‟ as a system of moral values that is 
concerned with the degree to which research procedures adhere to professional, 
legal, and social obligations to study participants. Creswell (2014:97-98) states that 
there are fundamental ethical principles that guide researchers during the data 
collection process. To that end, the researcher discloses the purpose of the study, 
respects the site, disrupts as little as possible, and makes sure that all participants 
receive the benefits, avoids deceiving participants, respects potential power 
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imbalances, avoids exploitation of participants, and avoids collecting harmful 
information. These principles are based on the human rights that need to be 
protected in research, namely the right to respect human dignity and privacy, 
anonymity and confidentiality, fair treatment, and being protected from discomfort 
and harm. 
 
3.6.3  Right to privacy 
 
Research with humans involves intrusions into personal lives. Researchers should 
ensure that their research is not more intrusive than it needs to be and participants‟ 
privacy is maintained. Botma, et al. (2016:277) state that privacy must be respected 
and risks to participants should be minimal. Respondents have the right to expect 
that their data will be kept in the strictest confidence (Polit & Beck 2017:141). The 
researcher respected the privacy of the respondents during the data collection 
session; only one respondent was allowed in the private room without distractions 
during the time it took to complete the questionnaire. The information provided by the 
respondents was not linked to them personally as the data were combined to form a 
bigger picture about status disclosure to partners. A message was posted on the 
door: “do not disturb, interview in progress”. 
 
The researcher explained the nature and purpose of the study, and assured 
respondents that the results might contribute to assist health care workers with 
disclosure education to enhance status disclosure by HIV positive pregnant women 
to their partners in future. 
 
3.6.4  Beneficence 
 
Beneficence imposes a duty on researchers to minimise harm and maximise benefits 
(Polit & Beck 2017:139). The topic under discussion is a sensitive one; therefore, the 
researcher offered respondents information about the purpose of the research to 
give them an opportunity to consider if they were willing to take part. The researcher 
provided debriefing sessions for the respondents to express their feelings and ask 
questions. A private room at the ARV clinic away from the public was utilised by the 
researcher to prevent stigmatisation. None of the respondents experienced a need 
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or wished to be referred to the psychologist (free of charge) for emotional support. 
The respondents were told that participation in this study was voluntary, and that 
they could terminate at any point in time without losing treatment benefits and no 
incentive was given. Respondents would not benefit from the study directly, but 
pregnant women who need to disclose their HIV status to their partners in future 
might benefit as barriers of disclosure would be explored. The researcher is a trained 
health professional who could identify respondents who could not cope during the 
study to refer them to a psychologist for follow-up. The researcher‟s contact details 
were provided if support was needed at a later stage or if questions arose. 
 
3.6.5  Principle of justice 
 
The principle of justice means that participants should be treated fairly. The 
researcher should adhere to the information given in the information leaflet (Botma, 
et al. 2016:19-20). Respondents who complied with the inclusion criteria and who 
were at the ARV clinic during the data collection period were chosen. The time that 
the respondents took to answer the questionnaire did not exceed the estimated time. 
No follow-up of respondents was done after the data were collected. 
 
3.6.6  Confidentiality and anonymity 
 
Polit and Beck (2017:147) define „confidentiality‟ as the pledge that the information 
participants provide will not be publicly reported in a manner that identifies them. 
Confidentiality can be viewed as a continuation of privacy, which refers to 
agreements between persons that limit others‟ access to private information (De 
Vos, et al. 2017:119). The respondents were given the questionnaires to complete in 
a quiet private room at the ARV clinics, and they were assured that the information 
collected would be kept in the strictest confidence; no names were linked with the 
information obtained. 
 
Anonymity is defined as the protection of participants‟ confidentiality to such a 
degree that even the researcher cannot link individuals with the data they provided 
(Polit & Beck 2017:719). The respondents were informed not to write their names on 
the questionnaires. They were notified that raw data would be entered into the 
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computer using codes. They were assured that their names or that of the hospital 
would not appear on the research report as an HIV positive status is highly 
confidential. The respondents were assured that the questionnaires were not made 
available to anyone who was not directly involved in the study. Those who were 
involved signed a confidentiality agreement. A locked box was provided in the room 
where the questionnaires were completed to return the completed questionnaires, so 
that respondents did not feel that they would be seen by others who participated in 
the study when they return the questionnaires and thereby know their status. The 
researcher collected the box on the same day of data collection. The box was kept 
under lock and key, and only the researcher had access to the completed 
questionnaires. 
 
3.6.7  Respect for human dignity 
 
The principle of respect for human dignity includes the right to self-determination and 
the right to full disclosure. 
 
3.6.7.1 The right to self-determination 
 
Humans should be treated as autonomous agents, capable of controlling their 
actions. Self-determination means that prospective participants can voluntarily 
decide whether to take part in a study, without risk of prejudicial treatment. It also 
means that people have the right to ask questions, to refuse to give information, and 
to withdraw from study (Polit & Beck 2017:140). The respondents were provided with 
an information leaflet and made aware that they would sign an informed consent 
form if they agreed to participate in the study and to indicate that there was no 
coercion. Participation in the study was not compulsory, therefore, respondents were 
told that they could terminate their participation at any time without losing benefits. It 
was made clear that if respondents withdrew from the study, they would not be 
affected in terms of the treatment they receive at the ARV clinics or hospitals. The 
researcher‟s contact number was given to the respondents in the event of further 
questions, comments, and complains. The respondents voluntarily completed the 
questionnaire at the ARV clinics. 
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3.6.7.2 Right to full disclosure 
 
Full disclosure means that the researcher has fully described the study, the person‟s 
right to refuse participation, the researcher‟s responsibilities, and the likely risks and 
benefits (Polit & Beck 2017:140). The researcher provided the respondents with a 
written information leaflet which was comprehensive regarding the purpose, 
objectives and process of the research; no information was withheld. The researcher 
was available to answer any questions from respondents. 
 
3.6.8 Informed consent 
 
Informed consent is an ethical principle that requires researchers to obtain peoples‟ 
voluntary participation, after informing them of possible risks and benefits (Polit & 
Beck 2017:731). Respondents were informed about the purpose of the study and 
that they could participate in the study by answering the questionnaire if they so 
wished. The respondents were told that they could withdraw from taking part without 
losing treatment benefits and no incentives were given for participating in the study. 
There were no risks for participating in the study and none of the respondents 
required to be referred to the psychologist for emotional support. The study may 
benefit future HIV positive pregnant women who have barriers of disclosing their 
status to their partners. Respondents completed the consent form before 
participating in the study. 
 
3.6.9  Significance of the study 
 
The significance or value of the study often refers to the influence on clinician 
practice, the influence on programmes, methods or interventions, what will improve, 
and how it should be implemented (Botma, et al. 2016:281). Creswell (2014:248) 
states that the significance of the study in an introduction conveys the importance of 
the problem for different audiences that may profit from reading and using the study. 
The perceived barriers of HIV status disclosure of pregnant women to their partners 
in the Capricorn District, Limpopo Province were investigated. The identification and 
knowledge of perceived barriers of HIV status disclosure could enlighten society and 
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reduce new infections. Adherence to treatment will be enhanced while MTCT may be 
reduced, lowering morbidity and mortality in the entire society. 
 
The proposed results of the research might contribute to the already existing 
knowledge in the Capricorn District and improvements in quality of life for the 
pregnant women with HIV upon disclosure of their status to their partners. The 
findings of the study might strengthen the accessibility and availability of disclosure 
education and improve the current practice. The results of the study will lead to the 
development of guidelines which will assist health care workers with disclosure 
education to enhance status disclosure of HIV positive pregnant women to their 
partners. This can assist practitioners to improve the practice and inform policy 
makers to address challenges related to barriers of status disclosure of HIV positive 
pregnant women to their partners in the Capricorn District, Limpopo Province. 
 
3.7  SUMMARY 
 
This chapter discussed the research methodology, including the research design, 
population, settings, sample and sampling techniques, data analysis, as well as 
ethical considerations to meet the research objectives. Quantitative, descriptive, 
exploratory and cross-sectional research designs were also outlined. In the next 
chapter, the study findings will be analysed. 
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CHAPTER 4 
ANALYSIS, PRESENTATION AND DESCRIPTION OF THE 
RESEARCH FINDINGS 
 
4.1  INTRODUCTION 
 
The previous chapter reflected on the research process. Chapter 4 will focus on the 
analysis of data and the presentation thereof in tables and figures. The purpose of 
this chapter is to present and describe the empirical findings of this research. The 
aim of the study was to investigate the perceived barriers of HIV status disclosure of 
pregnant women to their partners in the Capricorn District, Limpopo Province, to 
enhance status disclosure to partners through disclosure education by health care 
workers. 
 
The objectives of the study were to: 
 
 Explore and describe the perceived barriers of HIV status disclosure of pregnant 
women to their partners in the Capricorn District, Limpopo Province. 
 Make recommendations on disclosure education to health care workers 
performing VHCT to enhance the self-efficacy of these women to disclose their 
HIV status to their partners based on the study findings. 
 
Data were collected from the 1st February to the 3rd of May 2017 from respondents 
that were conveniently sampled. One hundred and eighty-six (186) questionnaires 
were handed out, 171 questionnaires were returned, and one (1) was discarded 
(N=170). 
 
During the description of the findings, the immediate results were translated into 
integrated and meaningful statistics and findings. The findings were proved to be 
related to the objectives of the research. The success of this study was assured 
through the data analysis and description of findings which were carried out in an 
orderly manner. 
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4.2  DATA MANAGEMENT AND ANALYSIS 
 
This section presents the research results, discussions and conclusion. The findings 
were supported, interpreted and integrated with literature. Data were manually coded 
and recorded in an Excel spreadsheet with the assistance of a statistician. The 
symbol „N‟ will refer to the total number of subjects (respondents), while the symbol 
„n‟ will refer to the number of subjects (respondents) in a subgroup of the study (Polit 
& Beck 2012:loc 24262b, Polit & Beck 2017:358). The term „respondent‟ will refer to 
a pregnant woman who is HIV positive, who meets the inclusion criteria, and who 
attended the ARV clinic at the identified hospitals. Where applicable, the researcher 
rounded the percentages off to the 100th after the decimal. If the number was more 
than 5, one was added to the digit. If it was less than 5, it remained unchanged 
(Taylor-Powell n.d.). 
 
4.2.1  Response rate, results and discussions 
 
The results are illustrated with tables, graphs, and charts. This chapter reveals the 
responses on a question-by-question basis. Results from all sections of the 
questionnaire are also compared to existing empirical evidence to assess 
consistency. Table 4.1 shows the statistics on the response rate of questionnaires 
provided to pregnant women on HIV status disclosure to their partners in the 
Capricorn District, Limpopo Province. 
 
Table 4.1: Response rate (N=170) 
Sample 
 
Total Percentage 
Original sample 186 100% 
Not returned 15 8.06% 
Returned 171 91.93% 
Discarded 1 0.58% 
Response rate 170 91.40% 
 
Table 4.1 illustrates that a total of 186 questionnaires were provided to respondents 
and 171 questionnaires were returned. Of the returned questionnaires, one (1) was 
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incomplete and discarded. Thus, 170 questionnaires were analysed (N=170). This 
gave a 91.40% response rate which is high enough to guarantee accurate results. 
The response rate is defined as the rate of participation in a study, calculated by 
dividing the number of people participating by the number of people sampled (Polit & 
Beck 2017:743). Polit and Beck (2017:256) further state that a well-designed study 
normally achieves response rates of 80% to 90%. 
 
4.2.2  Statistical analysis 
 
Statistical analysis is the organisation and analysis of quantitative data using 
statistical procedures, including both descriptive and inferential statistics (Polit & 
Beck 2017:725a). 
 
4.2.2.1 Statistical software 
 
Data analysis enables the researcher to organise and communicate numeric 
information (Polit & Beck 2012:379a). 
 
A statistician from the University of Limpopo was consulted and the software 
program SPSS version 24 was used to analyse data obtained from the 
questionnaires (Annexure G). 
 
4.2.2.2 Descriptive statistical analysis 
 
Data were summarised and presented by making use of descriptive statistics. 
Tables, charts, graphs and percentages were used in the presentation of the 
frequencies and percentages of the findings. The mean, standard deviation, 
minimum and maximum values for all scaled questions were also computed and 
used in the explanation of the findings. 
 
4.2.2.3 Inferential statistical analysis 
 
A Chi-squared test is a distribution-free or non-parametric test used to test 
hypotheses when the data are presented in a contingency table. It tests for 
 94 
differences between observed and expected values (Botma, et al. 2016:172-173). A 
Chi-squared test was performed to respond to the research question: „What are the 
perceived barriers of HIV status disclosure of pregnant women to their partners?‟ 
The interpretation was reflected in tables and is illustrated as specified values, bar 
charts, and multiple bar charts. In addition, pie charts and percentage component bar 
charts were used to indicate proportions. The next section outlines the research 
results. 
 
4.3  RESEARCH RESULTS 
 
The results are presented in four sections: Section A: Socio-demographic 
characteristics of respondents; Section B: Sexual and reproductive health 
information; Section C: The motivating and enabling/modifying factors; and Section 
D: Challenges/Barriers of HIV status disclosure. 
 
4.3.1  Section A: Socio-demographic characteristics of respondents 
 
The researcher required respondents‟ personal information. This included age, 
religion, marital status, period with the current partner, number of children alive and 
deceased, duration of pregnancy, educational status, employment status, and head 
of household. Demographic information was useful in determining and comparing 
patterns among different categories of the research respondents. Some of the 
calculations are based on the number of respondents who answered the question. 
 
Table 4.2: Frequency distribution: Demographic characteristics of the 
study respondents 
Demographic characteristics HIV positive pregnant women 
Age (N=170) Frequency Percentage 
18 – 20 
21 – 35 
36 – 40 
Total 
 
7 
132 
31 
170 
 
4.12% 
77.65% 
18.23% 
100% 
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Demographic characteristics HIV positive pregnant women 
Religion (n=160) Frequency Percentage 
Christian 
Hindu 
Muslim 
Total 
Did not indicate 
157 
1 
2 
160 
10 
98.13% 
0.62% 
1.25% 
100% 
6.25% 
Relationship Status (N=170) Frequency Percentage 
Married 
Single 
Separated 
Widowed 
Cohabiting 
Total 
34 
94 
1 
2 
39 
170 
20,00% 
55.29% 
0.59% 
1.18% 
22.94% 
100% 
Duration with current partner 
(N=170) 
Frequency Percentage 
≤ 1 year 
2-5 years 
6-10 years 
> 10 years 
Total 
31 
69 
42 
28 
170 
18.24% 
40.59% 
24.70% 
16.47% 
100% 
Number of children alive (n=152) Frequency Percentage 
1 
2 
3 
4 
5 
6 
7 
Total 
Not indicated 
 
49 
49 
35 
10 
7 
1 
1 
152 
18 
 
32.24% 
32.24% 
23.03% 
6.57% 
4.60% 
0.66% 
0.66% 
100% 
10.58% 
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Demographic characteristics HIV positive pregnant women 
Number of children deceased 
(N=170) 
Frequency Percentage 
1 
2 
3 
5 
Not deceased 
Total 
23 
4 
2 
1 
140 
170 
13.53% 
2.36% 
1.17% 
0.58% 
82.36% 
100% 
Period of pregnancy (N = 170) Frequency Percentage 
≤ 3 months 
4-6 months 
˃ 6 months 
Total 
1 
9 
160 
170 
0.59% 
5.30% 
94.11% 
100% 
Place of origin (N=170) Frequency Percentage 
Rural 
Urban 
Total 
163 
7 
170 
95.88% 
4.12% 
100% 
Employment status (N=170) Frequency Percentage 
Employed: Part-time 
                  Full-time 
                  Self-employed 
                  Unemployed 
Total 
16 
26 
7 
121 
170 
9.41% 
15.29% 
4.12% 
71.18% 
100% 
Level of education (N=170) Frequency Percentage 
No education 
Primary school 
Secondary school 
College 
University 
Total 
 
1 
7 
118 
40 
4 
170 
 
0.58% 
4.12% 
69.42% 
23.52% 
2.36% 
100% 
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Demographic characteristics HIV positive pregnant women 
Partner’s level of education  
(n=163) 
Frequency Percentage 
No education 
Primary school 
Secondary school 
College 
University 
Total 
Not indicated 
2 
2 
107 
31 
21 
163 
7 
1.23% 
1.23% 
65.64% 
19.02% 
12.88% 
100% 
4.11% 
Head of household (N=170) Frequency Percentage 
Father 
Mother 
Brother 
Sister 
Husband 
Self 
Total 
22 
50 
5 
6 
68 
19 
170 
12.94% 
29.42% 
2.95% 
3.52% 
40,00% 
11.17% 
100% 
 
4.3.1.1 Age of respondents (in years) 
 
The age distribution enabled the researcher to be aware of the respondents‟ age 
intervals. The most represented age group was 21-35 years. The researcher was 
interested in respondents‟ age ranges between 18-40 years. The respondents in this 
age group were included in this study as the majority of them delivered their babies 
during this period. The minimum age of the respondents was 18 years, while the 
maximum age was 39 years old, and the average age was 30 years old. One 
hundred and thirty-two (132) out of 170 (77.65%; f=132) respondents were between 
21-35 years, while 31 out of 170 (18.24%; f=31) respondents were aged 36-40 
years. Only 7 out of 170 (4.12%; f=7) respondents were between 18-20 years (Refer 
to Table 4.2). Table 4.2 shows that most respondents delivered their babies between 
the ages of 21 and 35 years. 
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4.3.1.2 Religion affiliation of respondents 
 
The religious affiliation of respondents is discussed to identify the beliefs and 
practices regarding the perceived barriers the respondents have in disclosure of their 
HIV status to their partners. 
 
One hundred and sixty (160) respondents answered this question. Of all of the 
respondents who answered this question, 157 (98.13%; f=157) were Christians, 10 
(5.88%; f=10) did not indicate their religion, 1 (0.62%; f=1) was Hindu, and 2 (1.25%; 
f=2) were Muslims. Therefore, in this study, the majority of HIV positive pregnant 
women were Christians (Refer to Figure 4.1). 
 
The Christian, Hindu and Muslim religious groups were represented in the study. 
Only 10 out of 160 (5.88%; f=10) respondents did not wish to report their religious 
affiliation. This needs to be taken into account when interpreting religious affiliation 
data. 
 
 
Figure 4.1: Religion affiliation of respondents (n=160) 
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4.3.1.3 Relationship status 
 
Marital status was one of the demographic variables of the sample which was used 
to determine and compare patterns among different categories of the research 
respondents whereby they were to indicate: married, single, separated, widowed, 
and cohabiting. The categories were required to determine conditions/situations 
which are favourable for the respondents to disclose their HIV status to their 
partners. 
 
All of the respondents answered this question (N=170). Table 4.2 indicates that 94 
out of 170 (55.29%; f=94) respondents were single (not married), 34 (20%; f=34) 
respondents were married, only 1 (0.59%; f=1) respondent was separated from her 
husband, 2 (1.18%; f=2) respondents were widows, and 39 (22.94%; f=39) 
respondents were cohabiting (living together without being married). 
 
 
Figure 4.2: Relationship status of respondents (N=170) 
 
Figure 4.2 shows a graphical representation of both the frequency and percentages 
of marital status of all 170 respondents. Based on these study findings, 94 out of 170 
(55.29%; f=94) respondents were single (not married). 
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4.3.1.4 Duration or period with current partner 
 
All of the respondents answered this question (N=170). The duration of a 
relationship with the current partner ranged from less than one year to more than 10 
years. Thirty-one (31) (18.24%; f=31) respondents were in their relationship less 
than a year, 69 (40.59%; f=69) respondents were in their relationship between 2-5 
years, 42 (24.70%; f=42) respondents were in their relationship between 6-10 years, 
and 28 (16.47%; f=28) respondents were in their relationship more than 10 years. 
The shortest relationship period was less than a year (< 12 months) and the longest 
relationship was more than 10 years. 
 
4.3.1.5 Number of children alive 
 
This question focused on the number of children still alive for each individual 
respondent. The numbers of children still alive ranged from 1 to 7. As indicated in 
Table 4.2, 152 out of 170 (89.41%; f=152) respondents answered this question 
and 18 out of 170 (10.58%; f=18) did not indicate the number of their children that 
are alive because it was their first pregnancy. Forty-nine (49) out of 152 (32.24%; 
f=49) respondents had only 1 child alive, 49 out of 152 (32.24%; f=49) 
respondents had 2 children alive, 35 out of 152 (23.03%; f=35) respondents had 3 
children alive. Ten (10) out of 152 (6.57%; f=10) respondents had 4 children alive, 
7 out of 152 (4.60%; f=7) respondents had 5 children alive, 1 (0.66%; f=1) 
respondent had 6 children alive, and 1 (0.66%; f=1) respondent had 7 children 
alive. 
 
4.3.1.6 Number of children deceased 
 
This is one of the variables which is sensitive, but it was used in this research study 
to display the impact that non-disclosure of HIV status to the partner has. This 
question focused on the number of children deceased for each individual respondent. 
The numbers of children deceased ranged from 1 to 5. On average, each respondent 
had 2 children who were deceased. 
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Table 4.2 shows that 23 out of 170 (13.53%; f=23) respondents had lost 1 child, 4 
(2.36%; f=4) respondents lost 2 children, 2 (1.17%; f=2) respondents lost 3 children, 
and 1 (0.58%; f=1) respondent lost 5 children. The table further indicates that 140 
(82.36%; f=140) respondents did not have any deceased children. 
 
4.3.1.7 Period of pregnancy 
 
Respondents indicated the period of pregnancy according to specific intervals. 
The intervals were as follows: ≤ 3 months, 4-6 months, and > 6 months (Refer to 
Table 4.2 and Figure 4.3). 
 
Table 4.2 indicates that 1 (0.59%; f=1) respondent was less than 3 months pregnant, 
9 (5.30%; f=9) respondents were 4-6 months pregnant, while 160 (94.11%; f=160) 
respondents were more than 6 months pregnant during the data collection period. 
Figure 4.3 shows the percentage representation of pregnancy intervals for the 170 
respondents. 
 
 
Figure 4.3: Period of respondents’ pregnancy (N=170) 
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4.3.1.8 Place of origin 
 
Place of origin referred to where respondents grew up, and was subdivided into two 
categories: rural and urban. All respondents answered this question (N=170) and the 
results in Table 4.2 illustrate that 163 (95.88%; f=163) respondents grew up in rural 
areas while only 7 (4.12%; f=7) respondents grew up in urban areas. Most 
respondents grew up in rural villages (Refer to Figure 4.4). 
 
 
Figure 4.4: Place of respondents’ origin (N=170) 
 
4.3.1.9 Employment status 
 
The researcher wanted to explore the correlation between employment status and 
the rate of HIV infection. Respondents‟ employment status was categorised into the 
following groups: employed, self-employed, full-time, part-time, and unemployed. All 
170 respondents answered this question (N=170). 
 
According to Table 4.2, 16 (9.41%; f=16) respondents were employed part-time, 26 
(15.29%; f=26) respondents were employed full-time, 7 (4.12%; f=7) respondents 
were self-employed, and 121 (71.18%; f=121) respondents were unemployed (Refer 
to Figure 4.5). 
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Figure 4.5: Employment status of respondents (N=170) 
 
4.3.1.10 Respondents’ level of education 
 
All respondents answered this question (N=170). The level of education was divided 
into the following categories: No education, primary school, secondary school, 
college, and university. 
 
As indicated in Table 4.2, 1 out of 170 (0.58%; f=1) respondents did not attend any 
formal school, 7 out of 170 (4.12%; f=7) respondents attended up to primary level, 
118 out of 170 (69.42%; f=118) respondents attended secondary school, 40 out of 
170 (23.52%; f=40) respondents attended up to college level, and only 4 out of 170 
(2.36%; f=4) respondents attended up to university level. 
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Figure 4.6: Respondents’ level of education (N=170) 
 
The results in Figure 4.6 portray that most of the respondents‟ (69.42%) level of 
education was secondary. 
 
4.3.1.11 Partner’s level of education 
 
The partners‟ level of education was categorised into the following five groups: no 
education, primary school, secondary school, college, and university. Table 4.2 
shows that 7 out of 170 (4.11%; f=7) respondents did not answer the question. The 
calculations were thus based on the 163 respondents who answered the question. 
 
Table 4.2 indicates that 2 (1.23%; f=2) respondents‟ partners did not attend any 
formal school, 2 (1.23%; f=2) respondents‟ partners attended primary level, 107 
(65.64%; f=107) respondents‟ partners went up to secondary school level, 31 
(19.02%; f=31) respondents‟ partners attended up to college level, and 21 (12.88%; 
f=21) respondents‟ partners attended up to university level. 
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Figure 4.7: Partner’s level of education (n= 163) 
 
The results in Figure 4.7 shows that most respondents‟ partners‟ level of education 
was secondary school as indicated by 107 out of 163 (65.64%; f=107) respondents. 
Figure 4.8 displays the comparison of respondents and their partners‟ level of 
education. 
 
 
Figure 4.8: Respondents and their partners’ level of education 
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Figure 4.8 shows that the respondents had higher levels of education at primary, 
secondary and college level, while at university level the partners‟ level of education 
was higher than that of the respondents. 
 
4.3.1.12 Head of the household 
 
Head of the household was categorised as follows: father, mother, brother, sister, 
husband, and self. Frequency and percentages are represented in Table 4.2. 
whereby 22 out of 170 (12.94%; f=22) respondents indicated that their families were 
headed by their fathers, 50 (29.42%; f=50) respondents stated the household was 
headed by their mothers, 5 (2.95%; f=5) respondents reported that the household 
was headed by their brothers, 6 (3.52%; f=6) respondents indicated the head of the 
household was their sisters, 68 (40%; f=68) respondents indicated their husbands as 
the head of the household, and 19 (11.17%; f=19) respondents reported their 
households were headed by themselves. Refer to Figure 4.9 for a visual 
representation of the information. 
 
 
Figure 4.9: Head of the household of respondents (N=170) 
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Section A provided an overview of the demographic characteristics of the 
respondents and Section B will outline the sexual and reproductive health 
information obtained from respondents. 
 
4.3.2  Section B: sexual and reproductive health information 
 
The following topics are discussed in this section: respondent‟s period/duration 
diagnosed with HIV, knowledge of anyone who is HIV positive, disclosure of HIV 
status after diagnosis, partner‟s reaction to status disclosure, respondents‟ 
knowledge of their partner(s) HIV status, number of sexual partners respondents had 
in the last 3-6 months, number of sexual partners respondents‟ partner had in the 
last 3-6 months, and condom use. 
 
4.3.2.1 Respondent’s period/duration diagnosed with HIV (N=170) 
 
The question was developed to determine the period/duration since respondents‟ 
initial diagnosis with HIV. Table 4.3 presents the respondents‟ answers. Based on 
the answers provided by the respondents, the researcher decided to group them 
according to the following intervals: < 1 year, 1-3 years, 4-6 years, 7-9 years, and ≥ 
10 years. 
 
Table 4.3: Respondent’s period/duration diagnosed with HIV for the first 
time (N=170) 
Duration since initial 
diagnosis 
Frequency Percentage 
< 1 year 68 40.00% 
1-3 years 44 25.88% 
4-6 years 27 15.88% 
7-9 years 29 17.06% 
≥ 10 years 2 1.18% 
Total 170 100% 
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All respondents answered this question (N=170). According to Table 4.3, 68 (40%; 
f=68) respondents had been diagnosed < 1 year, 44 (25.88%; f=44) respondents 
had been diagnosed for 1-3 years, 27 (15.88%; f=27) had been diagnosed for 4-6 
years, and 29 (17.06%; f=29) respondents had been diagnosed for 7-9 years. Two 
(2) (1.18%; f=2) respondents had been diagnosed for ≥ 10 years. Sixty-eight (68) 
(40%; f=68) respondents were diagnosed less than 1 year ago, which might denote 
that the majority of women are diagnosed with HIV during pregnancy. 
 
4.3.2.2 Knowledge of anyone who is HIV positive 
 
The following two questions were asked with regard to respondents‟ knowledge of 
anyone who is HIV positive: “Do you know of anyone who is HIV positive?” and “Did 
the person you know (who is HIV positive) disclose her/his status to you?” 
 
 Do you know of anyone who is HIV positive? (n=154) 
 
Respondents had to indicate either Yes or No to this question. Answers are provided 
in Table 4.4. Figure 4.10 graphically depicts the frequency and percentages of 
respondents who knew anyone who is HIV positive. 
 
Figure 4.10: Knowledge of anyone who is HIV positive (n=154) 
 
The results in Figure 4.10 indicates that 79 out of 154 (51.30%; f=79) respondents 
knew someone who is HIV positive, and 75 out of 154 (48.70%; f=75) respondents 
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did not know anyone who is HIV positive. Sixteen (16) respondents did not answer 
this question. 
 
4.3.2.3 Disclosure of HIV status after diagnosis 
 
Table 4.4 indicates the frequency and percentages related to: knowledge of anyone 
who is HIV positive, disclosure education received, number of days/months/years 
taken to disclose the diagnosis, disclosure of HIV status after diagnosis, person to 
whom HIV positive status was disclosed, person who performed the disclosure 
education, advice by the health care worker to disclose the status, disclosure of HIV 
positive status to the partner, and anyone who disclosed her/his status to the 
respondents. 
 
Table 4.4: Disclosure of HIV status after diagnosis 
Knowledge of anyone who 
is HIV positive (n=154) 
Frequency Percentage 
Yes 
No 
Total 
Not indicated 
79 
75 
154 
16 
51.30% 
48.70% 
100% 
9.41% 
Disclosure education 
received (N=170) 
Frequency Percentage 
Yes 
No 
Total 
149 
21 
170 
87.64% 
12.36% 
100% 
Number of days/months/ 
years taken to disclose the 
diagnosis (n=153) 
Frequency Percentage 
< 1 month 
1-12 months 
1-5 years 
> 5 years 
Total 
Not yet disclosed 
96 
52 
3 
2 
153 
17 
62.77% 
33.98% 
1.95% 
1.30% 
100% 
10% 
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Did you disclose your 
status after diagnosis 
(N=170) 
Frequency Percentage 
Yes 
No 
Total 
153 
17 
170 
90.00% 
10.00% 
100% 
Person to whom HIV 
positive status was 
disclosed (n=150) 
Frequency Percentage 
Partner 
Family member 
Other 
Total 
Not indicated 
85 
62 
3 
150 
20 
56.66% 
41.34% 
2.00% 
100% 
11.76% 
Person who performed the 
disclosure education (n=151) 
Frequency Percentage 
Health professionals 
Not indicated 
151 
19 
100% 
11.17% 
Where you advised by the 
health care worker to 
disclose the status? 
(N=170) 
Frequency Percentage 
Yes 
No 
Total 
152 
18 
170 
89.40% 
10.60% 
100% 
Disclosure of HIV positive 
status to the partner (N170) 
Frequency Percentage 
Yes 
No 
Total 
 
 
 
136 
34 
170 
 
 
 
80.00% 
20.00% 
100% 
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Is there anyone who 
disclosed her/his status to 
you? (n=161) 
Frequency Percentage 
Yes 
No 
Total 
Not indicated 
84 
77 
161 
9 
52.17% 
47.83% 
100% 
5.29% 
 
 Did you disclose your status after diagnosis (N=170) 
 
All the respondents answered this question (N=170). The respondents had to 
indicate either Yes or No to answer this question. 
 
 
Figure 4.11: Disclosure of HIV status after diagnosis (N=170) 
 
Figure 4.11 shows that 153 (90%; f=153) respondents disclosed their HIV status to 
someone, while 17 (10%; f=17) respondents did not disclose their HIV status to 
anyone. 
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 Disclosure education received (N=170) 
 
All the respondents answered this question (N=170). The question was developed to 
ascertain if respondents received any form of disclosure education from health care 
workers. The respondents had to indicate either Yes or No to answer this question, 
as reflected in Table 4.4. The results show that 149 (87.64%; f=149) respondents 
received disclosure education, while 21 (12.36%; f=21) respondents did not receive 
disclosure education. 
 
 
Figure 4.12: Disclosure education received by respondents (N=170) 
 
Figure 4.12 illustrates disclosure education received in percentages. Most of the 
respondents (87.64%) received disclosure education. 
 
 Number days/months/years taken to disclose the diagnosis (n=153) 
 
Responses indicated that 96 out of 153 (62.77%; f=96) respondents disclosed their 
status within the first month after the diagnosis, while 52 out of 153 (33.98%; f=52) 
respondents took 1-12 months to disclose their HIV positive status. Three (3) out of 
153 (1.95%; f=3) respondents took 1-5 years to disclose their HIV positive status, 
and 2 out of 153 (1.30%; f=2) respondents took more than 5 years to disclose their 
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HIV positive status. Seventeen (17) out of 170 (10%; f=17) respondents did not 
disclose their HIV status. 
 
 Person to whom HIV positive status was disclosed (n=150) 
 
The person to whom respondents disclosed their HIV positive status is presented in 
tabular form. Each respondent indicated the person to whom her HIV status was 
disclosed: 147 out of 150 (98%; f=147) respondents stated family members, 3 out 
150 (2%; f=3) respondents indicated others, while 20 out of 170 (11.76%; f=20) 
respondents did not indicate at all. 
 
 Person who performed the disclosure education (n=151) 
 
The person who performed the disclosure education is presented in Table 4.4. The 
results in Table 4.4 indicate that 151 out of 151 (100%; f=151) of those who 
indicated that they received disclosure education, received the education from health 
care workers. There were 19 out of 170 (11.17%; f=19) respondents who did not 
indicate whether they have received disclosure education. 
 
 Where you advised by the health care worker to disclose the status? 
(N=170) 
 
All respondents answered this question (N=170). The question was developed to 
determine if the respondents were advised by health care workers to disclose their 
HIV status. The respondents had to indicate either Yes or No to answer this 
question. Table 4.4 shows that 152 (89.40%; f=152) respondents indicated that they 
were advised by health care workers to disclose their status, while 18 (10.60%; f=18) 
respondents indicated that they were not advised by the health care workers to 
disclose their status. Eighty-nine point four zero (89.40%) of the respondents who 
received disclosure advice correlates with the 80% who disclosed their status to their 
partners. Therefore, the recommendations of this study are crucial to enhance 
disclosure education provided by health care workers. 
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Figure 4.13: Health care worker advised you to disclose the status (N=170) 
 
Figure 4.13 illustrates the respondents who were advised by the health care worker 
to disclose their status in percentages. Most of the respondents (89.40%) were 
advised by the health care worker to disclose their HIV status. 
 
 Disclosure of HIV positive status to the partner (N=170) 
 
Table 4.4 and Figure 4.14 demonstrate the number of respondents who disclosed 
their HIV status to their partners. The respondents had to indicate either Yes or No to 
answer this question. All respondents answered this question (N=170). One hundred 
and thirty-six (136) (80%; f=136) respondents indicated that they disclosed their HIV 
status to their partners, while 34 (20%; f=34) respondents did not disclose their 
status to their partners (Refer to Figure 4.14). 
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Figure 4.14: Disclosure of HIV positive status to the partner as indicated by 
respondents (N=170) 
 
The majority of respondents (80%) disclosed their HIV status to their partners. 
Partners‟ reactions to respondents‟ HIV status will be discussed in the next section. 
 
 Did the person the respondent knows (who is HIV positive) disclose her/his 
status to you? (n=161) 
 
Table 4.4 demonstrates the number of people who disclosed their HIV status to the 
respondents. The respondents had to indicate either Yes or No to answer this 
question. 
 
The results in Table 4.4 indicate that 84 out of 161 (52.20%; f=84) respondents knew 
people who disclosed their HIV status to them, while 77 out of 161 (47.80%; f=77) 
respondents indicated that no one disclosed his/her HIV status to them. Nine (9) out 
of 170 (5.29%; f=9) respondents did not indicate if there was anyone who disclosed 
their HIV status to them. 
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4.3.2.4 Partner’s reaction to your status 
 
Table 4.5 presents the partners‟ reactions to respondents‟ HIV status disclosure. The 
respondents had to indicate “strongly agree”, “agree”, “uncertain”, “disagree” and 
“strongly disagree” according to a Likert scale. The total number of respondents who 
answered a specific question in Table 4.5 will differ between each question asked. 
 
The results in Table 4.5 indicate that 102 out of 135 respondents‟ partners (75.56%; 
f=102) were not disappointed with the respondents‟ HIV status. One hundred and 
seventeen (117) out of 134 (87.31%; f=118) disagreed that their partners were 
judgemental towards their HIV positive status, 126 out of 136 (92.65%; f=126) 
respondents‟ partners were supportive and caring, and 127 out of 135 (94.07%; 
f=127) of respondents‟ partners accepted their HIV status. One hundred and twenty-
six (126) out of 133 (94.74%; f=126) respondents disagreed that their partners 
rejected them, and 127 out of 134 (94.78%; f=127) respondents disagreed that their 
partners ignored them. 
 
Table 4.5: Partner’s reaction to HIV positive status 
Items 
Strongly 
agree 
Agree 
Uncer-
tain 
Disagree 
Strongly 
disagree 
Did not 
answer 
n % n % n % n % N % n % 
Disappointed 
in me 
4 2.96 26 19.26 3 2.22 88 65.19 14 10.37 35 20.59 
Judgemental 
towards me 
5 3.73 11 8.20 1 0.75 
10
0 
74.63 17 12.69 36 21.18 
Caring and 
supportive 
towards me 
28 20.59 98 72.06   6 4.41 4 2.94 34 20 
Accepted me 
27 20 
10
0 
74.07   6 4.44 2 1.49 35 20.59 
Rejected me 1 0.75 6 4.51   94 70.68 32 24.06 37 21.76 
Ignored me 4 2.98 3 2.24   94 70.15 33 24.63 36 21.18 
 
The next section considers the respondents‟ knowledge of their partners‟ HIV status. 
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4.3.2.5 Respondents’ knowledge of their partner(s) HIV status 
 
The question was developed to determine if the respondents knew the HIV status of 
their partners. The respondents had to indicate “strongly agree”, “agree”, “uncertain”, 
“disagree” and “strongly disagree” according to the Likert scale. The number of 
respondents who answered each specific question in Table 4.6 will differ between 
each question asked. 
 
Table 4.6: Respondents’ knowledge of their partner’s HIV status 
Items 
Strongly 
agree 
Agree Uncertain Disagree 
Strongly 
disagree 
Did not 
answer 
n % n % n % N % n % N % 
I know the 
HIV status 
of my 
partner 
22 13.02 85 50.29 5 2.96 50 29.59 7 4.14 1 0.59 
My partner 
(s) know 
my HIV 
status 
25 14.79 111 65.68 1 0.59 29 17.16 3 1.78 1 0.59 
It is the 
right of 
my 
partner(s) 
to know my 
HIV status 
28 16.57 126 74.56 1 0.59 14 8.28   1 0.59 
I have a 
right to 
know the 
HIV status 
of my 
partner(s) 
24 14.29 129 76.79 2 1.19 11 6.54 2 1.19 2 1.18 
I do not 
think it is 
important 
that my 
7 4.14 17 10.06 1 0.59 105 62.13 39 23.08 1 0.59 
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Items 
Strongly 
agree 
Agree Uncertain Disagree 
Strongly 
disagree 
Did not 
answer 
n % n % n % N % n % N % 
partner(s) 
know my 
HIV status 
I do not 
think it is 
important 
that I know 
my 
partner(s) 
HIV status 
3 1.79 17 10.12 1 0.59 106 63.10 41 24.40 2 1.18 
 
Table 4.6 indicates that 107 out of 169 (63.31%; f=107) respondents agreed that 
they know the HIV status of their partners, while 136 out of 169 (80.47%; f=136) 
respondents indicated that their partners know their HIV status. This correlates with 
the 80% respondents who disclosed their HIV positive status to their partners. One 
hundred and fifty-four (154) out of 169 (91.12% f=154) respondents agreed that it is 
the right of their partners to know their HIV status, while 153 out of 168 (91.07%; 
f=153) respondents agreed that they have the right to know the HIV status of their 
partners. One hundred and forty-four (144) out of 169 (85.21%; f=144) respondents 
disagreed with the question which indicated that it is not essential for their partners 
to know their HIV status, and 147 out of 168 (87.5%; f=147) respondents disagreed 
that they do not think it is important that they know their partners‟ HIV status. The 
majority, 154 out of 169 (91.12% f=154) respondents, agreed that it is their partner‟s 
right to know the respondent‟s HIV status, and 153 out of 168 (91.07%; f=153) 
respondents stated that they also have the right to know their partners‟ HIV status. 
 
4.3.2.6 Number of sexual partners respondents had in the last 3-6 months 
(N=170) 
 
All the respondents answered this question (N=170). Table 4.7 indicates the number 
of sexual partners the respondents had in the last 3-6 months. 
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Table 4.7: Number of sexual partners respondents had in the last 3-6 
months (N=170) 
Number of sexual partners Frequency Percentage 
0 3 1.76% 
1 162 95.30% 
2 3 1.76% 
3 and above 2 1.18% 
Total 170 100% 
 
The results in Table 4.7 and Figure 4.15 indicate that 3 (1.76%; f=3) respondents 
had no sexual partners, 162 (95.30%; f=162) respondents had 1 sexual partner, 3 
(1.76%; f=3) respondents had 2 sexual partners, and 2 (1.18%; f=2) respondents 
had 3 sexual partners in the last 3-6 months. 
 
 
Figure 4.15: Number of sexual partners respondents had in the last 3-6 
months (N=170) 
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Figure 4.15 and Table 4.7 illustrate that most of the respondents (95.30%) had only 
one sexual partner in the last 3-6 months 
 
4.3.2.7 Number of sexual partners your partner had in the last 3-6 months 
(N=170) 
  
All the respondents answered this question (N=170). 
 
Table 4.8: Number of sexual partners your partner had in the last 3-6 
months (N=170) 
Number of sexual partners Frequency Percentage 
None 7 4.11% 
1 148 87.06% 
2 13 7.65% 
4 1 0.59% 
5 and more 1 0.59% 
Total 170 100% 
 
Table 4.8 and Figure 4.16 indicate that 7 (4.11%; f=7) respondents‟ partners had no 
sexual partner in the last 3-6 months, 148 (87.06%; f=148) of the respondents‟ 
partners had 1 sexual partner in the last 3-6 months, 13 (7.65%; f=13) respondents‟ 
partners had 2 sexual partners in the last 3-6 months, 1 (0.59%; f=1) respondent‟s 
partner had 4 sexual partners in the last 3-6 months, and 1 (0.59%; f=1) 
respondent‟s partner had 5 sexual partners in the last 3-6 months. 
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Figure 4.16: Number of sexual partners your partner had in the last 3-6 
months (N=170) 
 
The results in Figure 4.16 illustrate that most of the respondents‟ sexual partners 
(87.06%) had only 1 sexual partner in the last 3-6 months. 
 
4.3.2.8 Condom use (N=170) 
 
All respondents answered this question (N=170). This question was developed with 
the aim of determining how often the respondents used condoms according to a 
Likert scale. Respondents had to indicate whether they “never”, “rarely”, 
“sometimes”, “most of the time” or “always” use a condom. Answers are provided in 
Table 4.9. 
 
Table 4.9: Condom use (N=170) 
Condom usage  Frequency Percentage 
Never 24 14.12% 
Rarely 8 4.71% 
Sometimes 80 47.06% 
Most of the time 25 14.70% 
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Condom usage  Frequency Percentage 
Always 33 19.41% 
Total 170 100% 
 
According to Table 4.9 and Figure 4.16, 24 (14.12%; f=24) respondents never use 
condoms, 8 (4.71%; f=8) respondents rarely use condoms, and 80 (47.06%; f=80) 
respondents indicated that they sometimes use condoms. Twenty-five (25) (14.70%; 
f=25) respondents use condoms most of the time, and 33 (19.41%; f=33) 
respondents indicated that they always use condoms. 
 
 
Figure 4.17: Condom use according to respondents (N=170) 
 
Most of the respondents (47.06%) sometimes use condoms while only 19.41% 
always use condoms. It is crucial to highlight condom use as part of the 
recommendations of this study to enhance disclosure education and ensure a lower 
MTCT rate and viral load. More details will follow in Chapter 5. 
 
4.2.3.9 Number of pregnancies respondents had while HIV positive (n=136) 
 
Table 4.10 shows the number of pregnancies the respondents had while being HIV 
positive. The respondents had to indicate how many times they fell pregnant while 
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HIV positive; whether it was one time, two times, three times, or more than three 
times. Thirty-four (34) out of 170 (20%; f=34) respondents did not answer this 
question. The calculations are thus based on the respondents (n=136) who did 
answer the question. 
 
Table 4.10: Number of pregnancies respondents had while being HIV 
positive (n=136) 
Number of pregnancies while 
being HIV positive   
Frequency Percentage 
One time 79 58.09% 
Two times 36 26.47% 
Three times 20 14.70% 
More than three times 1 0.74% 
Total 136 100% 
Not indicated 34 20% 
 
As indicated in Table 4.10, 79 out of 136 (58.09%; f=79) respondents were pregnant 
once while being HIV positive, 36 out of 136 (26.47%; f=36) were pregnant twice 
while being HIV positive, and 20 out of 136 (14.70%; f=20) were pregnant three 
times while being HIV positive. One (1) respondent was pregnant more than three 
times while being HIV positive, and 34 out of 136 (20%; f=34) did not indicate, as 
they were pregnant for the first time. 
 
4.3.2.10 Number of the last CD4 cell count (n=95) 
 
The question was developed to determine if respondents knew the result of their last 
CD4 cell count. The respondents were to indicate if the CD4 cell count results were 
< 300 cells/mmᵌ, from 300 cells/mmᵌ to 500 cells/mmᵌ, and > 500 cells/mmᵌ. Table 
4.11 indicates that 75 out of 170 (44.12%; f=75) respondents did not answer the 
question. The calculations are thus based on the respondents (n=95) who did 
answer the question. 
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Table 4.11: Number of the last CD4 cell count (n=95) 
CD4 cell count Frequency Percentage 
< 300 cells/mmᵌ 23 24.21% 
From 300 cells/mmᵌ to 500 
cells/mmᵌ 
27 28.42% 
> 500 cells/mmᵌ 45 47.37% 
Total 95 100% 
No respond 75 44.12% 
 
Table 4.11 and Figure 4.18 illustrate the respondents‟ CD4 cell count in percentages. 
Twenty-three (23) out of 95 (24.21%; f=23) respondents had a CD4 cell count of less 
than 300 cells/mmᵌ, 27 out of 95 (28.42%; f=27) respondents had CD4 cell count of 
300 cells/mmᵌ to 500 cells/mmᵌ, and 45 out of 95 (47.37%; f=45) respondents had 
more than 500 cells/mmᵌ CD4 cell count. Seventy-five (75) out of 170 (44.12%; f=75) 
respondents did not answer this question. 
 
Figure 4.18: Number of CD4 cell count of respondents (n=95) 
 
Sub-section B provided respondents‟ sexual and reproductive health information. 
The next section will focus on one of the components of the HBM which is the 
motivating factors of HIV status disclosure to partners (Polit & Beck 2017:124). The 
relationship between age, relationship status, employment status, level of education, 
and status disclosure to partners is discussed in the next section. 
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4.3.3  Relationship/correlation/association between age, relationship status, 
employment status, level of education, disclosure education received 
and disclosure of their HIV status to partners 
 
Table 4.12 compares the p-values between two variables. Statistical significance 
shall be discussed in Chapter 5. 
 
Table 4.12: Relationship of the following: age, relationship status, 
employment status and level of education, and disclosure of HIV 
status to partners (N=170) 
Variable: Disclosure 
to partner 
Disclosed 
(N=170) 
Did not 
disclosed 
(N=170) 
Chi-Square P-Value 
Age: 
 18-30yrs 
 31-40yrs 
 
70 (41.18%) 
66 (38.82%) 
 
19 (11.18%) 
15 (8.82%) 
 
0.10 
0.11 
 
0.71 
0.71 
Relationship status: 
 In relationship 
 Single 
 Separated 
 
68 (40%) 
68 (40%) 
00 (0.00%) 
 
5 (2.94%) 
28 (16.47%) 
01 (0.59%) 
 
7.89 
5.04 
4.0 
 
0.01 
0.03 
0.04 
  Employment status: 
 Employed 
 Unemployed 
 
37 (21.76%) 
99 (58.24%) 
 
12 (7.06%) 
22 (12.94%) 
 
0.57 
0.23 
 
0.51 
0.65 
Level of education: 
 ≤ Secondary 
 Tertiary  
 
102 (60.00%) 
34 (20.00%) 
 
24 (14.12%) 
10 (5.88%) 
 
0.07 
0.20 
 
0.81 
0.70 
Disclosure education: 
 Received 
 Not received 
 
131 (77.06%) 
05 (2.94%) 
 
18 (10.59%) 
16 (9.41%) 
 
5.84 
41.44 
 
0.02 
0.000 
 
As indicated in Table 4.12, 41.18% of HIV positive pregnant women who were 
between 18-30 years, and 38.82% who were between 31-40 years, were able to 
discloses their HIV status to their partners. Both the chi-squares and p-values are 
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more or less the same (x2 = 0.1, p-value = 0.71). P-values of the age interval were ˃ 
0.05. 
 
Table 4.12 indicates that 40% of those respondents who were in relationships 
disclosed their HIV status to their partners, 40% of those who were single and 0.59% 
of those who were separated reported to have disclosed to their previous partners. 
The chi-square of those in a relationship was (x2 = 7.89, p-value = 0.01), for those 
who were single it was (x2 = 5.04, p-value = 0.03), and for separated respondents it 
was (x2 = 4.0, p-value = 0.04). All p-values were ˂ 0.05. 
 
According to Table 4.12, 58.24% of the unemployed HIV positive pregnant women 
disclosed their HIV status to their partners (x2 = 0.23, p-value = 0.65) while 21.76% 
of those who were employed (x2 = 0.57, p-value = 0.51) disclosed their status. Both 
p-values were ˃ 0.05. 
 
As indicated in Table 4.12, 60% of HIV positive pregnant women who schooled up to 
secondary level disclosed their HIV status to their partners (x2 = 0.07, p-value = 
0.81), and 20.00% of HIV positive pregnant women who schooled up to tertiary level 
disclosed their HIV status to their partners (x2 = 0.20, p-value = 0.71). Both p-values 
were ˃ 0.05. 
 
From Table 4.12 it is evident that 77.06% of respondents who received disclosure 
education were reported to have disclosed their HIV status to their partners, while 
2.94% of those who did not receive disclosure education disclosed. The chi-square 
of those who received disclosure education was (x2 = 5.84, p-value = 0.02), and 
those who did not receive disclosure education was (x2 = 41.44, p-value = 0.000). 
Both p-values were ˂ 0.05. A more comprehensive discussion follows in Chapter 5. 
 
4.3.4  Section C: Motivating/enabling or modifying factors for disclosure 
 
In Section C of the questionnaire, the following topics were addressed: 
motivating/enabling or modifying factors, and the benefits of HIV status disclosure. 
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4.3.4.1 Motivating/enabling or modifying factors for disclosure 
 
The question was developed to determine factors that motivated the respondents to 
disclose their HIV status, so as to comply with the planned treatment protocols which 
are in line with the HBM (Polit & Beck 2017:124). The respondents had to indicate 
“strongly agree”, “agree”, “uncertain”, “disagree” and “strongly disagree” according to 
the Likert scale. The number of respondents who answered the questions in Table 
4.13 will differ from one sub-question to another. 
 
Table 4.13: Motivating/enabling or modifying factors for disclosure 
Motivating 
factors 
Strongly 
agree 
Agree Uncertain Disagree 
Strongly 
disagree 
Did not 
answer 
n % n % n % n % n % N % 
ARVs are 
available at 
the health 
facility 
31 18.35 135 79.88 2 1.18 1 0.59   1 0.59 
ARVs cure 
HIV 
7 4.14 82 48.53 14 8.28 54 31.95 12 7.10 1 0.59 
Someone who 
is on ARVs 
can transmit 
HIV 
15 8.82 78 45.88 33 19.41 36 21.18 8 4.71   
You and your 
partner should 
adhere to 
safer sex 
practices i.e. 
condom use 
25 14.71 135 79.41 1 0.59 8 4.70 1 
0.59 
 
  
Female 
condom is 
available at 
the health 
27 15.98 138 81.66 1 0.59 3 1.77   1 0.59 
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Motivating 
factors 
Strongly 
agree 
Agree Uncertain Disagree 
Strongly 
disagree 
Did not 
answer 
n % n % n % n % n % N % 
facilities 
You can still 
have another 
baby after 
delivery 
10 5.88 62 36.47 11 6.47 69 40.59 18 10.59 
  
Disclosure is 
important to 
you and your 
partner 
24 14.12 130 76.47 3 1.76 12 7.06 1 0.59 
  
 
Table 4.13 indicates that the majority of respondents, 166 out of 169 (98.22%; 
f=166), agreed that ARVs are available in their health facilities. Eighty-nine (89) out 
of 169 (52.66%; f=89) agreed that ARVs cure HIV. Ninety-three (93) out of 170 
(54.71%; f=93) respondents agreed that someone on ARV treatment can transmit 
HIV. One hundred and sixty (160) out of 170 (94.12%; f=160) respondents agreed 
that they should adhere to safer sex practice, for instance with the use of condoms, 
and 165 out of 169 (97.63%; f=165) agreed that female condoms are available in 
their health facilities. One hundred and fifty-four (154) out of 170 (90.59%; f=154) 
respondents agreed that HIV status disclosure is important for them and their 
partners. There were 87 out of 170 (51.18%; f=87) respondents who disagreed that 
they can have another baby after delivery. 
 
According to information in Table 4.13, 166 out of 169 (98.22%; f=166) respondents 
indicated that condoms are available at health facilities, while 165 out of 169 
(97.63%; f=165) reported that female condoms are available in their health facilities. 
 
 
 
 
 
 129 
4.3.4.2 Any other factors that motivated the respondents to disclose their 
status 
 
Respondents were requested to indicate what motivated them to disclose their HIV 
status to their partners. Table 4.14 shows the motivating factors for respondents‟ 
disclosure of their HIV status to their partners. Ninety-three (93) out of 170 (54.71%; 
f=93) respondents did not answer the question. The following calculations are thus 
based on respondents (n=77) who did answer the question. 
 
Table 4.14: Any other motivating/enabling or modifying factors for status 
disclosure to their partners (n=77) 
Motivating factors Frequency Percentage 
To know my status 25 32.47% 
To get support from partners 47 61.04% 
Ill health 5 6.49% 
Total 77 100% 
Not indicated 93 54.71% 
 
Table 4.14 indicates what motivated the respondents to disclose their HIV status: 25 
out of 77 (32.47%; f=25) respondents were interested in knowing their status, 47 out 
of 77 (61.04%; f=47) respondents needed support from their partners, and 5 out of 
77 (6.49%; f=5) respondents were motivated by ill health. Ninety-three (93) out of 
170 (54.71%; f=93) respondents did not indicate what motivated them to disclose 
their status to their partners. According to the HBM, respondents who perceive that 
there are benefits and who believe that treatment may cure the illness or help 
prevent it, may be encouraged to disclosure their HIV status to their partners. Table 
4.15 analyses the benefits of HIV status disclosure. 
 
4.3.4.3  Benefits of disclosure 
 
Respondents were requested to indicate the benefits of HIV status disclosure. Table 
4.15 indicates that 110 out of 170 (64.71%; f=110) respondents did not answer the 
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question. The calculations are based on the respondents (n=60) who did answer the 
question. 
 
Table 4.15: The benefits of disclosure according to respondents (n=60)  
Benefits of disclosure Frequency Percentage 
Freedom from secrets 9 15.00% 
Support from partners 29 48.33% 
Improving health status 18 30.00% 
Encouraging partner testing 4 6.67% 
Total 60 100% 
Not indicated 110 64.71% 
 
The results in Table 4.15 indicate that 9 out of 60 (15%; f=9) respondents needed to 
feel free, 29 out of 60 (48.34%; f=29) respondents‟ benefits of disclosure was to get 
support from their partners, 18 out of 60 (30%; f=18) respondents benefited from 
good health, and 4 out of 60 (6.67%; f=4) respondents reported that their disclosure 
prompted partner testing. One hundred and ten (110) (64.71%; f=110) respondents 
did not indicate the benefits of HIV status disclosure. In the next section, the 
challenges of HIV status disclosure will determine the challenges/barriers/ 
disadvantages of HIV status disclosure. 
 
4.3.5  Section D: The challenges/barriers of disclosure 
 
Under Section D of the questionnaire the challenges/barriers and the disadvantages 
of disclosure were addressed. 
 
4.3.5.1 The challenges/barriers of disclosure 
 
The question was developed to determine challenges/barriers that prohibited the 
respondents to disclose their HIV status. The HBM identified the following disclosure 
challenges: complexity, duration, and accessibility of treatment. The respondents 
had to indicate “strongly agree”, “agree”, “uncertain”, “disagree” and “strongly 
disagree” according to the Likert scale. The calculations in Table 4.16 are based on 
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the number of respondents who answered the sub-question, and will differ from one 
sub-question to another. 
 
Table 4.16: Challenges or barriers of disclosure according to respondents 
Items 
Strongly 
agree 
Agree Uncertain Disagree 
Strongly 
disagree 
Did not 
answer 
n % n % N % n % n % N % 
I am afraid of 
accusations of 
infidelity 
5 3.13 48 30 4 2.5 87 54.37 16 10 10 5.88 
I am afraid 
that my 
partner will 
abandon me 
4 2.44 41 25 5 3.05 97 59.15 17 10.36 6 3.53 
My partner 
will beat me 
1 0.61 17 10.43 4 2.45 119 73.01 22 13.50 7 4.12 
I am not 
working so my 
partner will no 
longer finance 
me 
1 0.61 27 16.46 4 2.44 111 67.69 21 12.80 6 3.53 
My partner 
will throw me 
out of the 
house 
  16 13.01 7 5.69 80 65.04 20 16.26 47 27.65 
My partner 
works far 
3 1.85 42 25.93 2 1.23 97 59.88 18 11.11 8 4.71 
My partner 
may tell 
others 
1 0.61 22 13.41 9 5.49 112 68.29 20 12.20 6 3.53 
I do not know 
that I should 
tell my partner 
5 3.07 19 11.66 2 1.23 114 69.93 23 14.11 7 4.12 
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According to Table 4.16, 53 out of 160 (33.13%; f=53) respondents were afraid of 
accusations of infidelity, and 45 out of 164 (27.44%; f=45) were fearful that their 
partners would abandon them. Eighteen (18) out of 163 (11.04%; f=18) respondents 
were worried that their partners would beat them. Twenty-eight (28) out of 164 
(17.07%; f=28) agreed that their partners would no longer finance them if they 
disclosed their status. Sixteen (16) out of 123 (13.01%; f=16) agreed that their 
partners would throw them out of the house. One hundred and fifteen (115) out of 
162 (70.99%; f=115) respondents‟ partners work far from home, making disclosure 
difficult, and 23 out of 164 (14.02%; f=23) agreed that their partners may tell others. 
 
One hundred and thirty-seven (137) out of 163 (84.05%; f=137) respondents agreed 
that they know that they should tell their partners, while 24 out of 163 (14.72%; f=24) 
respondents indicated that they do not know whether they should tell their partners. 
 
4.3.5.2 Any other challenges/barriers/disadvantages not mentioned (n=40) 
 
Respondents were requested to indicate any other challenges/barriers/ 
disadvantages of disclosure that were not mentioned previously. Table 4.17 
indicates that 130 out of 170 (76.47%; f=130) respondents did not answer the 
question. The calculations are based on the respondents (n=40) who answered the 
question. 
 
Table 4.17: Any other challenges/barriers/disadvantages not mentioned 
(n=40) 
Challenges/disadvantages Frequency Percentage 
Fear of rejection 19 47.50% 
Violent behaviour/violence by 
partner 
07 17.50% 
Projection of blame by partner 04 10.00% 
Fear of stigmatisation 10 25.00% 
Total 40 100% 
Not indicated 130 76.47% 
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The results in Table 4.17 indicate the challenges/barriers/disadvantages that 
prohibited the respondents from disclosing their HIV positive status to their partners 
include: 19 out of 40 (47.50%; f=19) feared rejection from partners, 7 out of 40 
(17.50%; f=7) indicated violent behaviour/violence by their partners, 4 out of 40 
(10.00%; f=4) indicated projections of blame by their partners, and 10 out of 40 
(25.00%; f=10) feared stigmatisation. One hundred and thirty (130) out of 170 
(76.47%; f=130) of the respondents did not answer this question. 
 
4.4  OVERVIEW OF RESEARCH FINDINGS 
 
In this chapter the findings were presented, analysed and described using tables and 
graphs. The findings reflected perceived barriers of HIV status disclosure of pregnant 
women to their partners in the Capricorn District, Limpopo Province. It was 
supported by 34 out of 170 (20%; f=34) of the respondents who did not disclose their 
HIV status to their partners. One hundred and seventy (170) out of 186 (91.40%; 
f=170) respondents participated in the study. One hundred and thirty-two (132) 
(77.65%; f=132) respondents were between 21-35 years of age, 157 (92.35%; 
f=157) were Christians, and 94 (55.29%; f=94) respondents were single. Sixty-nine 
(69) (40.59%; f=69) respondents were in a relationship for 2-5 years with their 
current partner. Forty-nine (49) out of 152 (32.24%; f=49) respondents had only 1 
child alive, 49 out of 152 (32.24%; f=49) respondents had 2 children alive, while 23 
out of 152 (13.53%; f=23) respondents had lost 1 child. One hundred and sixty-three 
(163) (95.88%; f=160) respondents lived in rural areas, and 121 (71.18%; f=121) 
were unemployed. One hundred and eighteen (118) (69.41%; f=118) respondents 
had secondary levels of education, and 107 out of 163 (65.64%; f=107) respondents‟ 
partners went up to secondary school level. 
 
Sixty-eight (68) (40%; f=68) respondents were diagnosed for less than 1 year; the 
respondents might have been diagnosed with HIV during the current pregnancy. 
Seventy-nine (79) out of 154 (51.30%; f=79) respondents knew someone who is HIV 
positive, and 84 out of 161 (52.17%; f=84) respondents knew people who disclosed 
their HIV status to them. One hundred and forty-nine (149) (87.64%; f=149) 
respondents received disclosure education, and 96 out of 153 (62.75%; f=96) took 
less than a month to disclose their diagnosis to their partners. One hundred and two 
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(102) out of 135 (75.56%; f=102) respondents‟ partners were not disappointed with 
respondents‟ HIV status, and 126 out of 136 (92.65%; f=126) respondents‟ partners 
were supportive and caring. One hundred and sixty-two (162) (95.29%; f=162) 
respondents had 1 sexual partner in the last 3-6 months, while 148 out of 170 
(87.06%; f=148) of the respondents‟ partners had 1 sexual partner in the last 3-6 
months. Eighty (80) (47.06%; f=80) respondents sometimes used condoms, and 21 
out of 136 (15.44%; f=21) fell pregnant three times or more while being HIV positive. 
Forty-five (45) out of 95 (47.37%; f=95) respondents had a CD4 cell count of more 
than 500 cells/mmᵌ. 
 
Ninety-three (93) out of 170 (54.71%; f=93) respondents agreed that someone on 
ARVs can transmit HIV to their sexual partner. Forty-seven (47) out of 77 (61.04%; 
f=47) of the respondents needed support from their partners, and 29 out of 60 
(48.33%; f=29) got support from their partners. Fifty-three (53) out of 160 (33.13%; 
f=53) respondents were afraid of accusations of infidelity, while 45 out of 164 
(27.44%; f=45) were afraid that their partners would abandon them. Ten (10) out of 
40 (25.00%; f=10) respondents‟ barriers/challenges/disadvantages of HIV status 
disclosure to the partner was stigmatisation. 
 
This data assisted the researcher to reach the objectives of the study which were to 
explore and describe the perceived barriers of HIV status disclosure of pregnant 
women to their partners in the Capricorn District, Limpopo Province. A number of 
HIV positive pregnant women (34 out of 170 (20%; f=34)) indicated that they were 
unable to disclose their HIV status to their partners, which has the potential to 
increase as respondents are still sexually active and pregnant. Even though 
resources are available to help the respondents and the community to understand 
HIV/AIDS through many forms of media, it is still a challenge for HIV positive 
pregnant women to disclose their HIV status to their partners in the Capricorn 
District, Limpopo Province. 
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4.5  CONCLUSION 
 
In this chapter, data were collected from 170 HIV positive pregnant women (N=170). 
The researcher analysed the data using SPSS version 24, and presented the 
research findings in tables, graphs, and figures. 
 
The data obtained serves to confirm that women who are socio-economically 
vulnerable, with lower levels of education, who are single and unemployed, and who 
grew up in rural areas, tended to have barriers of HIV status disclosure. Statistics 
indicated that 136 out of 170 (80%; f=136) respondents reported that they disclosed 
their HIV status, while 34 out of 170 (20%; f=34) did not disclose their status to their 
partners. Chapter 5 will present the summary, interpretation of the research findings, 
the limitations, conclusions, and recommendations of this study. 
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CHAPTER 5 
FINDINGS, CONCLUSIONS, LIMITATIONS AND 
RECOMMENDATIONS 
 
5.1   INTRODUCTION 
 
Effective management of disclosure barriers/challenges enhances the prevention of 
HIV transmission by pregnant women and their partners. In Chapter 4, data were 
presented and the data analysis was done. The aim of this study was to investigate 
the perceived barriers of HIV status disclosure of pregnant women to their partners 
in the Capricorn District, Limpopo Province. The researcher used the HBM as a 
theoretical framework for this study, which includes perceived susceptibility, 
perceived severity, perceived benefits, barriers and costs, motivation and enabling or 
modifying factors (Polit & Beck 2017:124). These aspects will be applied in this 
chapter. 
 
The research objectives were as follows: 
 
Objective one: 
 
 Explore and describe the perceived barriers of HIV status disclosure of pregnant 
women to their partners in the Capricorn District, Limpopo Province. 
 
A literature review was conducted to adapt and develop an existing questionnaire 
(with permission from developers) to meet this objective. Chapter 3 focused on the 
methodology of the research. In Chapter 4, 136 out of 170 (80%; f=136) respondents 
indicated that they disclosed their HIV status to their partners. Therefore, 80% of the 
respondents did not experience barriers of HIV disclosure as they did disclose their 
status to their partners. Despite the absence of barriers in HIV status disclosure, 
fears that could create barriers of disclosure were identified. These fears related to 
their partner‟s reaction to their HIV status disclosure, and included accusations of 
infidelity, fear of abandonment, and loss of financial support. Table 4.15 indicated 
that 53 out of 160 (33.13%; f=53) respondents feared accusations of infidelity, 45 out 
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of 164 (27.44%; f=45) feared their partners would abandon (reject) them, and 28 out 
of 164 (17.07%; f=28) feared loss of financial support from their partners after 
disclosure. 
 
Objective two: 
 
 Make recommendations on disclosure education to health care workers 
performing VHCT to enhance the self-efficacy of these women to disclose their 
HIV status to their partners based on the study findings. 
 
Self-efficacy refers to HIV positive pregnant women‟s belief that they are able to 
disclose their status to their partner. Motivating or enabling factors enhanced their 
belief in status disclosure to their partners. 
 
Table 4.13 indicates that 166 out of 169 (98.22%; f=166) respondents agreed that 
ARVs are available in their health facilities. One hundred and sixty (160) out of 170 
(94.12%; f=160) respondents agreed that they should adhere to safer sex practices, 
for instance, using condoms, and 165 out of 169 (97.63%; f=165) agreed that female 
condoms are available in their health facilities. 
 
The factors that motivated the respondents to disclose their HIV status in Table 4.14 
were: 25 out of 77 (32.47%; f=25) respondents were interested in knowing their 
status, and 47 out of 77 (61.04%; f=47) needed support from their partners. The 
HBM, according to Polit and Beck (2017:124), indicates that respondents who 
perceive that there are benefits, and who believe that the treatment may cure the 
illness or help prevent it, may be encouraged to disclosure their HIV status to their 
partners. 
 
Figure 4.12 illustrates that 149 out of 170 (87.64%; f=149) respondents received 
disclosure education. One hundred and fifty-four (154) out of 170 (90.59%; f=154) 
respondents agreed that HIV status disclosure is important for them and their 
partners (Refer to Table 4.13). Although HIV status disclosure is vital to the 
respondents and their partners, only 4 out of 60 (6.67%) respondents indicated the 
benefits of disclosure as encouragement for their partners to go for HIV testing. 
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Table 4.15 further shows that 29 out of 60 (48.33%; f=29) respondents‟ benefits of 
disclosure was to get support from their partners, and 18 out of 60 (30%; f=18) 
wanted to maintain good health. 
 
The respondents need to have self-efficacy to be able to disclose their HIV status to 
their partners. The disclosure education received by respondents, the availability of 
ARVs and female condoms in their health facilities, the need to get support from their 
partners, and a need to maintain good health, might encourage them to disclosure 
their HIV status to their partners. Self-efficacy and the belief that they can disclose 
their status to their partners through disclosure education can enhance status 
disclosure to partners. 
 
Recommendations to clinical practice on disclosure education and in-service training 
of the health care workers and future research were proposed to enhance the 
pregnant women‟s HIV status disclosure to their partners. The components of the 
HBM were used to investigate factors that may contribute to respondents‟ self-
efficacy to disclose their status to their partners and the realisation of the sexually 
risky behaviour that needed to change. It was recommended that the health care 
workers should also disseminate the disclosure information to community members 
through awareness campaigns. 
 
5.2  RESEARCH DESIGN AND METHOD 
 
An explorative, descriptive and cross-sectional quantitative research design was 
used to explore and describe the perceived barriers of HIV status disclosure of 
pregnant women to their partners in the Capricorn District, Limpopo Province. The 
research was conducted in three hospitals that were purposively and conveniently 
sampled in the specified district. One hospital was situated in an urban area, while 
two of these hospitals were in the rural area. The three ARV clinics are in hospitals 
that pregnant women are referred to for high risk antenatal care from local 
clinics/hospitals as they need to make hospital bookings for delivery. Therefore, ARV 
clinics in these hospitals were selected for this study as a vast number of pregnant 
women visit them. 
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Data were collected from HIV positive pregnant women who were purposively and 
conveniently sampled and who met the inclusion criteria, which was discussed in 
detail in Chapter 3. A questionnaire was utilised as a data collection instrument. The 
instrument was adapted from an existing questionnaire (with the permission of the 
developers), combined with a literature search and the HBM as theoretical 
framework. The questionnaire consisted of structured and open-ended questions 
and took 20-25 minutes to complete. The following headings were covered in the 
data collection instrument: the socio-demographic characteristics, sexual and 
reproductive health information, the motivating and enabling/modifying factors, and 
the challenges/barriers of HIV status disclosure. The structured questions were 
analysed with descriptive statistics (SPSS version 24), and open-ended questions 
were analysed using thematic coding (Refer to Chapter 4 for details). 
 
One hundred and eighty-six (186) respondents were invited to take part in the study 
and 171 respondents completed the questionnaires. Of the returned questionnaires, 
1 was incomplete and discarded. The response rate was 91.40% (calculated from 
170, as the incomplete questionnaire was discarded thus not used during data 
analysis). The response rate was discussed with the statistician who agreed that it 
was high enough to guarantee accurate results. 
 
5.3  INTERPRETATION OF THE RESEARCH FINDINGS 
 
As indicated in Chapter 4, the interpretation of the research findings was presented 
in four sections: Section A: Socio-demographic characteristics of respondents, 
Section B: Sexual and reproductive health information, Section C: The motivating 
and enabling/modifying factors, and Section D: Challenges/Barriers of HIV 
disclosure. 
 
5.3.1  Section A: Socio-Demographic characteristics of respondents 
 
Section A dealt with respondents‟ biographic data including age, religion, marital 
status, duration with current partner, number of children alive and deceased, 
employment status, level of education, period of pregnancy, and place of origin. 
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Employment status, respondents‟ partners‟ level of education, and head of the 
household were also included. 
 
The inclusion criteria in Chapters 1 (Refer to Section 1.9.4) and 3 (Refer to Section 
3.3.3) included HIV positive pregnant women within the age range from 18-40 years 
who were on ARTs for at least one month prior to the study. The reason behind the 
period of one month prior to participating in this study was to give the HIV positive 
pregnant women time to disclose their status to their partners. The results indicated 
that 139 out of 170 (81.76%; f=139) respondents were between 18-35 years old 
(Refer to Table 4.2). This age group represents the child-bearing age for women who 
are sexually active, and 31 out of 170 (18.23%; f=31) respondents were between 36-
40 years of age. The youngest respondent was 18 years old, while the oldest 
respondents were 39 years old. The mean age was 30 years (Refer to Table 4.2). In 
contrast to this study, a study by Shamu, Zarowsky, Shefer, Temmerman and 
Abrahams (2014:2) in Harare, Zimbabwe indicated that the youngest women who 
attended a postpartum clinic were 15 years old. According to another study 
conducted in Botswana, 56.4% respondents were 21-25 years old, 15.4% were 26-
30 years old, 12.8% were 31-35 years old, and 15.4% of the respondents were older 
than 35 years (Tshisuyi & Davis 2014:28). Letsoalo and Madiba (2014:14) found that 
participants aged 18-40 years took part in their study; the age range of their 
participants is thus similar to the respondents‟ age in the current study. According to 
Statistics South Africa (NDoH 2017:7), the reproductive age is 15-49 years. The age 
group 18-40 years in this study falls within the South African reproductive age. 
 
Based on Table 4.2, 157 out of 160 (98.13%; f=157) respondents indicated that they 
were Christians. The results of the study conducted in Botswana showed 24 out of 
37 (64.86%; f=24) respondents‟ religious affiliation was also Christian (Tshisuyi & 
Davis 2014:29). Batte, et al. (2015:4) concur with this study that 88.4% of their 
Ugandan participants were Christians. The result in the South African study on non-
disclosure of HIV status at primary health care clinics in the West Rand shows that 
100 out of 106 (94.34%; f=100) respondents were Christians, thus proving similar 
results to this study (Selebogo, et al. 2014:76). According to Statistics South Africa 
(NDH 2015), 86% of people belong to a Christian religion in South Africa. Christianity 
per province is found to be: 79.9% Limpopo, 92.2% Mpumalanga, 87.1% Gauteng, 
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87.8% Western Cape, 83.5% Eastern, 98.4% Northern Cape, 97.7% Free State, 
78.5% KwaZulu-Natal, and 93.3% North West (NDoH 2015). This study was 
conducted in Limpopo Province and respondents were predominantly Christian 
(98.12%) which is higher than that 79.9% of Limpopo Province (Statistics South 
Africa 2015). However, it correlates well with other studies mentioned as most 
respondents belonged to the Christian religion. 
 
Table 4.2 reported that 94 out of 170 (55.29%; f=94) respondents were single, which 
concurs with the study by Selebogo, et al. (2014:76) which also had 71 out of 106 
(66.98%; f=71) of their South African respondents listed as unmarried. Letsoalo and 
Madiba‟s (2014:14) study further indicates that 28% of participants in their study 
were married. Alemayehu, et al. (2014:3) also state that 44.1% of respondents in 
their Ethiopian study were married. In contrast, 78% of the respondents in the study 
conducted in China were married (Qiao, et al. 2016:39). The findings from this study 
fit well with studies from Africa, as most respondents were not married. 
 
In the current study, 31 out of 170 (18.24%; f=31) respondents were with their 
current partner for less than a year, 69 out of 170 (40.59%; f=69) respondents were 
with their current partner between 2-5 years, and 42 out of 170 (24.70%; f=42) 
respondents were in their current relationship between 6-10 years. One hundred and 
thirty-nine (139) out of 170 (81.76%; f=139) respondents were in their current 
relationships for more than a year. The duration in the relationship with the current 
partner of less than a year as indicated by 31 out of 170 (18.24%; f=31) respondents 
might have contributed to non-disclosure of HIV status, as 34 out of 170 (20%; f=34) 
respondents did not disclose their status to their partners. According to the study by 
Batte, et al. (2015:6), women who were in an unstable relationship were associated 
with non-disclosure of HIV status to their partners. 
 
Forty-nine (49) out of 152 (32.24%; f=49) of the respondents had only 1 child alive 
and 49 out of 152 (32.24%; f=49) respondents had 2 children alive. According to 
Table 4.2, 23 out of 170 (13.53%; f=23) respondents had lost 1 child. According to 
Walcott, et al. (2013:3), 53% of their respondents had 3 or more children alive. The 
findings in this study differ from the study by Walcott et al (2013:3) as 32.24% 
respondents had 1 child, and 32.24% respondents had 2 children alive. Ten (10) out 
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of 49 (20.41%; f=10) of the respondents had 2 children alive in the age group 18-25, 
while 32 out 49 (65.31; f=32) had 2 children alive. The result may indicate that 
younger women had 1 child alive while older ones had 2 children alive. 
 
Table 4.2 reported that 1 (0.59%; f=1) respondent was ≤ 3 months pregnant, 9 
(5.30%; f=9) respondents were 4-6 months pregnant. One hundred and sixty (160) 
(94.11%; f=160) respondents were > 6 months pregnant during the data collection 
period. In contrast to the current study, Jones, et al. (2013:703), in their study 
conducted in South Africa, 239 out of 478 (50%; f=239) respondents who enrolled in 
their study were from 24-30 weeks‟ gestation (from 6-7 months). 
 
One hundred and sixty-three (163) out of 170 (95.88%; f=163) respondents grew up 
in rural areas, while only 7 out of 170 (4.12%; f=7) grew up in urban areas. In 
contrast with these findings, 82% respondents from Aregay, et al‟s. (2014:2) study 
were urban dwellers, while 18% were from rural areas. The study conducted in 
Mpumalanga Province, South Africa by Jones, et al. (2013:705) concurs with the 
findings in this study, with 100% of their respondents being primarily rural. Qiao, et 
al. (2016:39) indicated that 83% of their respondents lived in rural areas. Two 
hospital ARV clinics are situated in the rural area while one hospital ARV clinic is in 
an urban area. This might have influenced the findings to represent a more rural 
population. However, it correlates well with the statement of the Department of 
Health of South Africa (2016), which indicates that approximately 80% of the 
population in Limpopo Province is based in rural areas. 
 
One hundred and twenty-one (121) out of 170 (71.18%; f=121) respondents in this 
study were unemployed. The study conducted in Botswana by Tshisuyi and Davis 
(2014:44) had similar results, with 26 out of 39 (66.67%; f=26) of their respondents 
being unemployed. According to Habedi, et al‟s. (2015:68) study, 90% of their North 
West Province participants were unemployed. Dlamini and Mokoboto-Zwane 
(2015:49) also support this study‟s finding with 63 out of 90 (70%; f=63) of their 
respondents being unemployed. In China, Qiao, et al. (2016:77) indicate that 17.20% 
of respondents were unemployed, while 82.43% of the respondents were employed, 
which is in contrast to this study‟s findings. China had a lower unemployment rate of 
4.11% in 2017 while 26.7% South African population was unemployed in 2017 
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(NDoH 2017). In Ethiopia, Gatta, Limando and Thupayagale-Tshweneagae 
(2015:71) found 76.7% of employed respondents were able to discuss the risk of HIV 
transmission with their partners. The unemployment status in this study can thus 
influence the HIV positive pregnant women‟s decision to disclose their HIV status to 
their partner. Fifty percent (50%) of the female youth in the 20-24 years age group 
were not in employment, education or training (Statistics SA 2017:11). 
 
One hundred and eighteen (118) out of 170 (69.42%; f=118) respondents had 
secondary education and 44 out of 170 (25.88%; f=44) had tertiary education. One 
hundred and seven (107) out of 163 (65.64%; f=107) respondents‟ partners attended 
secondary school, and 52 out of 163 (31.90%; f=52) respondents‟ partners attended 
up to tertiary education. There was a higher percentage of respondents‟ partners 
who had tertiary education; 31.90% as compared to 25.88% of respondents who had 
tertiary education. Tshisuyi and Davis (2014:28) had similar findings; 28 out of 39 
(71.79%; f=28) pregnant women in their study had secondary education, and 9 out of 
39 (23.07%; f=9) had tertiary education. According to Madiba and Mokgatle 
(2017:176), 14.8% of their respondents had no formal education, 24.1% had primary 
education, 40.2% secondary education, 17% completed Grade 12, and 3.9% had 
tertiary education. Madiba and Mokgatle‟s (2017:176) findings are in contrast to this 
study, as 69.42% respondents from this study had secondary education and 25.88% 
had tertiary education, while 40.2% in their study had secondary education, and 
3.9% had tertiary education. According to Statistics South Africa (NDoH 2016), 1 244 
208 learners are registered for Grade 1, yet only 687 230 complete Grade 12. About 
150 000 (22%) pass matric, and 1 in 5 makes it to Higher Education Institutions. 
Looking at it a little differently, only 12% (or around 1 in 9) of schoolchildren entering 
Grade 1 will make it to Higher Education Institutions. Higher levels of education, 
such as secondary and tertiary education, can have an influence in the decision 
making process such as disclosure of HIV status to the partner. 
 
Sixty-eight (68) out of 170 (40%; f=68) respondents indicated that their households 
were headed by their husbands. In Hlabisa District in KwaZulu-Natal, South Africa, 
the majority of participants lived with their families: parents, grandparents, and 
siblings (Van Rooyen & Mhlongo 2015:52). Section B will provide the sexual and 
reproductive health information of the respondents. 
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5.3.2 Section B: Sexual and reproductive health information 
 
Section B analysed the sexual reproductive health information of respondents. The 
following topics were covered: respondents‟ period/duration diagnosed with HIV for 
the first time, knowledge of anyone who is HIV positive, disclosure of HIV status, and 
duration the respondents took to disclose their HIV status. To whom the HIV status 
was disclosed, disclosure education received, and who performed the disclosure 
education was also addressed, as well as: Did the person the respondents know 
disclose her/his status? Did the respondents disclose their HIV status to their 
partner? Partners‟ reactions to the respondents‟ positive status, and partners‟ HIV 
status were explored. The number of sexual partners respondents had in the last 3-6 
months, the number of sexual partners the respondents‟ partner(s) had in the last 3- 
6 months, and the use of condoms also formed part of the questions respondents 
were asked. The number of pregnancies respondents had while HIV positive and 
their last CD4 cell count results were also considered under Section B of the 
questionnaire (Annexure G). 
 
5.3.2.1 Respondent’s period/duration diagnosed with HIV for the first time 
 
This portion explored the diagnosis and disclosure practices of respondents. 
 
 Respondent’s period/duration diagnosed with HIV for the first time (N=170) 
 
Respondents indicated in Table 4.3 that 68 out of 170 (40%; f=68) respondents had 
been diagnosed with HIV for less than a year, while 44 out of 170 (25.88%; f=44) 
were diagnosed 1-3 years ago. Twenty-nine (29) out of 170 (17.06%; f=29) 
respondents were diagnosed 7-9 years ago, and 2 out of 170 (1.18%; f=2) 
respondents were diagnosed more than 10 years ago. The Tanzanian study by 
Kiula, et al. (2013:5) states that knowledge of the woman‟s HIV status before current 
pregnancy positively influenced HIV disclosure to the partner. This is consistent with 
this study as 41.76% respondents were diagnosed more than 1-6 years ago, and 
80% respondents disclosed their HIV status to their partners. The findings from 
Tshisuyi and Davis‟ (2014:30) study indicated that 69.23% respondents knew their 
HIV status for more than one month, and in this study 41.76% had known about their 
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diagnosis for 1-6 years. The longer the duration of knowledge of HIV status and the 
availability and accessibility to ART may have increased the likelihood of disclosure 
(Longinetti, et al. 2014:4). According to Qiao, et al. (2016:39), the average duration 
since the respondents were diagnosed with HIV was 4 years, and 205 out of 405 
(50.62%; f=205) disclosed their status to their partners. Shiyoleni and Thomson 
(2013:28) reported that 56% of their respondents had known their HIV status for 2 
years or less. According to the literature mentioned, it seems as if most of the 
women were diagnosed between 1-6 years ago and disclosed their HIV status. This 
is in contrast to the findings of this study whereby 41.76% were diagnosed 1-6 years 
ago and 80% disclosed their HIV status to their partners. Thus, according to the 
literature it seems more likely for HIV positive pregnant women to disclose their 
status after being diagnosed between 1-6 years. 
 
 Knowledge of anyone who is HIV positive and the person you know 
disclosed her/his status to you (n=154) 
 
Seventy-nine (79) out of 154 (51.30%; f=79) respondents knew someone who was 
HIV positive and 75 out of 154 (48.70%; f=75) respondents did not know any person 
who was HIV positive (Refer to Table 4.4). According to the Northern Ethiopian 
study, women who had seen an HIV positive person disclosing his/her status to the 
community had double the odds of disclosing their HIV status to their partners 
(Alemayehu, et al. 2014:3). It appears that knowing and witnessing someone 
disclosing his or her HIV positive status to someone, can motivate disclosure of 
her/his own status. 
 
 Disclosure education received (N=170) 
 
One hundred and forty-nine (149) out of 170 (87.64%; f=149) respondents reported 
that they received disclosure education, while 21 out of 170 (12.36%; f=21) 
respondents indicated that they did not receive disclosure education (Refer to Table 
4.4). Disclosure education entails providing information before and after an HIV test 
by the health care workers to the patient. For health care workers, post counselling 
after a positive or negative HIV test entails making sure you have the right results, 
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you understand what the results mean, you have time to spend with the patient, and 
you are emotionally ready to give the results to the patient personally (van Dyk 2013: 
275). According to Katirayi, Namadingo, Phiri, Bobrow, Ahimbisibwe, Berhan, Buono, 
Moland and Tylleskar (2016:1), before receiving their first supply of ART, participants 
received general group counselling, followed by individual counselling. Women 
received monthly adherence counselling for the next 6 months followed by a general 
adherence counselling session to transition to three-monthly follow-up visits. 
Selebogo, et al. (2014:78) concur, as 93.39% of their respondents received health 
education on disclosure of HIV/AIDS. Alemayehu, et al. (2014:3) found that pre-test 
counselling was also positively associated with HIV status disclosure. Compared to 
this study, fewer rates were reported in the study conducted in Botswana by Tshisuyi 
and Davis (2014:38), where 23.1% respondents were offered health education, and 
30.8% received couple counselling and testing, which assisted with HIV status 
disclosure. Respondents are given time to decide when to disclose their HIV status. 
The next section will outline the average time taken to disclose an HIV positive 
status. 
 
 Number of days/months/years taken to disclose the status 
 
This question referred to disclosing in general; not specifically to the partner. The 
findings reported on the number of days/months/years the HIV positive pregnant 
women took to disclose their status. Respondents in Table 4.4 indicated that 52 out 
of 153 (33.98%; f=52) disclosed their HIV status after a year, 96 out of 153 (62.77%; 
f=96) disclosed in less than a month, and 17 out of 170 (10%; f=17) did not disclose 
their HIV diagnosis to anyone, including their partners. This can be associated with 
the unemployment rate in this study of 121 out of 170 (71.18%; f=121) while 49 out 
of 170 (28.82%; f=49) respondents were employed. Genet, et al. (2015:5) state that 
58% respondents delayed their status disclosure until one month after initial 
diagnosis, 28% disclosed their HIV positive status within 1-2 months, while 13.4% of 
their respondents disclosed after 6 months. Alema, et al. (2017:54) found that 67% 
of respondents disclosed their HIV positive status after one month, and as with 
Genet, et al‟s. (2015:5) study, 13.4% disclosed after 6 months. In contrast to the 
current study, Tshisuyi and Davis (2014:34) reported that 62.2% disclosed their HIV 
status to another person the same day of diagnosis, 10.8% disclosed in less than a 
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week, 10.8% disclosed after a week, 2.7% disclosed after a month, 5.4% disclosed 
after 3 months, and 8.1% disclosed after a year. As many as 12% of Tshisuyi and 
Davis‟ (2014:34) respondents had never disclosed their HIV-positive status to others, 
even though these interviews were conducted 6-14 weeks after their babies‟ births. 
Mbokane, et al. (2016:14) stated that 65.3% respondents disclosed their HIV status 
within one week after their diagnosis, 21.6% did so within one month of their 
diagnosis, 8% waited 6 months before disclosure, and 5.1% only did so after a year. 
The results are consistent with the findings by Tshisuyi and Davis (2014:34) whereby 
the duration from diagnosis to disclosure differed from less than a month to a year. In 
the current study, 160 out of 170 (94.11%; f=160) respondents were more than 6 
months pregnant during the data collection period and 62.77% disclosed their status 
in less than a month. The period of pregnancy is 9 months; therefore, pregnant 
women are encouraged to disclose their HIV status to their partners as soon as 
possible to comply with PMTCT. The next section will discuss whether the 
respondents disclosed their HIV status after diagnosis. 
 
 Did you disclose your HIV status after diagnosis? 
 
This question referred to disclosing in general and not specifically to the partner. 
Results in Table 4.4 indicated that 153 out of 170 (90%; f=153) respondents 
disclosed their HIV status after diagnosis, while 17 out of 170 (10%; f=17) 
respondents did not disclose their HIV status to anyone after diagnosis, not even 
their family members or friends. Findings of Alema, et al‟s. (2017:54) study indicate 
80.1% HIV status disclosure among respondents. The findings in this study are 
similar to Dima, Stutterheim, Lyimo and De Bruin (2014:170) which stated that 
94.3% respondents disclosed their HIV status. Similarly, 94.7% of Tshisuyi and 
Davis‟s (2014:56) respondents disclosed their HIV status to someone. According to 
Mbokane, et al. (2016:14), 124 out of 176 (70.45%; f=124) women had disclosed 
their HIV status to others. These results show that disclosure of HIV status after 
diagnosis ranges from 70.5% to 94.7%. Disclosure to someone is also encouraged 
during counselling sessions, even though it may not reduce MTCT of HIV while 
disclosure to a partner may reduce MTCT. 
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 Person to whom HIV positive status was disclosed (n=150) 
 
The results in Table 4.4 shows that 62 out of 150 (41.34%; f=63) respondents 
disclosed to their family members and 3 out of 150 (2%; f=3) disclosed their HIV 
status to others who were not their family members. Therefore, there was a higher 
incidence of disclosure to family member in comparison to others. This correlates 
with Alema, et al‟s. (2017:54) findings which indicated that 35.18% respondents 
preferred to disclose their HIV status to their parents. The lack of disclosure to the 
partners does not aid in the reduction of new infections, as the partners will continue 
to infect others unknowingly. The immune system may not be able to keep up the 
fight against the HIV infections as a higher viral load is associated with lower CD4 
cell count as the virus lowers the CD4 cells (van Dyk 2013:62). According to Tshisuyi 
and Davis (2014:32), 66.7% of their respondents disclosed their HIV status to their 
boyfriend, 41% disclosed to a family member, 23% to friend, 7.7% to their spouse, 
5.1% to their casual sex partner, 2.6% to a colleague, and 2.6% to their neighbour. 
Mbokane, et al. (2016:14) had similar results; 43.8% of pregnant women disclosed 
their HIV status first to their parents, 25% to their sisters, and 20.5% to their friends. 
Also, 8% of the HIV-positive women initially disclosed to their brothers, 5.1% to 
unspecified relatives, and 1.7% to their mothers-in-law. The disclosure of HIV may 
be associated with disclosure education received. The next section relates to 
disclosure education which is relevant in addressing objective two. 
 
 Person who performed the disclosure education (n=151) 
 
According to Table 4.4, 149 out of 170 (87.64%; f=149) respondents reported that 
they received disclosure education, and 151 out of 151 (100%; f=151) of the 
respondents who received disclosure education stated that they received disclosure 
education from health care workers. 
 
 Health care worker advised you to disclose the status (N=170) 
 
The findings in Figure 4.13 illustrate that 152 out of 170 (89.40%; f=152) 
respondents were advised by the health care worker to disclose their HIV status, 
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while only 18 out of 170 (10.60%; f=18) reported that they were not advised by the 
health care worker to disclose their HIV status. Genet, et al‟s. (2015:5) study 
indicated that continuous counselling of respondents at each contact with the health 
care workers and the use of behavioural rehearsal increased disclosure of an HIV 
positive status. Respondents in Tanzania indicated that advice and counselling from 
health care workers were reported to have led to HIV status disclosure (Yonah, et al. 
2014:4). The studies by Genet, et al. (2015:5) and Yonah, et al. (2014:4), and the 
current study, show that health care workers‟ advice may enhance the disclosure of 
an HIV positive status. The next section discusses disclosure of HIV status to the 
partner. 
 
 Disclosure of HIV positive status to the partner (N=170) 
 
The results in Table 4.4 indicated that 136 out of 170 (80%; f=136) respondents 
disclosed their HIV status to their partners, while 34 out of 170 (20%; f=34) did not 
disclose their HIV positive status to their partners. These findings are in contrast with 
Letsoalo and Madiba‟s (2014:16) study; only 40% of their participants disclosed their 
HIV status to their partners. Letsoalo and Madiba‟s findings are however similar to 
the study by Alema, et al. (2017:54), whereby 41.8% of their respondents disclosed 
their HIV status to their sexual partners. The proportion of women in a study 
conducted in Uganda further revealed that 38% disclosed their HIV status to partners 
(Kiweewa, et al. 2015:5). Yonah, et al. (2014:5) reported the lowest rate of 25.4% of 
respondents who disclosed their HIV status to their spouses. Alemayehu, et al. 
(2014:3) found that 63.8% of their respondents disclosed their HIV status to their 
partners. The proportion of HIV status disclosure to their partners was 60.9% in Togo 
(Yaya, et al. 2015:6). The above African studies indicate the disclosure rate to a 
partner from 25% to 60.9% as compared to 80% of respondents in this study. 
Disclosure to the partner is an essential strategy for the success of PMTCT (Yonah, 
et al. 2014:4). It also plays a crucial role in the adoption of consistent condom use 
among couples to prevent new infections and re-infections, and improves the 
adherence to ARTs, thus enhancing the health status of patients (Yonah, et al. 
2014:4). The next section will discuss if there was anyone who disclosed her/his 
status to the respondent. 
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 Is there anyone who disclosed her/his status to you? (n=161) 
 
Eighty-four (84) out of 161 (52.17%; f=84) respondents knew people who disclosed 
their HIV status to them, while 77 out of 161 (47.83%; f=77) respondents indicated 
that no one disclosed his/her HIV status to them. These results may imply that there 
are people who still hide their HIV status by non-disclosure. The next section will 
review the respondents‟ partners‟ reaction to HIV status disclosure. 
 
 Partner’s reaction to HIV status disclosure 
 
Table 4.5 shows that 102 out of 135 (75.56%; f=102) respondents‟ partners were not 
disappointed with the respondents‟ HIV status, while 33 out 135 (24.44%; f=33) were 
disappointed with the respondents‟ HIV status. Thirty-five (35) out of 170 (20.59%; 
f=35) respondents did not answer this question. 
 
One hundred and seventeen (117) out of 134 (87.31%; f=117) respondents 
disagreed that their partners were judgemental towards their HIV positive status, and 
17 out of 134 (12.69%; f=17) respondents‟ partners agreed that their partners were 
judgemental towards their HIV status. Thirty-six (36) out of 170 (21.18%; f=36) 
respondents did not answer the question. 
 
One hundred and twenty-six (126) out of 136 (92.65%; f=126) respondents‟ partners 
were supportive and caring, while 10 out of 136 (7.35%; f=10) respondents‟ partners 
were not supportive or caring. Thirty-four (34) out of 170 (20%; f=34) respondents 
did not answer the question. 
 
One hundred and twenty-seven (127) out of 135 (94.07%; f=127) respondents‟ 
partners accepted their HIV status, while 8 out of 135 (5.93%; f=8) respondents‟ 
partners did not accept their HIV status. Thirty-five (35) out of 170 (20.59%; f=35) 
respondents did not answer this question. 
 
One hundred and twenty-six (126) out of 133 (94.74%; f=126) respondents 
disagreed that their partners rejected them, and 7 out of 133 (5.26%; f=7) agreed 
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that their partners rejected them. Thirty-seven (37) out 170 (21.76%; f=37) 
respondents did not answer the question. 
 
One hundred and twenty-seven (127) out of 134 (94.78%; f=127) respondents 
disagreed that their partners ignored them, while 7 out of 134 (5.22%; f=7) 
respondents agreed that their partners ignored them. Thirty-six (36) out of 170 
(21.18%; f=36) respondents did not answer the question. The number of 
respondents who did not answer the questions in Table 4.5 plus the number of 
respondents who had negative reactions from their partners, is an indication that 
there might be barriers of disclosing an HIV status to the partner(s). The percentage 
(21.18%) of the respondents that did not answer this question correlates with the 
20% who did not disclose to their partners. 
 
According to the study by Loukid, Abadie, Henry, Hilali, Fugon, Rafif, Mellouk, 
Lahoucine, Otis and Préau (2014:56), women overestimated the risks of negative 
reactions by their partners. Nineteen (19) out of 51 (37.25%; f=19) of their 
respondents declared that it had been an error to disclose their HIV positive status to 
their partners. In the current study, 94.07% respondents‟ partners accepted the 
respondents‟ HIV status, 92.64% respondents‟ partners were supportive and caring, 
and 24.44% were disappointed with the respondents‟ HIV status. The results indicate 
that with continued support, the health care workers might help the respondents to 
find ways to disclose their HIV status so that their partners might offer them support 
and accept their status. 
 
Yaya, et al‟s. (2015:7) study indicated that patients living in union already have a 
stable relationship with their partners; this creates an environment of mutual trust 
and support, and therefore facilitates the sharing of information such as HIV status. 
The next section will outline the respondents‟ knowledge of their partner‟s HIV 
status. 
 
 Respondents’ knowledge of their partner(s) HIV status 
 
Table 4.6 indicates that 107 out of 169 (63.31%; f=107) respondents agreed that 
they know the HIV status of their partners, while 136 out of 169 (80.47%; f=136) of 
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the respondents indicated that their partners know their HIV status. One hundred 
and sixty-nine (169) out of 170 (99.41%; f=169) respondents answered this question. 
One hundred and fifty-four (154) out of 169 (91.12%; f=154) respondents agreed that 
it is their partner‟s right to know their status, while 153 out of 168 (91.07%; f=153) 
agreed that they have a right to know the HIV status of their partners. The 91.12%, 
who agreed that their partners have a right to know their status, correlates with the 
80.47% of partners who know respondents‟ status. Disparity exists were 91.07% of 
respondents agreed that they have the right to know the status of their partners while 
63.31% of the respondents knew the HIV status of their partners. It seems as if the 
respondents‟ partners do not necessarily disclose their HIV status to the 
respondents, even though 80% of respondents disclosed their status to their 
partners. 
 
One hundred and forty-four (144) out of 169 (85.21%; f=144) respondents agreed to 
the importance of their partners knowing their HIV status, and 147 out of 168 (87.5%; 
f=147) disagreed that they do not think it is important that they know their partners‟ 
HIV status. It seems crucial for respondents that both partners in the relationship 
should disclose their status. 
 
According to Alemayehu, et al. (2014:4-5), knowledge of partners‟ HIV status in the 
study conducted in Northern Ethiopia might have helped the women to have 
communication and freedom to disclose their status without fear. Overall, a 63.8% 
disclosure rate of HIV status to their partners was reported in their study. According 
to another Ethiopian study, knowledge of a partner‟s HIV status was significantly 
associated with HIV status disclosure (Alema, et al. 2017:57). In the study conducted 
in Kampala-Uganda, respondents reported that 39% were aware of their spouses or 
partners ever testing for HIV, and 31% reported having known their partners were 
HIV positive (Kiweewa, et al. 2015:3). Knowing the HIV status of their partners had 
an influence on disclosure. One of the components of the HBM is the 
motivating/enabling or modifying factors of HIV status disclosure. Knowledge of 
partners‟ HIV status might motivate the respondents to disclose their status to their 
partners. The number of sexual partners respondents and respondents‟ partners had 
in the last 3-6 months are discussed next. 
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 Number of sexual partners’ respondents and respondents’ partners had in 
the last 3-6 months (N=170) 
 
The findings in Table 4.7 revealed that 3 out of 170 (1.76%; f=3) respondents had no 
sexual partners in the last 3-6 months, as one responded separated from her partner 
and two were widowed. One hundred and sixty-two (162) out of 170 (95.30%; f=162) 
respondents had one partner in the last 3-6 months. Five (5) out of 170 (2.94%; f=5) 
respondents indicated that they had more than one sexual partners. 
 
As indicated in Table 4.8, 148 out of 170 (87.06%; f=148) respondents reported that 
their partners had one sexual partner, while 15 out of 170 (8.82%; f=15) reported 
that their partners had more than one partners. One respondent‟s partner had more 
than four partners, and another one had five partners in the last 3-6 months. This 
type of behaviour may increase the spread of HIV to other partners and increase the 
viral load. 
 
According to Tshibangu-Kalala and Mavhandu-Mudzusi (2014:57), young girls‟ 
cultural beliefs include considering an older man to be more suited to take care of 
many wives, to protect, and provide for a woman‟s necessary needs. This 
encourages young girls to have relationships with older men to get support from 
them. However, this exposes young girls to the risk of contracting HIV infection and 
such a relationship decreases their ability to discuss safe sex, and status disclosure 
is unlikely. 
 
Extra-marital sexual engagements by respondents who were HIV positive in a 
qualitative study conducted by Mamogobo, et al. (2013:41) indicated that 20% of 
respondents continued to have unprotected sex with sexual partners outside of 
marriage. This is consistent with the findings from a study in Soweto, South Africa by 
Longinetti, et al. (2014:3), which indicated that 2.72% of their participants had 2 to 4 
sexual partners. Respondents in this study shared similar findings to the one by 
Tshisuyi and Davis (2014:40), where 92.3% had only one partner, while 7.7% had no 
sexual partners at the time of research. No respondent had more than one sexual 
partner in their study. Having multiple partners in a relationship require consistent 
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condom use to prevent the spread of HIV, and re-infection with new strains of HIV 
diseases to the uninfected partners. 
 
 Condom use (N=170) 
 
Eighty (80) out of 170 (47.06%; f=80) respondents indicated that they sometimes 
use condoms, while 33 out of 170 (19.41%; f=33) always use condoms (Refer to 
Table 4.9). Twenty-five (25) out of 170 (14.70%; f=25) use condoms most of the 
time, 24 out of 170 (14.12%; f=24) never use condoms, and 8 out of 170 (4.71%; 
f=8) rarely use condoms. 
 
It is a matter of concern to the health care workers that 137 out of 170 (80.59%; 
f=137) respondents do not always adhere to safe sex practices, which expose 
respondents, partners and their unborn babies to re-infections that can hamper 
MTCT prevention strategies. In the study conducted in Tanzania by Kiula, et al. 
(2013:5), 58.4% of respondents reported to have used condoms. This study‟s 
findings are also in contrast to Alema, et al‟s. (2017:57) findings where 39.61% 
respondents used condoms. 
 
Selebogo, et al. (2014:84) indicated that 21% of their respondents did have an 
unprotected sexual relationship since their last HIV test, while 78% indicated that 
they adhered to safe sex practices by using condoms since their last HIV test. 
Respondents‟ partners who refused to be tested were also not willing to use 
condoms, even though the women‟s partner(s) were told that they are HIV positive 
(Letsoalo & Madiba 2014:16-18). 
 
According to Dlamini and Mokoboto-Zwane (2015:64), giving health advice on 
disclosure of an HIV status and consistent condom use by partners was important. In 
their study, 28.9% of breastfeeding mothers concealed their HIV status from their 
partners, and 46.7% reported that their partners refuse or complain about condom 
use. This implies that the health care workers should continue to provide counselling 
on disclosure, to prevent re-infections and promote quality life of HIV positive 
patients. Consistent condom use may also prevent unwanted pregnancy. The next 
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section will indicate the number of pregnancies respondents had while being HIV 
positive. 
 
 Number of pregnancies respondents had while being HIV positive (n=136) 
 
The findings in Table 4.10 reveal that 57 out of 170 (41.91%; f=57) respondents 
became pregnant more than once after their initial HIV diagnosis. According to 
Katirayi, et al. (2016:3), in Malawi some of the participants had their first experience 
with HIV medication during their current pregnancy, while other women enrolled in a 
PMTCT programme during previous pregnancies. The acceptance of self and falling 
pregnant while being HIV-positive was also mentioned by Habedi, et al. (2015:79). 
The disclosure of HIV status, acceptance of self, and taking ARVs to protect the 
babies was also indicated (Habedi, et al. 2015:79). Habedi, et al‟s. (2015:79) results 
show the motivators of HIV status disclosure that are supported by the HBM (Polit & 
Beck 2017:124). Participants in Mamogobo, et al‟s. (2013:42) qualitative study show 
that female participants continued to engage in unprotected sex without using 
condoms and some even fell pregnant while they were aware of their HIV positive 
status. These results of Mamogobo, et al. (2013:42) correlate with the findings in this 
study, as 52% of the respondents became pregnant more than once after their initial 
HIV diagnosis. 
 
The study results suggest that the respondents‟ desire to have more babies 
supersedes the respondents‟ health status. These may elude that the respondents 
do not perceive that a threat exists which is caused by non-disclosure of HIV status 
as indicated by the HBM (Polit & Beck 2017:124). The next section will discuss the 
respondents‟ CD4 cell count. 
 
 Number of the last CD4 cell count (n=95) 
 
The CD4 cells are T-helper lymphocytes (a type of white blood cell). These cells play 
an important role in keeping the immune system healthy. The HI virus attaches itself 
to the CD4 receptors on the outer layer of the CD4 cells (van Dyk, et al. 2017:698). 
CD4 cell count is the laboratory test most commonly used to estimate the level of 
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immune deficiency in HIV-infected individuals by counting the CD4+T cells (van Dyk, 
et al. 2017:698). Women with confirmed HIV positive test results are classified 
according to the WHO 2007 clinical stages, and blood results for CD4 cell count and 
serum creatinine collected is used to refer pregnant women to the hospital ARV clinic 
for labour and delivery bookings. In 2015, South Africa started treating HIV-infected 
people in line with the WHO 2007 guidelines adopted in 2013, which was CD4 cell 
count of < 500 cells/ml as compared to CD4 cell count < 350 cells/ml that was used 
before 2013. On 10 May 2016, the South African government removed CD4 cell 
count as an eligibility criterion for ARV treatment. This means that all HIV-infected 
people are to be initiated on treatment as soon as possible after diagnosis (van Dyk, 
Tlou & van Dyk 2017:14). According to Longinetti, et al. (2014:4) 87.4% of their 
respondents had a CD4 cell count > 200 cells/mmᵌ. Eighty-eight point five percent 
(88.5%) had a viral load (VL) < 400 HIV ribonucleic acid (RNA) copies/ml. The 
advanced stage of HIV disease is defined as having a CD4 cell count below 200 
cells/mmᵌ and in their study, 87.4% of individuals had a CD4 cell count more than 
200 cells/mmᵌ (Longinetti, et al. 2014:6). This was an indication that the respondents‟ 
conditions were gradually improving. 
 
In this study, 45 out of 95 (47.37%; f=45) respondents had more than 500 cells/mmᵌ 
CD4 cell count (Refer to Table 4.11). Twenty-seven (27) out of 95 (28.42%; f=27) 
respondents had a CD4 cell count of more than 300 cells/mmᵌ but less than 500 
cells/mmᵌ. Twenty-three (23) out of 95 (24.21%; f=23) respondents had a CD4 cell 
count of less than 300 cells/mmᵌ. Seventy-five (75) out of 170 (44.12%; f=75) did not 
respond to this question. Falling pregnant with a CD4 cell count below 300cells/mmᵌ 
is a risk as a woman‟s immune system is severely compromised (van Dyk 2013:71). 
It is evident in the current study that 24.21% of the respondents‟ health status was 
compromised as they had CD4 cell counts < 300 cells/mmᵌ. According to the study 
conducted in Poland by Kolodzeij (2016:13), stress had detrimental effects on 
participants‟ HIV disease progression and clinical outcomes, including AIDS stage, 
CD4 decline, and AIDS mortality. 
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5.3.2.2 Relationship of the following: age, relationship status, employment 
status and level of education, and disclosure of HIV status to partners 
(N=170) 
 
 The correlation between pregnant women’s age and HIV status disclosure to 
their partners 
 
As indicated in Table 4.12, 41.18% of HIV positive pregnant women who were 
between 18-30 years, and 38.82% who were between 31-40 years were able to 
disclose their HIV status to their partners. Both chi-squares and p-values of the two 
interval years were more or less the same (x2 = 0.1, p-value = 0.71), which were less 
than the critical value of 3.841 (p = 0.05). The p-value of 0.05 is used as a cut-off for 
significance (math 2018). Since p ˃ 0.05, there is not sufficient evidence to reject the 
null hypothesis. The null hypothesis was that pregnant women‟s age does not 
influence HIV status disclosure to partners. In other words, there is no statistically 
significant difference between the ages of the pregnant women (respondents) and 
HIV status disclosure to their partner. 
 
 The association between pregnant women’s relationship status and HIV 
status disclosure to their partners 
 
Table 4.12 indicates that 40% of pregnant women who were in a relationship 
disclosed their HIV status to their partners, 40% of pregnant women who were single 
and 0.59% of pregnant women who were separated reported to have disclosed to 
their previous partners. The chi-square of those in relationship was (x2 = 7.89, p-
value = 0.01), for those who were single it was (x2 = 5.04, p-value = 0.03), and for 
those who were separated it was (x2 = 4.0, p-value = 0.04), which exceeds the critical 
value of 3.841 (at one degree of freedom and alpha level of 0.05). That means all p-
values are < 0.05, therefore there is sufficient evidence to reject the null hypothesis 
(math 2018). The null hypothesis was that there is no difference between pregnant 
women‟s relationship status and HIV status disclosure to their partners. The 
alternative hypothesis was that pregnant women‟s relationship status influenced HIV 
disclosure to their partners. There was sufficient evidence to accept the alternative 
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hypothesis that pregnant women‟s relationship status influence HIV status disclosure 
to partners. 
 
 The relationship between pregnant women’s employment status and HIV 
status disclosure to their partners 
 
Table 4.12 shows that 58.24% of the unemployed HIV positive pregnant women 
disclosed their HIV status to their partners (x2 = 0.23, p-value = 0.65), while 21.76% 
of those who were employed (x2 = 0.57, p-value = 0.51) disclosed their status. Both 
chi-squares of the employed and unemployed HIV positive pregnant women were 
less than the critical value of 3.841 (0.05). The p-values were > 0.05; there is thus 
not sufficient evidence to reject the null hypothesis. The null hypothesis was that the 
pregnant women‟s employment status does not influence HIV status disclosure to 
partners. Therefore, there is no statistical significance between pregnant women‟s 
employment status and HIV status disclosure to their partners. 
 
 The correlation between pregnant women’s level of education and HIV 
status disclosure to their partners 
 
As indicated in Table 4,12, 60% of HIV positive pregnant women who schooled up to 
secondary level disclosed their HIV status to their partners (x2 = 0.07, p-value = 
0.81), and 20% of HIV positive pregnant women who schooled up to tertiary level 
disclosed their HIV status to their partners (x2 = 0.20, p-value = 0.70). The chi-
squares of HIV positive pregnant women who schooled up to both secondary and 
tertiary levels were less than the critical value of 3.841 (0.05). This means that p-
values are > 0.05; there is thus not sufficient evidence to reject the null hypothesis 
(math 2018). The null hypothesis was that there is no difference between pregnant 
women‟s level of education and HIV status disclosure to their partners. Therefore, 
there is no statistically significant difference between pregnant women‟s level of 
education and HIV status disclosure. 
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 The association between disclosure education received by pregnant women 
and HIV status disclosure to their partners 
 
Table 4.12 displays that 77.06% of those who received disclosure education were 
reported to have disclosed their HIV status to their partners, while 2.94% of those 
who did not receive disclosure education disclosed their HIV status to their partners. 
The chi-square of those who received disclosure education was (x2 = 5.84, p-value = 
0.02), and those who did not receive disclosure education was (x2 = 41.44, p-value = 
0.000), which exceeds the critical value of 3.841 (at one degree of freedom and 
alpha level of 0.05). That means p-values are < 0.05; therefore, there is sufficient 
evidence to reject the null hypothesis (math 2018). The null hypothesis was that 
there was no difference between disclosure education received by the pregnant 
women and HIV status disclosure to their partners. The alternative hypothesis was 
that disclosure education provided to pregnant women influence HIV disclosure to 
their partners. There was sufficient evidence to accept the alternative hypothesis that 
disclosure education provided to pregnant women influence HIV status disclosure to 
their partners. 
 
Section C will discuss the motivating/enabling or modifying factors for disclosure. 
 
5.3.3  Section C: The motivating/enabling or modifying factors for disclosure 
 
Section B dealt with sexual and reproductive health information related to 
respondents‟ HIV disclosure. This section will cover the following topics: the 
motivating factors, the benefits of HIV status disclosure, and any other factors that 
motivated the respondents to disclose their HIV status. One of the components of 
the HBM – motivation, which is the desire to comply with treatment – was 
investigated, and the results will be discussed next. 
 
 Motivating/enabling or modifying factors for disclosure 
 
The findings from Table 4.13 revealed that 166 out of 169 (98.22%; f=166) 
respondents agreed that ARVs are available in their health facilities. One hundred 
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and sixty (160) out of 170 (94.12%; f=160) respondents agreed that they should 
adhere to safer sex practices, i.e. by the use of condoms, and 165 out of 169 
(97.63%; f=165) agreed that female condoms are available in their health facilities. 
There were 87 out of 170 (51.18%; f=87) respondents who disagreed that they can 
have another baby after delivery. Pregnant women diagnosed as HIV positive in 
South Africa are given HAART, irrespective of their CD4 cell count (Guidelines for 
Maternity care in South Africa 2015:134). The South African government has made 
provision for the supply of female condoms in most health facilities; the health care 
workers should encourage patients to utilise them as part of disclosure education. 
The health care workers should continue educating the community by whatever 
means they can to prevent re-infections. A limitation of this study is that the 
researcher did not ask the respondents if they use female condoms. Mantell, Smit, 
Exner, Mabude, Hoffman, Beksinska, Kelvin, Ngoloyi, Leu and Stein (2016:7) in the 
study conducted in South Africa reported that 4.7% of respondents reported they had 
used a female condom, whereas 97.6% partners had used male condoms. The 
results indicate that 97.63% of the respondents of this study were aware of the 
availability of female condoms at health facilities in South Africa. However, according 
to the study by Mantell, et al. (2016:7) a very small percentage of 4.7% utilise these 
condoms. Similarly, Chingwaru and Vidmar (2016:30) indicated that the recent fall in 
the prevalence rate and HIV-associated mortality in Zimbabwe was linked to greater 
access to ARTs by eligible HIV-infected individuals. The decline in the prevalence 
rate and mortality was possible as disclosure of HIV status was encouraged during 
ART visits (Chingwaru & Vidmar 2016:30). 
 
Eighty-nine (89) out of 169 (52.66%; f=89) participants agreed that ARVs cure HIV. 
Ninety-three (93) out of 170 (54.71%; f=93) of the respondents agreed that someone 
who is on ARV treatment can transmit HIV. The results from Table 4.13 indicate that 
respondents were motivated to take treatment with the hope that they will be cured 
and not transmit the HIV to their partners. According to the HBM, patients will be 
motivated to disclose their HIV status if they believe that the condition will be 
alleviated. According to van Dyk, et al. (2017:697), ARVs supress or prevent the 
replication of HIV in the cells, however, they do not cure HIV. The suppression of 
HIV infection might motivate the respondents to disclose their status to prevent re-
infections and decrease viral load to improve their health status and reduce the rate 
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of opportunistic infections. On the other hand, ARVs and the suppression of HIV can 
prevent them from disclosing their status as they might feel that they are cured or 
that it will not be necessary to disclose as their health is not deteriorating. The next 
section discusses any other factors that motivated the respondents to disclose their 
status. 
 
 Any other factors that motivated the respondents to disclose their status 
 
Through open-ended questions respondents‟ were asked to indicate what motivated 
them to disclose their HIV status. The following themes and sub-themes emerged: 
 
Theme 1: Motivators for status disclosure 
 
This theme had two sub-themes. 
 
Sub-theme 1.1: Motivated to gain support 
 
Forty-seven (47) out of 77 (61.04%; f=47) respondents indicated that they have 
disclosed their status in an effort to gain support from their partners. 
 
Sub-theme 1.2: Disclosing the because of ill health 
 
Five (5) out of 77 (6.49%; f=5) respondents reported that they were motivated by the 
need to disclose the cause of their ill health to disclose their status to their partners. 
Ninety-three (93) out of 170 (54.71%; f=93) respondents did not indicate any factor 
that motivated them to disclose their HIV status to their partners. 
 
Respondents in Yako and Memeza‟s (2013:83) study concur that major reasons for 
disclosure were fear of dying in isolation with no one being aware of their real health 
problem, and wanting support to be able to deal with HIV/AIDS. Yonah, et al. 
(2014:3) in their study in Mwanza, Tanzania, stated that 25.79% of respondents 
were in need of assistance when they disclosed their HIV status. In contrast to the 
current study, Qiao, et al (2016:74) found that participants were motivated to 
disclose their status to educate others about the facts of HIV infection, for fulfilling 
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personal gains such as ventilating feelings and seeking help, and similar to this 
study, for obtaining support from their partners. The most common findings which 
are similar to this study as supported by Qiao, et al. (2016:74), Yako and Memeza 
(2013:83), and Selebogo, et al. (2014:104) is a need to inform significant others 
about the HIV status to get support. Someone who is ill, needs physical, social and 
financial support from her partner, family members and friends for activities related to 
daily living. That may be the reason why the respondents felt a need to disclose their 
status to their partners to get support. According to the HBM, the desire to comply 
with treatment can motivate the patient to disclose their HIV status to their partner 
because hiding treatment may lead to non-adherence and its complications such as 
re-infection, MTCT, and infecting the partner. The next section centres on the 
benefits of disclosure. 
 
5.3.3.1  The benefits of disclosure 
 
An open-ended question was asked to indicate the benefits of HIV status disclosure. 
The following themes and sub-themes emerged: 
 
Theme 2: Benefits of disclosure 
 
This theme had three sub-themes. 
 
Sub-theme 2.1: Freedom from secrets 
 
Nine (9) out of 60 (15%; f=9) respondents reported that they wanted to feel free 
(Refer to Table 4.15), as hiding the condition may lead to feelings of guilt and 
unwarranted stress. 
 
Sub-theme 2.2: Improved health status 
 
Eighteen (18) out of 60 (30%; f=60) respondents indicated improved health status as 
one of the benefits of disclosure (Refer to Table 4.15). Non-disclosure may lead to ill 
health. 
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Sub-theme 2.3: Encouraging partner testing 
 
Four (4) out of 60 (6.67%; f=4) respondents indicated the benefits of disclosure as 
encouraging their partner to test for HIV (Refer to Table 4.15). Knowledge of the 
partner‟s HIV status is beneficial to both partners, as it will help in the prevention of 
re-infections and MTCT. One hundred and ten (110) out of 170 (64.71%; f=110) 
respondents did not indicate the benefits of HIV status disclosure to their partners. 
 
Yonah et al. (2014:4) reported similar findings as respondents claimed that the 
benefits of disclosure include: 4.8% freedom to use ARVs, 49.2% emotional support, 
and 11.9% financial support. According to Maman, van Rooyen and Groves 
(2014:5), some participants disclosed their HIV status so that their partners can get 
tested, while others also disclosed because they wanted support from their partners. 
 
Kiweewa, et al. (2015:4) concur that 67% of their respondents also received social 
support from their partners, and 25% of respondents‟ partners subsequently 
underwent HIV testing because of the disclosure. The respondents spoke of 
colleagues and managers viewing their HIV status as a non-issue and they had 
interest in their health status, also supporting them and showing empathy (Kiweewa 
et al. 2015:4). Respondents indicated that the benefits of HIV status disclosure in 
Yaya, et al‟s. (2015:6) study include access to health care services offered to people 
living with HIV/AIDS and social support activities implemented by non-governmental 
organisations. One of the components of the HBM‟s perceived benefits that the 
patients believe a given treatment will help prevent illness. The perceived benefits 
that a given treatment will help in the prevention of MTCT and in the advancement of 
the disease, is beneficial enough to encourage the respondents to disclose their 
status to their partners. Respondents care for their partners and want to encourage 
them to undergo HIV testing and start ARV treatment. Even though there are 
benefits to disclosing an HIV status, the health care workers should not ignore that 
the respondents may encounter challenges/barriers. Section D will outline the 
challenges/barriers of HIV status disclosure. 
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5.3.4  Section D: The challenges/barriers and disadvantages of disclosure 
 
Another of the components of the HBM is the perceived barriers of status disclosure. 
The respondents were requested to indicate “strongly agree”, “agree” or “strongly 
disagree” or “disagree” to answer the questions asked. These aspects focused on 
challenges and/or barriers that may inhibit the disclosure of HIV status to take place. 
The following topics were covered: the challenges and barriers of HIV status 
disclosure, any other challenges (barriers) that were not included in those 
mentioned, and disadvantages of disclosure. 
 
 The challenges/barriers of disclosure 
 
Respondents claimed that some of the challenges/barriers of disclosure were related 
to fears (Refer to Table 4.16). Fifty-three (53) out of 160 (33.13%; f=53) respondents 
were afraid of accusations of infidelity. The results in Table 4.16 is consistent with 
the number of respondents who did not disclose their status to their partners as 45 
out of 164 (27.44%; f=45) were afraid that their partners would abandon them. 
Although 70.98% of the respondents‟ partners worked far, 137 out of 163 (84.05%; 
f=137) agreed that they know that they should tell them. However, 33.13% of 
respondents were afraid of accusations of infidelity, 45 out of 164 (27.44%; f=45) 
were worried that their partners would abandon them, and 28 out of 164 (17.07%; 
f=28) indicated that their partners would no longer finance them. This may be an 
indication that the respondents had challenges to disclose their status. 
 
Barriers of disclosure according to van Rooyen and Mhlongo (2015:55-56), unlike in 
this study, included enacted stigma which was the usual reaction from the person the 
participants disclosed their HIV status to. Stigma is a feeling of disapproval that 
people have about a particular illness (Hornby 2015:1486). Respondents also 
witnessed fellow community members being stigmatised when a person was 
identified as being associated with HIV/AIDS, especially women. 
 
Kiweewa, et al. (2015:4) is supported by the current study in that 8% of respondents 
experienced separation/neglect from their partners due to their HIV positive status. 
Nine percent (9%) experienced negative reactions, which included 
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violence/stigmatisation and confidants telling other members of the community. Five 
percent (5%) experienced loss of monetary support. Maman, et al. (2014:447) also 
identified blame, abandonment, and violence as challenges for HIV status 
disclosure. According to Shilovskaya (2015:13-14), isolation at the clinics and 
stigmatisation by parents, family and community members were identified as barriers 
to disclosure. 
 
HIV positive pregnant women in the South African study were expelled from their 
homes by their parents because of their HIV positive status (Habedi, et al. 
2015:116). Another study by Malatji, Makhubele and Makofane (2014:416) alluded 
that relatives and in-laws blamed the participants for the death of their husbands for 
not being faithful. The results are consistent with other studies conducted in South 
Africa. 
 
Unless the challenges/barriers of disclosure are addressed, disclosure of HIV status 
is unlikely to take place and new infections will continue to emerge. 
 
 Any other challenges (barriers) that were not included in those mentioned 
above 
 
This question was phrased as on open-ended question to provide the opportunity to 
triangulate quantitative data with qualitative data. 
 
 Disadvantages of disclosure 
 
The heading on any other challenges (barriers) that were not previously included 
was combined with the disadvantages as it yielded similar results. 
 
The results are based on respondents (n=40) who answered this question. A variety 
of disadvantages/challenges in the disclosure of HIV status to the partner was 
identified. The following themes and sub-themes emerged: 
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Theme 3: Challenges/barriers/disadvantages of status disclosure 
 
This theme had four (4) sub-themes. 
 
Sub-theme 3.1: Fear of rejection 
 
One hundred and thirty (130) out of 170 (76.47%; f=130) respondents did not answer 
the question. Nineteen (19) out of 40 (47.50%; f=19) respondents stated one of the 
fears of disclosure was rejection. The risks of HIV status disclosure to the partners 
include: fear of infidelity, blame, abandonment, rejection, discrimination, and 
disruptions of family relationships, and physical and emotional abuse (Tshweneagae, 
et al. 2015:4). Similar to Letsoalo and Madiba‟s findings, Nyandat and van Rensburg 
(2015:61) in a study conducted in Kenya also reported that 17% of HIV positive 
women did not disclose their status as they had a fear of abandonment, 
discrimination, violence, accusations of infidelity, and denial of social support from 
their partners. 
 
Sub-theme 3.2: Violent response by partner 
 
Seven (7) out of 40 (17.50%; f=7) respondents indicated violent responses with 
aggressive behaviour as a challenge in disclosure of HIV status. Refer to sub-theme 
3.1. 
 
Sub-theme 3.3: Projection of blame by partner 
 
Four (4) out of 40 (10%; f=4) respondents identified a disadvantage of disclosure as 
being blamed by the partners that they brought HIV into their relationships. Refer to 
sub-theme 3.1. 
 
Sub-theme 3.4: Fear of stigmatisation 
 
Ten (10) out of 40 (25%; f=10) respondents reported fear of stigmatisation as a 
disadvantage in disclosing their HIV status to their partners. According to the HBM, 
the focus is on changing the behaviour by encouraging compliance and preventive 
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healthcare practices. Identifying the disadvantages of status disclosure can assist in 
the facilitation of disclosure through disclosure education and self-efficacy that can 
enhance compliance with treatment and condom use as a preventive strategy. Van 
Rooyen and Mhlongo (2015:76-77), in their study conducted in Hlabisa District, 
KwaZulu-Natal, South Africa reported that 7 out of 10 participants indicated that 
living with HIV/AIDS exposed them to stigmatisation. 
 
5.4 CONCLUSIONS 
 
The conclusion of this study will be discussed based on how the objectives of the 
study were met. 
 
5.4.1  The first objective 
 
 Explore and describe the perceived barriers of HIV status disclosure of 
pregnant women to their partners in the Capricorn District, Limpopo 
Province 
 
In this chapter, the findings regarding the perceived barriers of HIV status disclosure 
of pregnant women to their partners were presented. One hundred and fifty-three 
(153) out of 170 (90%; f=153) respondents indicated that they disclosed their status 
to family members, while 17 out of 170 (10%; f=17) respondents did not disclose 
their status to anybody. One hundred and thirty-six (136) out of 170 (80%; f=136) 
respondents disclosed their HIV status to their partners, and 34 out of 170 (20%; 
f=34) did not disclose their HIV status to their partners. It is evident that 80% of 
respondents did not experience barriers of disclosing their status to their partners, 
yet 20% had challenge/barriers in disclosing their HIV status to their partners. 
 
One hundred and thirty-six (136) out of 170 (80%; f=136) respondents do not adhere 
to safe sex practices, and only 33 out of 170 (19.41%; f=33) respondents always use 
condoms. Even though 80% of the respondents disclosed their HIV status to their 
partners, 80% do not adhere to safe sex practices. This statement was supported by 
the fact that 41.91% of HIV positive pregnant women became pregnant more than 
once after their initial HIV diagnosis. 
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There were 45 out of 164 (27.44%; f=45) respondents in this study who indicated 
that their partners might abandon them after disclosure of their HIV status. Most of 
the respondents in this study were single, 94 out of 170 (55.29%; f=94), 121 out of 
170 (71.18%; f=121) of the respondents were unemployed (Refer to Figure 4.2) and 
financially dependent on their partners, which might be a barrier to disclose their 
status to their partners. Some of the respondents alluded to the issue of stigma, 
anger and rejection as disadvantages of HIV status disclosure. The motivators 
(Theme 1) confirmed that 61.04% of the respondents were motivated to disclose 
their status in an effort to gain support from their partners, and 6.49% of the 
respondents were motivated by their ill health to disclose their status to their 
partners. The benefits (Theme 2) indicated that 48.33% of respondents (Refer to 
Table 4.14) needed support from partners, 30% viewed a benefit of HIV status 
disclosure as improving ones‟ health status, and 6.67% claimed it encouraged their 
partners to test. 
 
The HBM postulates that health-seeking behaviour is influenced by a person‟s 
perception of a threat posed by a health problem and the value associated with 
actions aimed at reducing it. The following major components of the HBM formed 
part of the conclusions of this study: perceived susceptibility, perceived severity, 
perceived benefits, perceived costs, motivation and enabling or modifying factors 
(Polit & Beck 2017:124). 
 
 Perceived susceptibility 
 
Perceived susceptibility is a person‟s perception that a health problem is personally 
relevant or that a diagnosis is accurate (Polit & Beck 2017:124). Table 4.3 displayed 
that 100% of the respondents had been diagnosed with HIV between 1 year to more 
than 10 years. This is an indication that they perceive that a health problem exists 
and that the diagnosis was accurate as they received pre- and post-test counselling 
and disclosure education by health care workers. 
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 Perceived severity 
 
Perceived severity is a person‟s perception of the severity of a health problem and 
the serious implications of the problem (Polit & Beck 2017:124). Unless the HIV 
positive pregnant woman perceives the severity of the diagnosis to be high enough 
to have serious implications, status disclosure to the partner is unlikely to happen. 
Respondents may perceive the severity of disclosure as high as the implications are 
linked to physical and social consequences. Disclosure of HIV status to the partner 
can result in financial loss as a physical consequence, and stigma and rejection from 
their community as social consequences. 
 
According to the findings in this study, respondents‟ lack of knowledge on HIV, and 
the incorrect belief that ARVs could cure the disease resulted in them viewing their 
HIV status as less severe. If they think it is curable, it loses perceived severity. As 
the respondents incorrectly believed that ARVs cure HIV, they might have decided 
not to disclose to their partners as they thought they were cured and did not see the 
severity of the illness and the necessity for disclosure. Sixty percent (60%) of the 
respondents had a period of less than a year since they were diagnosed with HIV. 
Eighty-seven point six four percent (87.64%) reported that they received disclosure 
education and 100% stated that the health care workers advised them to disclose 
their HIV status to their partners. The time since diagnosis can relate to the 
perceived severity, as the HIV positive pregnant women come to terms with the 
illness and what it entails. Disclosure education can also create awareness of the 
severity of the illness as they realise that they need to take lifelong ARV treatment. 
Some of the respondents disclosed their status due to the physical consequence of 
their health failing. Therefore, they perceive it as severe. 
 
 Perceived benefits 
 
Perceived benefits are the patients‟ beliefs that a given treatment will cure the illness 
or help prevent it (Polit & Beck 2017:124). The benefits of disclosure (Theme 2) 
indicate that 48.33% of the respondents needed to receive support from partners, 
30% needed improved health status, and 6.67% saw the benefits of their partners 
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testing for HIV. The respondents might benefit from HIV status disclosure to their 
partners by receiving support from partners, improved health status, treatment 
adherence, and partners testing to enhance preventive measures such as, 
consistent condom usage, unwanted/unplanned pregnancies, MTCT, re-infections, 
and the spread of infection to the partner by the respondents. 
 
 Perceived costs 
 
Perceived costs include the complexity, duration, and accessibility of the treatment 
(Polit & Beck 2017:124). Pregnant women who are diagnosed with HIV are to take 
ARVs for the rest of their lives. The ARVs are available free of charge in government 
health facilities. The majority of respondents in this study, 166 out of 169 (98.22%; 
f=166), agreed that ARVs are available in their health facilities. Obtaining and using 
ARVs can enhance status disclosure as the partner might become aware of regular 
clinic visits and additional medicine (ARVs) that the pregnant woman is taking. The 
nature of ARV treatment is lifelong, thus it might enhance status disclosure as the 
partner will become aware, as the ARVs are taken even after the pregnancy. 
 
 Motivation and enabling or modifying factors for status disclosure 
 
According to the HBM (Polit & Beck 2017:124), motivation is the desire to comply 
with treatment. Respondents, who are motivated to adhere to the treatment, are also 
liable to disclose their HIV status and adhere to treatment protocols. Theme 1 stated 
that the motivators of disclosure were: 61.04% of the respondents needed to gain 
support from their partners, and 6.49% were motivated by their ill health to disclose 
their HIV status to their partners. This study further indicates that 98.22% 
respondents agreed that ARVs are available in their health facilities. Respondents 
need support from their partners to cope with the effects of their HIV status and to 
ensure treatment adherence. 
 
One hundred and sixty-nine (165) out of 169 (97.63%; f=165) respondents agreed 
that female condoms are available in their health facilities, and 160 out of 170 
(94.12%; f=160) agreed that they should adhere to safer sex practices, i.e. the use of 
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condoms. The research further indicates that 47 out of 77 (61.04%; f=47) 
respondents needed support from partners, 25 out of 77 (32.47%; f=25) were 
interested in knowing their partners‟ status, and 5 out of 77 (6.49%; f=5) were 
motivated by their deteriorating health. Enabling or modifying factors also include 
aspects of patient satisfaction, which concerns service delivery at ART clinics. 
 
5.4.2 The second objective 
 
 To make recommendations on disclosure education to health care workers 
performing VHCT to enhance the self-efficacy of these women to disclose 
their HIV status to their partners based on the study findings 
 
The health care workers should enhance self-efficacy. Self-efficacy is the belief in 
ones‟ ability to perform a desired behaviour (van Dyk, et al. 2017:189). Respondents 
need to have a strong desire to disclose their HIV status to their partners without fear 
so that the couples are able to adhere to treatment and preventive strategies during 
sexual relations. According to the HBM, the desire to comply with treatment might 
motivate the respondents not to hide their status from their partner. 
 
5.5  LIMITATIONS 
 
The study was conducted with HIV positive pregnant women in the Capricorn 
District, Limpopo Province, therefore, the results may not be generalised to other 
settings of HIV-infected people. One hundred and eighty-six (186) respondents were 
invited to take part in the study, and 171 respondents completed the questionnaires. 
Of the returned questionnaires, 1 was incomplete and discarded, thus the response 
rate was 91.40%, which was high enough to guarantee accurate results. One 
hundred and seventy (170) questionnaires were analysed. The number of 
respondents was a limitation as the topic under study is sensitive. Therefore, some 
of the respondents who were invited to participate in the study were not willing to 
share their private lives with the researcher. An aspect of the HBM (Polit & Beck 
2017:124) is personality as an enabling factor, and patient satisfaction of service 
delivery at ART clinics could have been added to the questionnaire for more depth. 
Only the HIV positive pregnant women were included in the study and the voices of 
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their partners were not heard. The researcher included these aspects as 
recommendations. Utilisation of female condoms was also not investigated in this 
study; therefore, it is recommended that future research should also investigate the 
use of female condoms. 
 
5.6 RECOMMENDATIONS 
 
The study revealed that 80% of respondents did not have barriers of HIV status 
disclosure as they disclosed their HIV status to their partners, while 20% did not 
disclose. For HIV to be prevented and for mortality/morbidity to decrease, every HIV 
positive pregnant woman should be encouraged to disclose her status to her partner. 
Status disclosure can be enhanced through disclosure education to strengthen the 
self-efficacy of the HIV positive pregnant women. However, clinical practice, 
education on HIV disclosure, and further research on this topic need to be 
conducted. 
 
5.6.1  Clinical practice 
 
ARVs are available and accessible in all public health facilities in Limpopo Province, 
therefore pregnant women need to make an effort to visits them earlier to be 
screened for HIV. 
 
 The health care workers in Capricorn District, Limpopo Province should provide 
pre-pregnancy HIV screening to women who plan to fall pregnant to reduce 
complications of pregnancy, as time is an important factor in HIV status 
disclosure. A more extended duration on ARVs led to an increased 
tendency/likelihood to disclose HIV status among people living with HIV/AIDS in 
this study. 
 All partners should be encouraged to attend antenatal clinics with their pregnant 
partners to facilitate couple counselling as the p-values of those who were in a 
relationship, single, and separated were < 0.05. There was sufficient evidence to 
reject the null hypothesis. The null hypothesis was that there is no difference 
between relationship status of pregnant women and HIV status disclosure to their 
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partners. The alternative hypothesis was that relationship status of pregnant 
women influenced HIV disclosure to their partners. There was sufficient evidence 
to accept the alternative hypothesis that the relationship status of pregnant 
women affects HIV status disclosure to their partners. 
 The health care workers should continue to advise/encourage pregnant women to 
disclose their status to their partners at each clinic visit. Disclosure education 
should be an on-going process and not a once-off information giving. 
 The health care workers should provide information to pregnant women on CD4 
cell count, viral load and management/treatment of HIV during antenatal visits. 
 The health care workers should provide information to the pregnant women on 
MTCT and prevention strategies. 
 The health care workers should enhance self-efficacy, defined as the belief in 
ones‟ ability to perform a desired behaviour, e.g. to insist on condom use or to 
adhere to antiretroviral treatment (van Dyk, et al. 2017:189). The HIV positive 
pregnant women are required to have a strong belief in themselves to disclose 
their HIV status to their partners without fear. This will enhance respondents‟ 
adherence to safe sex practices with the use of condoms every time they engage 
in sex and taking treatment without interruptions. 
 The health care workers should discuss the perceived susceptibility and severity 
with the pregnant women as part of the post-test counselling and disclosure 
education. Any misconceptions need be addressed and it should be ensured that 
the HIV positive pregnant woman must take ownership of her status by sharing it 
with her partner. She should also understand her diagnosis and believe that it is 
accurate. 
 The health care workers can ensure that the HBM‟s enabling/modifying factors 
are addressed. The following enabling factors are to be covered: support from the 
partners, availability of condoms/treatment in health facilities, and ill health. The 
health care workers should make sure that HIV positive pregnant women are 
satisfied with the service delivery at the ART clinics. 
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5.6.2  Education 
 
Education relates to disclosure education and in-service training by the health care 
workers. The p-values of the disclosure education received against HIV status 
disclosure was < 0.05. The null hypothesis was rejected as there was a statistically 
significant difference between relationship status and HIV status disclosure to their 
partners. 
 
 Health care workers in the Capricorn District, Limpopo Province, should offer the 
HIV positive pregnant women disclosure education and highlight the importance 
of adherence to ARVs whenever they come to collect treatment to facilitate 
adherence to treatment. 
 The health care workers should re-educate the community of Capricorn District 
about the importance of condom use to prevent re-infection and transmission of 
HIV during their meetings to prevent the spread of the disease. 
 Health care workers should re-educate the Capricorn District communities about 
the benefits of disclosure and the impact of stigmatisation by the utilisation of 
stakeholders like Chiefs, politicians and the media. 
 The Department of Health should draw educational guidelines for HIV status 
disclosure that should be used during routine counselling and testing by health 
care workers. 
 Health care workers should facilitate or refer pregnant women who are HIV 
positive to support groups. Fears relating to status disclosure can be discussed in 
a safe and supportive environment. 
 The Department of Health should facilitate in-service training for health care 
workers on the application of the HBM in HIV counselling of pregnant women as 
discussed under the practice recommendations. 
 
5.6.3  Future research contributions 
 
 To investigate the trend of stigmatisation and its impact on society. 
 The views of the respondents‟ partners on ARVs were not heard and therefore 
further research could be conducted that includes respondents‟ partners. 
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 Pregnant women‟s satisfaction with service delivery at ART clinics should be 
researched. 
 It seems as if the respondents are aware of the availability of condoms, but the 
role of condom use in safe sex practices related to disclosure of HIV status needs 
to be explored in future research in more depth. 
 Condoms use by pregnant women, including female and male condoms, should 
be investigated. 
 
5.7  CONCLUDING REMARKS 
 
Recommendations were made on disclosure education for health care workers 
performing VHCT with HIV positive pregnant women, to enhance the self-efficacy of 
these women to disclose their HIV status to their partners based on the study 
findings. 
 
The perceived barriers of HIV status disclosure of pregnant women to their partners 
in this study were explored, presented and analysed. The purpose of this study was 
to investigate the perceived barriers of HIV status disclosure of pregnant women to 
their partners in the Capricorn District, Limpopo Province, to enhance disclosure of 
their HIV status to their partners. Disclosure can be enhanced through disclosure 
education and self-efficacy of these pregnant women. A quantitative, descriptive 
research design was used. A previously tested questionnaire was utilised with the 
permission from the developers to compile and collect data. Respondents were 
selected through non-probability (convenient and purposive) sampling. 
 
The study revealed that even though resources are available for the HIV positive 
pregnant women to disclose their HIV status to their partners, some challenges still 
exist. Lack of self-efficacy and an inability to apply the HBM might lead to MTCT of 
HIV, re-infection, transmission of HIV to the partner, and non-adherence to 
treatment, which can lead to mortality and morbidity. The study revealed that the p-
values of those who were in a relationship, single and separated were < 0.05. The 
null hypothesis was rejected since there was statistically significant difference 
between relationship status and HIV status disclosure to their partners. Health care 
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workers have a duty to invite respondents‟ partners to accompany the women to the 
clinic to enhance partner support. 
 
The study assisted the researcher to understand the challenges/barriers pregnant 
women deal with in the disclosure of HIV status to their partners. The provision of 
treatment by the Department of Health is commendable. Early diagnosis of HIV can 
enhance access to HIV/AIDS care that improves disclosure, which might assist in 
reducing new infections. Health care workers could be enlightened about the health 
care needs of their patients, which include re-education regarding the actions of the 
ARVs to enhance adherence to treatment. 
 
Even though the South African government provide treatment for HIV positive 
patients, adherence to the ARV drugs may be problematic with non-disclosure. The 
study revealed that 20% of the respondents had barriers of disclosing their HIV 
status to their partners as 80.58% respondents did not always use condoms, thus 
PMTCT was not adhered to. This revealed that p-values of the disclosure education 
received against HIV status disclosure were < 0.05. The null hypothesis was 
rejected. The null hypothesis was that that there was no difference between 
disclosure education received by the pregnant women and HIV status disclosure to 
their partners. The alternative hypothesis was that disclosure education provided to 
pregnant women influence HIV disclosure to their partners. There was sufficient 
evidence to accept the alternative hypothesis that disclosure education provided to 
pregnant women influence HIV status disclosure to their partners. 
 
Health care workers should be made aware of the importance of their role in 
disclosure education and in facilitating HIV status disclosure to partners. The health 
care workers should also disseminate the disclosure information to community 
members through awareness campaigns to reduce the number of new infections and 
stigma of the HI virus. Women are the cornerstone of society. Self-efficacy can guide 
them to disclose their status as the key components of the HBM is applied during 
disclosure education provided by health care workers. Disclosing their HIV status is 
crucial in breaking the silence and increasing prevention strategies to reduce MTCT 
and HIV-related mortality. 
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ANNEXURE A 
APPROVAL FROM THE HIGHER DEGREE COMMITTEE, 
UNIVERSITY OF SOUTH AFRICA: RESEARCH AND ETHICS 
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ANNEXURE B 
LETTER OF SEEKING CONSENT FROM THE DEPARTMENT OF 
HEALTH: LIMPOPO PROVINCE 
 
 
Enq: Seroto M. E          P. O Box 284     
Student N0:33878560        Lenyenye      
Cell N0: 08 297 3267        0857 
 
Head of Department  
Limpopo Department of Health 
 
Sir/Madam   
 
Re: Request for the use of HIV positive pregnant women to collect data (Master of Arts in 
Nursing Sciences).  
 
1. The above matter refers. 
2. Mapula Seroto student N0: 33878560, is conducting academic research study and is 
attached to the University of South Africa. The research study is for the Masters in Nursing 
Science.   
3. The title of the research study is “Perceived barriers of HIV status disclosure of pregnant 
women to their partners in Capricorn District, Limpopo Province”. 
4. Kindly, we are requesting the Department of Health to allow Mapula to collect data from 
HIV positive pregnant women within Mankweng, Pietersburg and Seshego Hospitals. 
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5. To verify and/or confirm the details kindly contact my supervisor of this research as 
follows: Dr. ES van Rensburg, Tel NO: 012 429 6545, Cell NO: 073 787 0896, Email 
address: jvrenes@unisa.ac.za.  
 
Your approval to conduct this study will be greatly appreciated. 
 
Yours Faithfully  
Seroto Mapula Ennia 
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ANNEXURE C 
APPROVAL FROM THE LIMPOPO DEPARTMENT OF HEALTH 
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ANNEXURE D 
APPROVALS FROM THE FACILITIES’ SUPERVISORS 
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ANNEXURE E 
APPROVAL FOR THE USE OF THE QUESTIONNAIRE  
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ANNEXURE F 
DATA COLLECTION INSTRUMENT (PRE-TEST) 
 
SECTION A: SOCIO-DEMOGRAPHIC CHARACTERISTICS 
PLEASE ANSWER THE FOLLOWING QUESTIONS BY PLACING AN (X) ON THE 
RELEVANT BLOCK. ALTERNATIVELY FILL IN THE BLOCK. MARK ONE ITEM PER 
QUESTION 
 
1. How old are you? (in years) 
 
 
2. What is your religion? 
 
Christian Hindu Moslem 
 
Other (please specify) 
______________________________________________________________ 
3. What is your marital status? 
Married Single Separated Divorced Widowed 
  
4. How long where you married/cohabiting? 
˃2yrs ≤2yrs 
         
5. How many children do you have? (Please indicate in the box) 
 
 
6. How far pregnant are you? 
≥ 3months 4 – 6 months 6 months+ 
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7. Where did you grow up? 
Rural Urban 
8. Do you drink alcohol? 
Yes No 
 
9. If “Yes” what is your drinking pattern? 
Occasionally Every weekend Every 
month  
When 
stressed 
 
      Other (please specify)......................................................................................... 
 
10. What is your employment status? 
Employed Self-employed Unemployed  
 
11 How can you relate your level of education? 
Never been to school Primary school  High school Tertiary  
 
12. How can you relate your partner‟s level of education? 
Never been to school Primary school  High school Tertiary  
 
13. Who is the head of the household? 
Father  Mother  Brother  Sister  Husband  Self 
 
14. Is there someone in your family who is HIV positive? 
Yes No I do not know 
 
 
 
SECTION B: SEXUAL AND REPRODUCTIVE HEALTH INFORMATION. 
 
Indicate to what extend you agree/disagree on the following regarding your 
disclosure. 
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15. How long ago were you diagnosed with HIV for the first time? 
 
 
16. How long after the diagnosis of HIV did you disclose your status? 
 
Same day >7 days >1 month >5 months Not yet 
 
  
17. Did you receive disclosure education? 
Yes No 
 
 
18. How best can you describe your feelings when you discover that you were 
pregnant (latest pregnancy)? 
Disappointed  Frustrated Shocked Relieved  
 
Other (please specify)............................................................................. 
 
19. When did you disclose your HIV status? 
Immediately after 
HIV positive 
diagnosis  
After one 
month after 
the HIV 
positive 
diagnosis 
After six month 
after the HIV 
positive 
diagnosis 
After a year after 
the HIV positive 
diagnosis 
Did not 
disclose 
 
 
20. If you have disclosed your status, please specify to whom did you disclose your 
status? (write in the box) 
 
 
21. Have you ever disclosed your HIV positive status to your partner? 
Yes No 
 
22. How was your partner‟s reaction to your status? 
Angry Silence Ignore Afraid Acceptance Supportive Rejection Secretive 
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23. What is your partners HIV status? 
Positive Negative Unknown 
 
24.  How often do you use condom?  
Never Rarely Sometimes Always  
 
25. Have you ever experience sexual assault? 
Often Sometimes Never 
 
26. How many times did you fall pregnant while you are HIV positive  
One time Two times Three times 
 
Other (please specify)…………………………………………………. 
27. How much was your last CD4 cell count? 
Less than 300 Less than 500 More than 500 
 
SECTION C: THE MOTIVATING AND ENABLING OR MODIFYING FACTORS: 
Item 
NO 
Answer the following questions by ticking either YES or NO: “Y = 
YES, N = NO ”  
Y N 
28. Can a mother infect her unborn child if not taking ARV treatment?   
29. Have you had sexual activity with another person besides your partner 
during the past three months? 
  
30.  Are you ARV‟s?   
31. Do you think ARV‟s can cure HIV?   
32. Can someone who is on ARV‟s transmit HIV?   
33. Do you and your partner adhere to safer sex practices? i.e. by the use   
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of condoms? 
34. Do you know that there is female condom?   
35. Did your partner offer emotional support during disclosure of your 
status? 
  
36. After delivery of your baby, do you still want another baby?      
37. Do you think disclosure is important?   
 
38. Please indicate any other factors that motivated you to disclose your status that were not 
included in those mentioned above?  
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________ 
 
SECTION D: THE CHALLENGES/BARRIERS. 
 
Indicate to what extend you agree/disagree with challenges of disclosure in HIV 
positive status.  
Key: SA = Strongly Agree, A =Agree, U = Uncertain, D = Disagree,  
SD = Strongly Disagree. 
WHAT PREVENTS YOU FROM DISCLOSING YOUR STATUS? 
 SA A U D SD 
39. I am afraid of accusations of infidelity.      
40. I am afraid that my partner will abandon me.      
41. My partner will beat me.      
42. I am not working, so my partner will no longer finance 
me. 
     
43. My partner will throw me out of the house.      
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44. My partner works far      
45. My partner will think I am unfaithful.      
46. My partner might assault me.      
47. My partner may tell others.      
48. I do not know that I should tell my partner.      
 
49. Please indicate any other challenges (barriers) that were not included in those 
mentioned above: 
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________ 
 
Thank you for your time and effort. 
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ANNEXURE G 
QUESTIONNAIRE: FINAL DATA COLLECTION INSTRUMENT 
 
SECTION A: SOCIO-DEMOGRAPHIC CHARACTERISTICS 
Please answer the following questions by placing an (x) on the relevant block. 
Alternatively fill in the block. Mark one item per question. 
 
1. How old are you? (in years) 
 
 
2. What is your religion? 
Christian Hindu Moslem 
 
Other (please specify) ____________________________________________ 
 
3. What is your marital status? 
Married Single Separated Divorced Widowed Cohabiting polygamy 
  
4. How long are you with the current partner? 
 
         
5. How many children do you have? (Please indicate in the box) 
Alive  Deceased  
 
6. How far pregnant are you? 
≥ 3months 4 – 6 months 6 months+ 
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7. Where did you grow up? 
Rural Urban 
 
 
8. What is your employment status? 
Employed Self-employed Full time Part time Unemployed  
 
9. How can you relate your level of education? 
No 
education  
Non-formal 
education 
Primary 
school  
Secondary  
school 
College 
 
University 
 
 
10. How can you relate your partner‟s level of education? 
No 
education 
Non-formal 
education 
Primary 
school 
Secondary  
school 
College 
 
University 
 
 
11. Who is the head of the household? 
Father  Mother  Brother  Sister  Husband  Self 
 
 
SECTION B: SEXUAL AND REPRODUCTIVE HEALTH INFORMATION. 
 
Please answer the following questions by placing an (x) on the relevant block. 
Alternatively fill in the block. Mark one item per question. 
 
12. How long (in months) ago were you diagnosed with HIV? 
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13. Do you know anyone who is HIV positive? 
Yes No I do not know 
 
14. Did you disclose your status after diagnosis?   
Yes  No  
 
15. If yes, indicate in the table below after how many days/months/years were you 
able to disclose your diagnosis? 
Same day  
Less than a month  
Between 1 to 3 months  
Between 4 to 6 months  
Between 7 to 12 months  
Between 1 to 3 years  
Between 4 to 5 years  
More than 5 years  
Not yet  
 
16. If you have disclosed your status, please specify to whom did you disclose your status? 
(Write in the box) 
 
 
17. Did you receive disclosure education? 
Yes No 
 
18. Who performed the disclosure education? 
 
 
19. Were you advised by the health care worker to disclose the status? 
Yes No 
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  20. Did the person you know disclose her/his status? 
Yes  No 
 
21. Have you ever disclosed your HIV positive status to your partner? 
Yes No 
 
22. Indicate in the table below your partner‟s reaction to your status by stating if  
    you strongly agree, agree, uncertain, disagree or strongly disagree.          
  Key: SA = Strongly Agree, A =Agree, U = Uncertain, D = Disagree,  
  SD = Strongly Disagree. 
 
Partner’s reaction to your HIV status  SA A U D SD 
Disappointed in me      
Judgmental towards me      
Caring and supportive towards me      
Accepted me      
Rejected me      
Ignored me      
     
 23. Indicate with the table below your partner(s) HIV status by stating if you 
  strongly agree, agree, uncertain, disagree or strongly disagree. 
  Key: SA = Strongly Agree, A =Agree, U = Uncertain, D = Disagree,  
  SD = Strongly Disagree. 
 
Partners’ HIV status SA A U D SD 
I know the HIV status of my partner      
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My sexual partner(s) know my HIV status      
It is the right of my partner(s) to know my HIV 
status 
     
I have a right to know the HIV status of my 
partner(s) 
     
I do not think it is important that my partner(s) 
know my HIV status 
     
I do not think it is important that I know my 
partner(s)‟ HIV status 
     
 
24. How many sexual partners have you had in the last 3-6 months? 
None  1 2 3 4 5 More than 5 
 
25. How many sexual partners have your partner had in the last 3-6 months? 
None  1 2 3 4 5 More than 5 
 
26. How often do you use condom?  
Never Rarely Sometimes Most of the time Always  
 
27. How many times did you fall pregnant while you are HIV positive?  
One time Two times Three times More than three times 
 
Other (please specify)…………………………………………………. 
28. How much was your last CD4 cell count? 
Less than 300 300 ≤ but ≥ 500 More than 500 
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SECTION C: THE MOTIVATING AND ENABLING OR MODIFYING FACTORS: 
29. Indicate the motivating and enabling or modifying factors of disclosure by stating if you 
strongly agree, agree, uncertain, disagree or strongly disagree. 
Key: SA = Strongly Agree, A =Agree, U = Uncertain, D = Disagree,  
SD = Strongly Disagree. 
 
The motivating factors of disclosure SA A U D SD 
ARVs are available in your health facility      
ARV‟s cure HIV      
Someone who is on ARV‟s can transmit HIV      
You and your partner should adhere to safer sex 
practices i.e. by the use of condoms 
     
Female condom is available in your health facilities      
You can still have another baby after delivery      
Disclosure is important to you and your partner      
 
30. Please indicate any other factors that motivated you to disclose your status that were not 
included in those mentioned above?  
_______________________________________________________________________
___________________________________________________________ 
31. What are the benefits of disclosure? 
_______________________________________________________________________
___________________________________________________________ 
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SECTION D: THE CHALLENGES/BARRIERS. 
 
32. Indicate to what extend you agree/disagree with challenges (barriers) of disclosure in 
HIV positive status. Tick in the below if you strongly agree, agree, uncertain, disagree or 
strongly disagree.  
Key: SA = Strongly Agree, A =Agree, U = Uncertain, D = Disagree,  
SD = Strongly Disagree. 
Challenges of disclosure HIV status disclosure SA A U D AD 
I am afraid of accusations of infidelity.      
I am afraid that my partner will abandon me.      
My partner will beat me.      
I am not working, so my partner will no longer finance 
me. 
     
My partner will throw me out of the house.      
My partner works far      
My partner may tell others.      
I do not know that I should tell my partner.      
 
33. Please indicate any other challenges (barriers) that were not included in those       
mentioned above: 
_________________________________________________________________ 
34. What are the disadvantages of disclosure? 
_________________________________________________________________ 
     
     Thank you for your time and effort. 
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ANNEXURE H 
INFORMATION LEAFLET AND CONSENT FORM 
 
INFORMATION LEAFLET 
 
Title of the study: Perceived barriers of pregnant women diagnosed as HIV positive towards 
disclosure of their HIV status to their partners in Capricorn District, Limpopo Province. I 
Mapula Seroto, student at UNISA am interested in investigating the perceived barriers of 
HIV positive pregnant women towards disclosure of their HIV status to their partners. 
 
The purpose of the study was to find out more about how pregnant women diagnosed as 
HIV positive see disclosure of their HIV status to their partners in Capricorn District, Limpopo 
Province to increase disclosure of their HIV status to their partners and improve their health.  
 
The researcher was interested in HIV positive pregnant women who are attending ARV 
clinics from 18 to 40 years. All women in this age range who attend ARV clinics during the 
data collection period will be invited to participate in the study. A self-administered 
questionnaire was completed by the respondents, which took 15 to 30 minutes. No risks 
were involved in the study, however if the respondent feel emotionally upset, she could talk 
to the researcher and be referred to a psychologist for free counselling at the ARV clinic for 
support.  
 
The information the respondent provided remained confidential and her name would not be 
disclosed at any time. Participation in the study was voluntary and no incentives or 
remuneration were provided. The findings from the study would be published in national and/ 
or international journals to create awareness of this topic. The respondents were to contact 
the researcher if there are further questions: Mapula Seroto, Nursing Sciences student. Cell 
Nr: 0832973267.   
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INFORMED CONSENT FOR THE RESPONDENT 
 
I hereby give consent to voluntary participate in this research study. I have read and 
understand the above information. I understand that participation is voluntary and that I can 
refuse or withdraw from this study if I so wish. In agreeing to complete a self-administered 
questionnaire, I provide informed consent. 
 
Respondent (full names): ………………………Signature: ……………Date: ………… 
Researcher‟s signature: ……………………..Date: ……………… 
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ANNEXURE I 
CERTIFICATE FROM THE LANGUAGE EDITOR 
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ANNEXURE J 
TURNITIN REPORT INTERPRETATION 
 
Turnitin Report – 30 May 2018 
 
Assistance was asked from Matshidiso Pooe (Turnitin training at Unisa) with the 
interpretation of the 26% similarity index. 
 
Interpretation as follows: 
„The overall 26% similarity index is the percentage of material overlap of the sources 
the student used, not plagiarism. All sources are duly acknowledged. There is not a 
problem with the highest source of 2%. 
The bibliography was not excluded for submission.‟ 
 
The full report is available on request. 
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TURNITIN REPORT 
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ORIGINALITY REPORT 
%26    %21        %9        %15 
SIMILARITY INDEX     INTERNET SOURCES    PUBLICATIONS            STUDENT PAPERS 
PRIMARY SOURCES 
1. scholar.sun.ac.za          %2 
     Internet Source 
2. ulspace.ul.ac.za            %1 
     Internet Source 
3. Submitted to University of Stellenbosch, South Africa    %1 
    Student Paper 
4. Submitted to Laureate Higher Education Group     %1 
     Student Paper 
5. www.ncbi.nlm.nih.gov         %1 
     Internet Source 
 
 
